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論文題目 
Formulation and characterization of micro/nanoemulsion systems 
encapsulating vitamins and phytochemicals using conventional and 
microchannel emulsification 
(機械的乳化及びマイクロチャネル乳化を利用したビタミン・ファイトケミカル
を内包したマイクロ・ナノエマルションの作製及び特性評価) 
 
 
The deficiency of micronutrients regarded as “hidden hunger” affects more than one-third of the world’s 
population, resulting devastating consequences for public health, social development and future of country. 
Vitamins and phytochemicals have a role in health beyond basic nutrition. These functional ingredients are 
very sensitive towards environmental stresses like heat, light and oxidation. Moreover, numerous 
physiological factors limit their usage in food and pharmaceutical products. The research focuses on the 
encapsulation of vitamins and phytochemicals in different emulsions and microspheres using microchannel 
and conventional emulsification systems. Moreover, the research also evaluates the physical and chemical 
stability of encapsulated vitamins and phytochemicals.  
The first part of thesis deals with the encapsulation of L-ascorbic acid (L-AA) in different systems. 
The study in chapters 2 and 3 aimed to formulate monodisperse food-grade water-in-oil-in-water (W/O/W) 
 ix 
emulsions and aqueous microspheres containing a high concentration of L-AA. The W/O/W emulsions 
were prepared using homogenization and subsequent microchannel emulsification (MCE). The asymmetric 
straight-through microchannel (MC) array constitutes numerous 10×100 µm microslots with a 30 µm 
depth, each connected to a 10 µm-diameter circular MC with a 70 µm depth. Monodisperse W/O/W 
emulsions containing W/O droplets with average diameters (dav) of 26.0 to 31.5 μm and coefficient of 
variations (CVs) below 10% were successfully formulated via an asymmetric straight-through MC array at 
a low hydrophobic emulsifier concentration, regardless of L-AA concentration. The dav represents the 
average of the diameters of all the droplets in the emulsion sample. The W/O droplets dispersed in these 
monodisperse W/O/W emulsions were physically stable in variation of dav and CV for more than 10 d of 
storage at 4 oC. The monodisperse W/O/W emulsions also exhibited L-AA encapsulation efficiency (EEL-
AA) exceeding 80% during storage. Stable monodisperse aqueous microspheres containing high 
concentrations of L-AA (up to 30% (w/w)) with different concentrations of sodium alginate and MgSO4 
were generated using MCE. The aqueous microspheres generated from the MCs under optimized 
conditions had a dav of 14 to 16 µm and a CV of less than 8% at the disperse phase pressures of 5 to 15 kPa. 
The L-AA loaded microspheres were physically stable in terms of their dav and CV for >10 d of storage at 
40 oC. The aqueous microspheres exhibited EEL-AA exceeding 70% during the evaluated storage period. 
Chapters 4 and 5 aimed to conduct comparative studies with conventional emulsification devices 
to encapsulate L-AA in the dispersed phase of W/O and W/O/W emulsions. W/O emulsions with EEL-AA 
greater than 95% were prepared using rotor-stator homogenizer at 7000 rpm for 5 min. The prepared W/O 
emulsions under this operating conditions had dav of 2.0 to 3.0 μm and CV of 13% to 22%. All the W/O 
emulsions were stable for more than 30 d at 4 oC or 25 oC with slight increase in dav and without phase 
separation. Their EEL-AA was 50% at 4 oC and 30% at 25 oC after 30 d of storage. Two-step homogenization 
was conducted to prepare W/O/W emulsions containing L-AA.  First-step homogenization prepared W/O 
emulsions with a dav of 2.0 to 3.0 m. Second-step homogenization prepared W/O/W emulsions with an 
average W/O droplet diameter of 14 to 18 μm and CVs of 18% to 25%. The results indicated that stable 
W/O/W emulsions containing a high concentration of L-AA were obtained by adding gelatin and MgSO4 in 
the inner aqueous phase and glucose in both aqueous phases. EEL-AA in the W/O/W emulsions was 40% on 
day 30 and followed first-order kinetics. 
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The second part of study encapsulates different forms of vitamin D. Chapter 6 deals with 
formulation of food grade O/W emulsions loaded with ergocalciferol (VD2) by MCE. The primary 
characterization was performed with grooved type MCE, while storage stability and vitamin D 
encapsulation efficiency was performed with straight through MCE. The grooved type MC array plate used 
has channel depth of around 5 m and channel width of about 18 m, while asymmetric straight-through 
MC array consists of numerous 10×80 µm microslots each connected to a 10 µm diameter circular MC. 
Monodisperse O/W emulsions with Sauter mean diameter (d3,2) of 33.9 m with relative span (RSF) width 
less than 0.20 (CV in between 5-10%) were successfully formulated via an asymmetric straight-through 
MC array. The d3,2  represents the diameter of a droplet having the same area per unit volume as that of the 
total collection of droplets in emulsions. The O/W droplets were physically stable for more than 15 d of 
storage at 4 oC without any significant increase in d3,2. The monodisperse O/W emulsions also exhibited 
VD2 encapsulation efficiency (EEVD2) of more than 85% during storage period. Chapter 7 deals with 
encapsulation of both VD2 and cholecalciferol (VD3) in food-grade O/W emulsions using asymmetric 
straight-through MCE. 1% (w/w) sodium cholate or Tween 20 in water was used as the continuous phase, 
while 0.5% (w/w) of each VD2 and VD3 in different oils served as the dispersed phase. Monodisperse O/W 
emulsions with d3,2 of 28 to 32 µm and RSF widths below 0.3 were formulated via an asymmetric straight-
through MC array under appropriate operating conditions. The monodisperse O/W emulsions stabilized 
with Tween 20 remained stable for >30 d with EEVD2 and EEVD3 of above 70% at 4 and 25 oC. In contrast, 
those stabilized with sodium cholate had stability of >30 d with EEVD2 and EEVD3 of over 70% only at 25 
oC.  
Chapter 8 deals with cross comparative studies with conventional homogenization techniques to 
encapsulate vitamin D. Both VD2 and VD3 at 0.5% (w/w) was encapsulated in refined soybean oil, olive oil 
and MCT. The phosphate buffer (pH 7) containing 1% (w/w) Tween 20 served as a continuous phase. The 
two liquid phases were emulsified with a homogenizer at 5,000 to 20,000 rpm for 5 min or the 
homogenizer at 7,000 rpm for 5 min plus a microfluidizer in a single pass at 100 MPa. The 
microfluidization produced the O/W emulsions with a volume mean diameter (d4,3) of 0.41 m and a RSF 
width of about 1.9. The d4,3 represents the diameter of a droplet having the same volume in total weight of 
emulsions. The emulsions prepared at the high homogenization speeds and by microfluidization maintain 
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liquid consistency and whitish color after 30 d of storage period. In contrast, those prepared at the low 
homogenization speeds were quickly destabilized after 1 d of storage. During the storage, there was no 
significant difference in d4,3 of the O/W emulsions prepared with the microfluidizer in comparison to d4,3 of 
the O/W emulsions prepared with the homogenizer. There was little effect of homogenization speed on 
release profile of the vitamin D-loaded O/W emulsions. The EE of both VD2 and VD3 became less than 
70% after 10 d of storage and less than 10% after 30 d of storage at 4 oC. 
The third part of research is to encapsulate phytochemicals and include quercetin, -oryzanol and 
-sitosterol. Chapter 9 encapsulates quercetin in different food-grade O/W emulsions stabilized by different 
emulsifiers. 1% (w/w) Tween 20, sodium cholate, decaglycerol monolaurate, polyglyerol-5-laurate or 
bovine serum albumin in Milli-Q water was used as the continuous phase, while 0.4 mg mL-1 in different 
oils served as dispersed phase. Successful emulsification was conducted with all emulsifiers. The produced 
monodisperse droplets have d3,2 of 28 to 34 µm with span width below 0.25. The d3,2 slightly decreased at 
25 oC, while increased d3,2 was observed in emulsions stabilized by sodium cholate at 4 oC. The emulsions 
stabilized with 1% Tween 20 have quercetin EE of 80% and 70% at 4 and 25 oC respectively. Chapter 10 
encapsulates a slight high concentration of -sitosteroland -oryzanol in different food-grade oil O/W 
emulsions using MCE. A 24 × 24-mm MCE chip (WMS 1-4) containing 23,348 straight-through MCs was 
used for this study. 1% (w/w) Tween 20 or decaglycerol monolaurate (ML-750) in Milli-Q water was used 
as the continuous phase, while 0.5-4% (w/w) -sitosteroland -oryzanol in MCT served as dispersed phase. 
Successful emulsification was conducted with different concentrations of -sitosteroland -oryzanol. The 
d3,2 of 1% (w/w) -sitosteroland -oryzanol loaded emulsions ranged between 26 to 28 µm with span width 
below 0.21 at Qd of  2 mL h-1 after 30 d of storage at 4 and 25oC. The O/W emulsions stabilized with 
Tween 20 have -sitosterol and -oryzanol EEs above 80% at 4 and 25oC, in comparison to the emulsions 
stabilized with ML-750 have EE of -sitosterol over 80% and -oryzanol EE above 50% at 4 and 25oC. 
  The research indicate that MCE is a promising technique for encapsulating vitamins and 
phytochemicals, with superior control of processing parameters and various other physical and chemical 
conditions. The forthcoming scaling up of MCE devices is expected to further improve the quality of 
different emulsions and make practical their production on industrial scales. 
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Health and safety are considered to be the prime factors for food industries and worldwide the number 
of functional foods are increasing at rapid rate. The functional foods improves the health promoting 
properties of polyunsaturated lipids, omega-3 fatty acids, phytochemicals, vitamins etc. However, the 
major challenges in incorporating these compounds in food matrix are their susceptibility towards 
oxidative deterioration, unpleasant odour, hydrophobicity and many more. These factors affect the 
organoleptic and sensory properties of the foods in which they are incorporated.   
1.1 Functional foods 
The recent trends in food and nutritional science proves that diet plays a significant role in 
maintaining health and homeostasis of body. The term ‘‘functional food’’ itself was ﬁrst used in Japan, 
in the 1980s, for food products fortiﬁed with special constituents that possess advantageous 
physiological effects 1). Functional foods not only satisfy hunger but also provide vital nutrients for 
mitigation of many diseases. However, there is no clear definition of functional foods. Technically, 
these are defined as foods that have a potentially positive effect on health beyond basic nutrition 1). In 
last decade (Fig. 1.1), there was more than 50,000 publications that describes functional attributes of 
these functional foods.  The global market of functional food is estimated to at least 33 billion US$ 2). 
Other experts like Sloan 3) has calculated the global functional food market to be 47.6 billion US$, 
being the United States the largest market segment, followed by Europe and Japan. Some estimations 
report even more global market value (nearly 61 billion US$) 4). Functional foods include many 
nutritive compounds which offer some kind of health benefits to consumers. These vital ingredients 
includes antioxidants, vitamins, phytochemicals, fish oil for omega 3 and omega 6 fatty acids, soy 
isoflavones, probiotics, co-enzymes and many micro-minerals.  
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Figure 1.1: The functional foods development in terms of scientific publications from 2000-2013. 
The values are obtained from Thomson reuters “ISI Web of Knowledge” search engine. 
1.2 Delivery systems for food ingredients  
The incorporation of functional compounds into food matrix has many challenges. These functional 
food ingredients are susceptible to degradation due to environmental stress conditions like temperature, 
humidity, light, oxygen and its interaction with other food ingredients and therefore lose their 
bioactivity and nutritive value. Different nutrient delivery systems like emulsification and 
encapsulation are prime tools to deliver these important nutrients in different food and pharmaceutical 
systems with good efficiencies. These systems encapsulates vital nutrients in form of emulsions, 
microspheres, solid lipid nanoparticles (SLNs) and many more 5). In recent decade numerous 
emulsification devices have been developed to encapsulate functional nutrients, each of these devices 
has numerous advantages and disadvantages 5). The choice of particular device depends upon 
production method, volume of materials to be homogenized, droplet size distribution and required 
physicochemical properties of final products 6). Recently, microfluidic devices have getting more 
popularity in comparison to conventional devices on the basis of energy and encapsulation efficiencies. 
Microfluidic devices produce monodisperse emulsions and limits the process of Ostward ripening and 
flocculation 7). The better stability and physicochemical properties of monodisperse emulsions have 
attracted various industries to produce valuable emulsion products like functional microparticles, 
nanoparticles and multiple emulsions 8).  
 27 
1.3 Emulsions  
Emulsion is a two-phase system of two immiscible liquids, in which low mass fraction liquid is 
dispersed as small spherical droplets and scientifically called as dispersed phase and the phase present 
in large mass fraction called as continuous phase. The simplest example of emulsion is oil-in-water 
(O/W) emulsion like milk and water-in-oil (W/O) emulsion like margarine.  
Emulsions are characterized on the basis of droplet sizes as micro or macro emulsions. The 
droplet sizes of emulsions generally range somewhere from 0.1 to 100 m 9). Emulsions are 
thermodynamically unstable and destabilization mechanisms can be observed as sedimentation and 
skimming due to density differences, droplet aggregation and coalescence 10). The stability of 
emulsions are govern by various factors like emulsion composition, strength of emulsifiers, 
emulsification devices and other physicochemical parameters 10). It is also possible to formulate 
multiple emulsions like water-in-oil-in-water (W/O/W) and oil-in-water-in-oil (O/W/O) emulsions 11). 
Multiple emulsions are designed for controlled or sustained drug delivery, bioavailability enhancement, 
enzyme immobilization and taste masking 11-13). 
1.4 Emulsification devices  
The emulsification devices are characterized into mechanical and microfluidic devices. The most 
common mechanical devices include rotor-stator homogenizers, static mixers colloid mills, high-
pressure homogenizers and ultrasonic homogenizers 6). Laminar, turbulent and cavitational flows 
driven by shear forces are common mechanism in these conventional devices 14, 15). The droplet 
distribution depends upon the amount of shear forces incorporated into emulsion fluids and further 
driven by interfacial forces and Laplace pressure16). The brief explanation of these mechanical devices 
are reviewed below.   
1.4.1 Mechanical emulsification devices 
Rotor-stator homogenizers (Fig. 1.4.1a) Rotor-stator (RS) homogenizers have practical applications in 
food, chemical, cosmetics and biochemical industries. RS homogenizers are used to produce 
dispersions like adhesives, pesticides, lattices, food ingredients and dairy products.  RS are referred as 
high shear mixers with rotating blades and have capacity to generate shear value of 104-105 s-1. RS 
homogenizers ranges from 1 to >1000 L in volume and usually operate from 50 to 20,000 rpm (rotation 
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per minute) depending upon unit operations in industries. Mixing in the RS is initiated when energy 
imparted by the rotating blades pushes the coarse emulsion up the mixing head and forces the emulsion 
through narrow clearances between the rotor blades and stator. The mixture is pushed axially from the 
rotating blades towards the gaps in the stator, where it is subjected to a chaotic environment and a 
number of stresses such as turbulence, cavitation, shear and elongational, causing droplet breakage 17). 
Emulsification with the rotor stator requires constant recirculation in the high shearing zones and the 
efficiency of recirculation is a fundamental problem that has received plenty of attention. The emulsion 
droplets formulated through RS homogenizer typically have droplet diameters between 1.5 to 10 m. 
Static mixers (Fig. 1.4.1b) Static mixers (SM) are motionless elements inserted in tubes or pipes. SM 
induce flow in the radial direction creating plug flow conditions with very little back mixing. The 
elements are very compact and they range in size from a few millimeters up to meters in diameter 
depending on the application 18). There are variety of SM available in industries and mostly differ in 
geometry, but operate in a relatively similar fashion. Mixing performance in SM is easily predicted 
based on flow rate, viscosity, density, percentage of mixture components and pipe dimensions 19). 
Moreover, mixing effect depends on the continuous separation, distribution, and reunion of particles in 
the stream of material SM have the advantage over other mixers because they are cheaper for use (loss 
of energy expenses), and they are very easy to install and to clean 19). The emulsion droplets formulated 
through SM typically have droplet diameters between 4 to 20 m. 
Colloid mills (Fig. 1.4.1c) are the devices used to reduce the particle size of a solid in suspension in a 
liquid. It basically work on the principle of RS homogenizer. Colloid mills (CM) are suitable for 
emulsification with fluids having velocities greater than 20 mPa s 14). In CM the coarse emulsion is 
passed through a narrow gap between the rotor and the stator. A rotor turns at high speeds of 3000 – 
20000 rpm. The high levels of hydraulic shear applied to the process disrupt structures in the fluid 15). 
CM produces emulsions with droplet diameter in between 1 to 5 m with throughput capacity up to 
20,000 L h-1. 
High pressure homogenizers (Fig. 1.4.1d) are widely used in the dairy industry for the homogenisation 
of milk and milk products. In high pressure homogenizer (HPH), a coarse emulsion is forced through a 
narrow gap(s), resulting in velocities of up to hundreds of m s-1 at high pressure ratings (5 - 500 MPa) 
and flow rates (10-10000 L h-1) 20). Velocity is driven by a pressure gradient dependent on the gap size 
of the flow channel and the pump. Cavitation, turbulent and laminar shear cause droplet breakage in the 
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active region. However, a deeper understanding of the dominant mechanism(s) is difficult to ascertain 
with confidence due to the high flow velocities within the narrow gap, which makes accurate 
measurements and models which estimating the velocity flow fields very difficult 21). 
Ultrasonic homogenizers (Fig. 1.4.1e) are devices well-suited for laboratory scale experiments due to 
its simplicity and ease of operation 22). Ultrasonic homogenization (UH) is a fairly quick and simple 
technique but has significant drawbacks preventing commercialisation, such as large energy 
requirements per unit volume and tremendous heat loss17). The mechanism of droplet breakage during 
emulsification using ultrasonication is attributed to intensified mechanical vibrations in the probe 
which create pressure waves in the emulsion that leads to the formation of bubbles 23). Commercial UH 
produces emulsions with throughput capacity up to 300,000 L h-1 with ultrasonic frequencies ranging 
between 20 to 50 kHz. 
1.4.2 Microfluidic emulsification devices 
Microfluidic devices produces energy efficient monodisperse emulsions. Various researchers 
investigated microstructured devices, like T or Y shaped junctions 24, 25), flow focusing devices 26), 
membrane emulsification devices 27) and microchannel emulsification devices 28). The brief explanation 
of these microfluidic devices are reviewed below. 
T or Y junctions (Fig. 1.4.2a) shows the simplest microfluidic structure for producing droplets and 
bubbles in T junctions 29-33). In standard geometry, the main channel carries the continuous phase and 
the dispersed phase is injected through the inlet channel. The shear stress generated by the continuous 
phase causes the tip of the dispersed phase to distort in the downstream direction until the neck of the 
dispersed phase breaks up into a droplet 34-36). It has been found that both monodispersed O/W and 
W/O emulsions can be prepared in the same T-junction device, by choosing appropriate surfactants in 
the oil or aqueous phase 37).  
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Figure 1.4.1: Schematic presentation of typical mechanical emulsification devices. (a) rotor-stator 
homogenizer, (b) static mixers, (c) colloid mill, (d) high pressure homogenizer and (e) ultrasonic 
homogenizer.  
 
In a Y-junction, the dispersed and continuous phases are injected through two separate inlet 
channels and the emulsion is removed using a common outlet channel (Fig. 1.4.2b). The size of the 
droplets formed in Y-junction is independent on the flow rate and viscosity of the dispersed phase 38), 
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which is a behaviour different to that in a T-junction. The typical droplet size regime in T or Y 
junctions range between 5 to 30 m. 
Microfluidic flow focusing devices (Fig. 1.4.21c) shows the typical planar microfluidic flow focusing 
device (MFFD) developed by Anna et al. 39). In MFFD devices, the droplets are generated in coflowing 
streams and forced through a small orifice which is known as hydrodynamic flow focusing 40-42). Drop 
generation in MFFDs take place with four different flow regimes i.e. squeezing, dripping, jetting and 
tip-streaming 43).  
Membrane emulsification Membrane emulsification (ME) is a process that forms emulsion by injecting 
a dispersed phase or premix through a microporous membrane into the continuous phase (Fig. 1.4.2d). 
In the former case, fine droplets are produced directly at the membrane/continuous phase interface, 
whereas in the latter case, pre-existing droplets are homogenised by passing premix through the 
membrane 27). A microporous glass membrane called Shirasu porous glass (SPG) membrane was 
originally used as emulsification device44). The droplet size in ME largely depends upon membrane 
pore size 44). Typical monodisperse droplets are produced with coefficient of variation (CV) less than 
10% 27). ME requires relative small shear stress and low energy input (104-106 J m-3) to prepare 
emulsions than conventional emulsification devices (106-108 J m-3) 45). Variety of materials are used to 
conduct membrane emulsification for production of O/W or W/O emulsions. These includes uniform 
porous glass 44), polypropylene hollow fibres 27), ceramics 46), polytetrafloroethylene 47) and silicon 
nitride 48). The surface of membrane must be completely wetted with continuous phase for production 
of monodisperse emulsions. Based upon geometry there are variety of membrane emulsification like 
dead end type 49), cross flow type 50), vibrating type 48) and rotating type membrane emulsification 51). 
The most widespread application of ME is in synthesis of particles through solidification of droplets 50). 
ME can be used to produce particles from a wide variety of organic and inorganic materials, including 
hydrogels, polymers, inorganic oxides, metals and solid lipids 27).  
Microchannel emulsification  The term MCE was coined by Kawakatsu et al. 52) and has capacity to 
form monodisperse emulsion droplets by using microchannel (MC) arrays precisely fabricated on 
single-crystal silicon microchip 52) or stainless steel microchips 53). These MC arrays can be fabricated 
as microgrooves horizontally to the microchip surface (Fig. 1.4.2e (i))52) or vertically as straight-
through microholes (Fig. 1.4.2e (ii))54). The grooved microchips exhibits low droplet productivity due 
to limited number of MCs but extremely productive in elucidating droplet generation behavior in MCs. 
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The straight-thorough microchips consist of several hundreds of thousands of MCs and have 
monodisperse droplet productivity even at dripping regime of 50 mL h-1 54).  
 Sugiura et al. 55) proposed interfacial tension-driven droplet formation mechanism form the 
channels with an elongated section. The model for predicting droplet diameter in MCE was also 
presented and is based on droplet formation mechanism and on experimental observation 56, 57). 
Monodisperse emulsion droplets with diameters of 1 m to 500 m and coefficient of variation below 
5% have been successfully formulated through MCE 27). The MCE has been used to produce many 
encapsulated dispersions with improved properties such as  β-carotene 58), oleuropein 59), γ-oryzanol 60), 
L-ascorbic acid 61) and ascorbic acid derivatives 62).  
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Figure 1.4.2: Schematic presentation of typical microfluidic emulsification devices. (a) T-
junction, (b) Y-junction, (c) flow focusing device, (d) membrane emulsification and (e) 
microchannel emulsification (MCE), (i) grooved type MCE (ii) straight through MCE.  
1.6 Micronutrient deficiencies  
1.6.1 Vitamins 
The deficiency of essential vitamins and minerals are regarded as “hidden hunger” and it affects more 
than one-third of the world’s population, threaten women and children, resulting devastating 
consequences for public health, social development and future of country. These micronutrient 
deficiencies contribute significantly to the burden of disease and linked to adverse functional outcomes 
such as stunting, wasting, increased susceptibility to infections during pregnancy, decreased IQ level, 
cognitive losses, blindness, and premature mortality. The major micronutrient malnutrition issues 
affecting populations in developed and developing countries addressed in the WHO Guidelines are 
shown in Table 1.1. The thesis focuses on the encapsulation of vitamin C and D. The brief overview of 
these vital vitamins are highlighted below. 
 34 
Vitamin C (Fig. 1.6.1a) shows the structural presentation of vitamin C, and this vitamin is also regarded 
as L-ascorbic acid. vitamin C market is segmented into dietary supplements, cosmetic formulations, 
animal feed fortification and food and beverage products. Vitamin C is also regarded as dietary intake 
of vitamin C 63). It is present in many leafy vegetables and fruits, noticeably in guava, orange, apple, 
strawberry, kiwi, capsicum, pawpaw and cauliflower 64). The importance of vitamin C is seen clearly in 
scurvy, a life-threatening vitamin C deficiency disease that results in loss of energy, depression, mood 
disorders, poor wound healing, and connective tissue disorders, culminating in death 65). Vitamin C 
plays an important role in formation of collagen (in bones, teeth and cartilage) and activation of various 
enzymes related nervous system, and detoxification of drugs in liver. Similarly, this vitamin increase 
the bioavailability of iron, calcium and folic acid 66). Vitamin C reduce aging process in human and 
brighten the skin by boasting immune system and stimulate the formation of bile in the gallbladder 67).  
 
Table 1.1: Vitamin deficiency conditions and their worldwide prevalence. Adapted from Allen et 
al. 68) 
 
Micronutrient Deficiency Prevalence Major Deficiency Disorders 
Folate  
(Vitamin B6) 
Insufficient data Megaloblastic anemia, neural tube and other 
birth defects, heart disease, stroke, impaired 
cognitive function, depression 
Cobolamine 
(Vitamin B12) 
Insufficient data Megaloblastic anemia (associated with 
Helicobacter pylori induced gastric atrophy 
Thiamine  
(Vitamin B1) 
Insufficient data, 
estimated as common in 
developing countries and 
in famines, displaced 
persons 
Beriberi (cardiac and neurologic), Wernicke 
and Korsakov syndromes (alcoholic confusion 
and paralysis) 
Riboflavin  
(Vitamin B2) 
Insufficient data, est. to 
be common in developing 
countries 
Non-specific-fatigue, eye changes, dermatitis, 
brain dysfunction, impaired iron absorption 
Niacin  
(Vitamins B3) 
Insufficient data, 
estimated as common in 
developing countries and 
in famines, displaced 
persons 
Pellagra (dermatitis, diarrhea, dementia, death) 
Vitamin B6 Insufficient data, 
estimated as common in 
developing countries and 
in famines, displaced 
persons 
Dermatitis, neurological disorders, 
convulsions, anemia, elevated plasma 
homocysteine 
Vitamin C Common in famines, 
displaced 
persons 
Scurvy (fatigue, hemorrhages, low resistance 
to infection, anemia) 
Vitamin D Widespread in all age 
groups, low exposure to 
ultra violet rays of sun 
Rickets, osteomalacia, osteoporosis, colo- 
rectal cancer 
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Vitamin D (Fig. 1.6.1b) shows different structural forms of vitamin D and this vitamin plays a vital role 
in maintaining and developing healthy skeletal system, since it maintains calcium level in the body. 
Deficiency of vitamin D results in increased risk of diabetes, hypertension, cancer and autoimmune 
diseases 69-72). Broad spectrum deficiencies of vitamin D includes rickets in children, osteomalacia in 
adults and osteoporosis in women, all of these lead to softening and weakening of bones 73-75).   
Vitamin D is synthesized in the skin and involves the phytochemical conversion of provitamin D by the 
action of ultra-violet (UV-B) rays 76, 77). The terminology and classification related to vitamin D is 
confusing and can be classified into 5 different forms and metabolites, among these vitamin D2 
(ergocalciferol) and D3 (cholecalciferol) are important (Fig. 1.6.1b (i, ii)) 78, 79). Both forms of vitamin 
D are converted to 25-hydoxyvitamin [25-(OH)D] in the liver. The quantification of 25-(OH)D in 
blood gives the quantitation of vitamin D status. A cutoff value of 30 ng/mL is sometimes used for 
optimal vitamin status 79).     
 
(a) 
 
 
(b) 
  
 
Figure 1.6.1: Structural illustration of vitamins used in research work. 
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1.6.2 Phytochemicals  
Phytochemicals are a large group of plant-derived compounds responsible for disease protection. These 
compounds are present in diets high in fruits, vegetables, beans, cereals, and plant-based beverages 
such as tea and wine 80). This diverse group comprises of phenolic acids, flavonoids, stilbenes, lignans 
and phytosterols 80). Among these diverse groups, flavonoids are the most extensively studied group. 
Research suggest that this group contributes to the reduced mortality rate in people consuming high 
level of plant based foods 81). Due to the lack of food composition data, the Standing Committee on the 
Scientific Evaluation of Dietary Reference Intakes and Its Panel on Dietary Antioxidants and Related 
Compounds of the Food and Nutrition Board at the Institute of Medicine chose not to create a Dietary 
Reference Intake (DRI) for these compounds and a recommended intake for phytochemicals does not 
currently exist 82). Table 1.2 shows potential health benefits from some of the phytochemical 
compounds.  
 
Table 1.2: Potential health benefits of some of the phytochemicals  
 
Food Phytochemical Health benefit 
Soybeans, soy milk, and 
tofu 
Isoflavones Reduction in blood pressure 83)  
Strawberries, red wine, 
blueberries 
Anthocyanins Improve vision, decreased platelet aggregation 
and neuroprotective effects 83) 
Red wine, grape juice, 
grape 
extracts, cocoa 
Proanthocyanidins and 
favan-3-ols 
Reduction in plasma cholesterol, inhibition of 
proinflammatory responses 83) 
Garlic, onions, leeks, 
olives, 
scallions 
Sulfides, thiols Decrease in low density lipoproteins 84) 
Carrots, tomatoes, and 
tomato 
products, and various types 
of 
fruits and vegetables 
Carotenoids, lycopene, -
carotenes 
Neutralization of free radicals 84) 
Broccoli and other 
cruciferous 
vegetables such as kale, 
horseradish 
Isothiocyanates Neutralization of free radicals, protection 
against cancer 85) 
 
This thesis focus on three important phytochemicals i.e. quercetin, -oryzanol and -sitosterol. The 
detail functionality of these compounds are highlighted in chapter 8 and 9. The brief description 
regarding their health benefits are reviewed below. 
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Quercetin (Fig. 1.6.2a) shows the structural presentation of quercetin (3,3’,4’,5,7-
pentahydroxyflavanone) and quercetin is categorized as a flavonol and belongs to the family of 
flavonoids 86). Flavonols are present in variety of fruits, vegetables, seeds, flowers and nuts 87). These 
are also abundant in variety of medicinal plants like Ginko bioloba, Solanum trilobatum and many 
others 88). Most of the dietary intake is as flavonol glycosides of quercetin, kaempferol and myricetin 
89). Quercetin exhibit a wide range of biological activities, including anti-oxidant, anti-cancer, anti-
toxic, anti-thrombotic, anti-aging, metal chelating and anti-microbial activities 88, 90-92). Similarly, it has 
impact on obesity, sleep and mood disorders 88, 93). Recently, quercetin is used in many sport 
supplements in order to reduce post-exercise immune system perturbations 94). 
-oryzanol (Fig. 1.6.2b) is a naturally occurring component in rice bran and rice germ which consist of 
a mixture of ferulic acid esters of sterols and triterpene alcohols 95). There are increasing number of 
reports indicating the benefits, efficacy and safety of γ-oryzanol. The antioxidant effect of -oryzanol 
was well documented and excellent in inhibiting lipid peroxidation.  Kanno et al. 96) reported that -
oryzanol (0.5% ~1%) inhibited thermal oxidative polymerization of soybean oil. Wilson et al. 97) 
reported that -oryzanol reduced plasma cholesterol in hypercholesterolemic hamsters. There are 
number of clinical studies reported that -oryzanol is beneficial in the treatment of relieving 
menopausal (climacteric) symptom 98). 
-sitosterol (Fig. 1.6.2c) is a predominant phytosterol found in higher plants and as well as in human 
foods 99). -sitosterol is the most extensive studied phytosterol due to its role in hypercholesterolemia 
100), cardiovascular diseases 101) and benign prostatic hyperplasia 102). β-sitosterol is used in a variety of 
enriched commercial foods such as fruits juice, milk, yoghurt and spreads. Safety concerns regarding 
the use of β-sitosterol have been well addressed in different in vivo and clinical studies 103, 104). 
(a) 
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(b) 
 
(c) 
 
Figure 1.6.2: Structural illustration of phytochemicals used in research work. 
1.7 Potential reasons for encapsulation of vitamins and phytochemicals  
Vitamins and phytochemicals have a role in health beyond basic nutrition. These functional ingredients 
are very sensitive towards environmental stress like heat, light and oxidation. Moreover, numerous 
physiological factors limit their usage in food and pharmaceutical products. Vitamin C can undergo 
reversible oxidation reactions 105). Moreover, the chemical properties of vitamin C allow it to react with 
a wide variety of potentially harmful reactive oxygen species. The environmental factors such as 
temperature, pH, oxygen, metal ion, UV and x-ray also affect the stability 106, 107). Vitamin C is highly 
oxidative which can cause a problem in food systems. In the processing stage, it can change color from 
whitish to yellowish which in turns destabilized the system. The challenges associated with vitamin D 
fortiﬁcation and encapsulation are: poor water solubility; chemical degradation when exposed to light, 
oxygen, or elevated temperatures; and variable oral bioavailability 108, 109). The main disadvantages of 
using quercetin and phytosterols in therapeutics and functional foods are, poor solubility in aqueous 
and oil medium, crystallization behavior at ambient and body temperatures, poor permeability and low 
bioavailability 110-112), degradability at high temperatures 113) and and moisture contents 114). 
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Recent developments toward the encapsulation of functional ingredients have focused mostly 
on optimizing encapsulation techniques, coupled with the use of natural ingredients to improve the 
functionalities and applications 115). In recent decade numerous delivery systems have developed to 
improve the stability and functionality of functional ingredients. These includes solid lipid 
nanoparticles, microspheres, gel microbeads, giant vesicles, and many others. All of these systems have 
its own advantages and disadvantages, but these technologies gave boom to market, in 2013 sales of 
vitamins and phytochemical encapsulated supplements in the United Kingdom totalled £ 674.6 million, 
a growth of about 16% over the previous five years 116).  
1.8 Objective of thesis 
The primary objective of this thesis was to formulate and characterize different dispersion systems 
encapsulating vitamins and phytochemicals using different homogenization techniques. One of the 
most important objective of emulsion science is to get extremely monodisperse emulsion droplets with 
minimum thermal impact on finished product. This monodispersity can be achieved using microfluidic 
devices that requires a low energy inputs (< 105 -106 J m-3). MCE is a promising techniques to produce 
monodisperse emulsions just by spontaneous transformation of interfaces. Previous literature points out 
the droplet generation mechanism in different MCE devices in detail but there is gap in elucidating the 
physical and chemical stabilities of emulsion droplets encapsulating vital bioactives in these MCE 
devices. The thesis focuses on the optimization, generation characteristics, physical and chemical 
stabilities of various bioactives in MCE. The other objective of this thesis was to encapsulate a slightly 
high concentration of bioactives in MCE. The outcome of this objective will help in designing new 
products containing a slight high amount of functional compounds that could be the replacers of high 
energy drinks or chemical supplements. The secondary objective of this thesis was to conduct a 
comparative study for evaluating physical and chemical stability of emulsion droplets encapsulating 
bioactives formulated with conventional emulsification and MCE.  
1.9 Structure of thesis  
The thesis is structured as shown in Fig. 1.9. The introduction briefly explained the emulsion devices 
and important of various bioactives in human health. The introduction also highlights the importance of 
encapsulation for bioactives. The chapter 2 to 5 deals with the encapsulation of vitamin C (L-ascorbic 
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acid) in different dispersion systems formulated either with conventional devices or MCE. The chapter 
6 to 8 shows the encapsulation of different forms of vitamin D in different dispersion systems 
formulated with MCE and high pressure homogenization. The chapter 9 and 10 deals with 
encapsulation of quercetin, -oryzanol and -sitosterol in O/W emulsions using MCE. The last chapter 
summarizes the conclusions and future perspectives of MCE. 
 
 
Figure 1.9: Structural presentation of thesis and bioactives used in research work. 
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Chapter 2  
 
Monodisperse W/O/W emulsions encapsulating L-ascorbic acid: 
Insights on their formulation using microchannel emulsification and 
stability studies* 
 
 
 
 
 
 
 
 
 
________________________________________________________________________ 
*This chapter has been published as Khalid N, Kobayashi I, Neves M, Uemura K, Nakajima M, 
Nabetani H. Monodisperse W/O/W emulsions encapsulating L-ascorbic acid: Insights in their 
formulation using Microchannel emulsification and stability studies. 2014. Colloids and Surface A: 
Physicochemical and Engineering Aspects. Vol. 458, no. 8, p. 69-77. 
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2.1 Introduction 
Double emulsions are complex polydisperse systems in which water-in-oil and oil-in-water emulsions, 
which are stabilized by lipophilic and hydrophilic emulsifiers respectively, simultaneously exists 1). 
These emulsions can further be categorized as water-in-oil-in-water (W/O/W) and oil-in-water-in-oil 
(O/W/O). O/W/O emulsions have limited applications in food and bio-industries 2). In contrast, W/O/W 
emulsions are useful for producing lower-calorie encapsulated products than traditional oil-in-water 
(O/W) emulsions because part of the oily dispersed phase is replaced by aqueous droplets 3). W/O/W 
emulsions have interesting applications in numerous industries, especially pharmaceutical industries for 
developing targeted drug delivery systems 4) and cosmetics and food industries for encapsulating 
flavors, therapeutics, and nutritional compounds 1, 5). 
To date, two-stage emulsification has been adopted to produce W/O/W emulsions using a variety 
of production techniques 6). Traditional emulsification devices include rotor-stator homogenizers (e.g., 
colloid mills, toothed-disk dispersing machines, and stirred vessels) and ultrasonic and high-pressure 
homogenizers 7). The formation of W/O/W emulsions by rotor-stator homogenizers incorporates 
intense energy in the system because of vigorous external forces, resulting in a broader droplet size 
distribution with polydispersity 8). The resultant emulsions usually have a coefficient of variation (CV) 
exceeding 20%. The typical droplet diameters are 1 to 10 µm for rotor-stator blenders, 1 to 5 µm for 
colloid mills, and 0.1 to 1 µm for high-pressure homogenizers 7). Membrane emulsification (ME) 9), 
microchannel emulsification (MCE) 10), and microfluidic emulsification (MFE) using different types of 
geometries 11) have been developed over the last two decades to produce monodisperse emulsions with 
narrow size distributions. All of these emulsification devices have their own benefits and limitations, as 
stated in a recent review 12). Major advantages of these emulsification techniques include the generation 
of uniform droplets, the precise control of droplet size and shape, and in situ microscopic monitoring 
(unusual for ME) that allows fine tuning of the process parameters during droplet generation 12).  
Kawakatsu et al. 13) introduced MCE, an advanced and promising technique that is capable of 
generating uniformly sized droplets with average diameters of 1 to 500 µm and CVs of <5%. MCE 
works on the droplet generation mechanism driven by spontaneous transformation of the liquid-liquid 
interface on the terrace that exploits interfacial tension dominant on a micron scale 14). This droplet 
generation requires no external shear force and minimum energy input (typically 103 to 104 J m-3) 14). 
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Microchannel (MC) arrays fabricated for MCE are classified as grooved MC arrays (each consisting of 
parallel MCs with slit-like terraces outside them) 13) and straight-through MC arrays (each consisting of 
two-dimensionally positioned through-holes) 15, 16). The droplet generation via each grooved MC array 
can be easily judged with direct microscopic observation, whereas straight-through MC arrays are 
advantageous for producing monodisperse emulsions at higher droplet productivity. Kobayashi et al. 
recently produced monodisperse O/W emulsions at a maximum droplet productivity of 1.4 L h-1 17).  
Various food-grade materials (e.g., refined vegetable oils, a medium-chain triglyceride oil, 
hydrophilic and hydrophilic emulsifiers, proteins, and hydrocolloids) have been examined for 
producing monodisperse O/W, W/O, and W/O/W emulsions by MCE 18). Monodisperse W/O/W 
emulsions can be produced by a two-step emulsification process: high-pressure homogenization 
followed by MCE 19, 20). Similarly, MCE has also been used to produce monodisperse microdispersions 
(e.g., solid lipid microspheres 21), gel microbeads 22), and giant vesicles 23)). MCE has promising 
potential for producing uniformly sized oil droplets containing such functional lipids as β-carotene 24) 
and γ-oryzanol 25). However, further investigation and optimization of the MCE process are needed in 
order to encapsulate hydrophilic compounds in aqueous droplets. 
L-AA is a powerful antioxidant because of its capacity to neutralize free radicals 26). The 
chemistry, functions, metabolism, bioavailability, and effect of processing have been comprehensively 
reviewed 27, 28). L-AA (vitamin C) is also important in minimizing the risk of serious diseases (e.g., 
heart disease, cataracts, improving the immune system and cancer). The recommended intake of L-AA 
is 30 to 40 mg per day, but some studies extend this limit to 250 to 1000 mg per day. L-AA is naturally 
present in many fruits and vegetables; however, exposure to high temperature during cooking and 
processing, moisture, oxygen, pH, and light deteriorate its antioxidant activity and thus results in the 
formation of toxic compounds 29). 
Encapsulation of bioactive compounds in W/O/W emulsions is an emerging technology that has 
undergone intensive research in recent years. Lack of stability of W/O/W emulsions is a major problem 
because of the presence of two thermodynamically unstable interfaces. Their stabilization requires two 
different emulsifiers: one with a low hydrophilic lipophilic balance (HLB) for stabilizing the water-oil 
interface and another with a high HLB for stabilizing the oil-water interface. A variety of processes can 
be utilized to encapsulate L-AA (e.g., spray drying 30), spray chilling 30), and extrusion 31)). L-AA can 
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also be encapsulated in different formulations (e.g., liposomes 31), W/O and W/O/W emulsions 32, 33), 
and nanoparticles). Despite the advantages of each of these techniques, no single stabilization method 
is available for different food-processing environments due to lack of long term storage stability and 
rapid decline in encapsulation efficiency. 
The objective of this study was to develop a novel method for preparing monodisperse W/O/W 
emulsions that encapsulate a high concentration of hydrophilic bioactive compound by using a two-
stage process including asymmetric straight-through MCE. We encapsulated L-AA, a model 
hydrophilic bioactive compound, in W/O/W emulsions at a high concentration up to 30% (w/v). We 
also analyzed the stability of the resultant W/O/W emulsions and the retention profile of L-AA 
encapsulated in them.  
2.2 Materials and methods 
Materials 
Refined soybean oil was purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).  Milli-Q 
water with a resistivity of 18MΩ cm was used to formulate all aqueous-phase solutions. L-AA (99.9% 
purity), D(+)-glucose, magnesium sulfate, gelatin, disodium hydrogen phosphate dodecahydrate 
(sodium phosphate, dibasic), sodium dihydrogen phosphate dehydrate, and HPLC grade methanol were 
purchased from Wako Pure Chemical Industries, Ltd. Tetraglycerin monolaurate condensed ricinoleic 
acid ester (CR-310, HLB: <1) was procured from Sakamoto Yakuhin Kogyo Co., Ltd. (Osaka, Japan). 
Decaglycerol monolaurate (Sunsoft A-12, HLB: 12) was supplied by Taiyo Kagaku Co., Ltd. 
(Yokkaichi, Japan). All the chemicals were of the highest grade available and were used without 
further purification. 
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Figure 2.1: Schematic representations of (a) an asymmetric straight-through MC array (WMS-1-
2) plate, (b) asymmetric straight-through MCs, and (c) MCE setup and generation of W/O/W 
emulsion droplets via asymmetric straight-through MCs. 
 
Formulation of W/O emulsions through homogenization 
Soybean oil solution containing 4 to 8% (w/w) CR-310 was used as the oil phase. Milli-Q water 
solution containing 10 to 30% (w/v) L-AA, 1% (w/w) magnesium sulfate, and 1% (w/v) gelatin was 
used as the inner aqueous phase. The L-AA has maximum solubility of 32% in water at 25 oC. A total 
of 100 mL of the water-oil mixture with a volume fraction () of the inner aqueous phase of 30% was 
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emulsified with a rotor-stator homogenizer (Polytron PT-3000; Kinematica AG, Littau, Switzerland) at 
10,000 rpm for 5 min to formulate a W/O emulsion. Homogenization at 10,000 rpm increased the 
system temperature to around 48 oC with L-AA retention to 90% in prepared W/O emulsions. The 
resultant W/O emulsions had a whitish color with smooth consistency. 
Formulation of W/O/W emulsions through microchannel emulsification 
W/O/W emulsions were formulated by MCE using an asymmetric straight-through MC array (Fig. 
2.1). The MCE instrument consists of a silicon asymmetric straight-through MC array plate (WMS1-2, 
EP Tech Co., Ltd., Hitachi, Japan), a stainless-steel module, a liquid chamber to feed a dispersed phase 
(W/O emulsion), a syringe pump (Model 11; Harvard Apparatus. Inc., Holliston, USA) to feed a 
continuous phase (outer aqueous phase), and a microscope video system to monitor droplet generation 
10, 19).  A 24 × 24 mm MC array plate fabricated using photolithography, deep reactive-ion etching, and 
thermal oxidation 19) was used in this study. An asymmetric straight-through MC array consisting of 
MCs lies within a 10×10 mm central region of the plate. Each asymmetric through-hole consisted of a 
10×100 m microslot with a 30 m depth on the outlet side and a 10 m-diameter circular MC with a 
70 m depth on the inlet side.  
The module was initially filled with the outer aqueous phase (5 mM phosphate buffer (pH 7.0) 
with 1% (w/w) Sunsoft A-12, 1% (w/w) magnesium sulfate, and 10 to 30% (w/v) glucose). An MC 
array plate that was hydrophilically treated was degassed in the outer aqueous phase by ultrasonic 
vibration at 100 kHz (VS-100III, As One Co., Osaka, Japan) for 20 min. This plate was then mounted 
in the module. The W/O emulsion was fed into the module by lifting the dispersed phase reservoir, 
subsequently reaching the MC inlets. Further pressurization of the W/O emulsion initiated its passage 
through MCs at breakthrough pressure (ΔPd,BT), leading to the generation of W/O droplets (defined as 
oil droplets containing smaller inner aqueous droplets) in the outer aqueous phase. The pressure applied 
to the dispersed phase (ΔPd) (kPa) was estimated by 
∆𝑃d =  𝜌d∆ℎd𝑔                     (2.1) 
where ρd is the dispersed phase density (kg m-3), Δhd is the height of the dispersed phase reservoir (m), 
and g is acceleration due to gravity (m s-2). To achieve stable W/O droplet generation, ΔPd,BT ranged 
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from 5.1 to 6.0 kPa, depending on the L-AA concentration in the inner aqueous phase. The flow rate of 
the outer aqueous phase (Qc) was controlled from 50 to 200 mL h-1 during droplet generation.  
 Osmotic pressure (Πd) plays a key role in the stability of W/O/W emulsions. In the present 
study, the osmotic pressure was calculated by the Morse equation, which is a modified form of the 
van’t Hoff equation: 
𝛱d = 𝑖𝑀𝑅𝑇                  (2.2) 
where i is the van’t Hoff factor with a value of 2 for magnesium sulfate, M is the molar mass of 
solvents (kmol m-3), R is the gas constant with a value of 8.31kPa m3 (K mol)-1, and T is the 
thermodynamic temperature (K). The Πd for inner and outer aqueous phases was adjusted to 0.164 MPa 
to avoid droplet instability.  
 
Measurement and analysis 
The average droplet diameter (dav) of the collected W/O and W/O/W emulsions were determined with 
image-analyzing software  (WinROOF, Mitani Co. Ltd., Fukui, Japan) using images of 250 droplets 
taken with an optical microscope (DM IRM, Leica Microsystems, Wetzler, Germany). The coefficient 
of variation (CV) of these emulsions were expressed as 
CV = (
𝜎
𝑑av
)  × 100         (2.3) 
where  is the standard deviation (m) and dav is the average droplet diameter (m).  
The densities of dispersed and continuous phases were measured using a density meter (DA-130 
N, Kyoto Electronics Manufacturing Co., Ltd., Kyoto, Japan) at 25 oC. The viscosities of dispersed and 
continuous phases were measured with a vibro viscometer (SV-10, A&D Co., Ltd., Tokyo, Japan) at 25 
oC by taking 35 mL of samples in a measuring vessel followed by immersion of sensor plates in that 
vessel. Viscosity was measured by detecting the electric current needed to resonate the sensor plates. 
The viscosity (η) was calculated by 
𝜂 =  
ηmea
𝜌
               (2.4) 
where ηmea is the measured fluid viscosity and ρ is the fluid density. The static interfacial tension 
between the oil and the inner or outer aqueous phases was measured with a fully automatic interfacial 
tensiometer (PD-W, Kyowa Interface Sciences Co., Ltd., Saitama, Japan) using a pendant drop method. 
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Physical and chemical stability of L-AA loaded W/O/W emulsions 
Physical stability of L-AA added W/O/W emulsions  
The W/O/W emulsions loaded with L-AA formulated through MCE were observed under an optical 
microscope (DM IRM, Leica Microsystems, Wetzler, Germany) to evaluate consistency, homogeneity, 
and coalescence during 30d of refrigerated storage at 4 °C. The size and size distribution of the 
collected W/O droplets during storage time were determined using WinROOF software.   
Chemical stability of L-AA in W/O/W emulsions 
The amount of L-AA encapsulated in the W/O/W emulsions was determined by the spectrophotometric 
method reported by Zeng et al. 34) with slight modifications. All spectral measurements of methanolic 
extracts of W/O and W/O/W emulsions were carried out using a UV/VIS/NIR spectrophotometer (V-
570, JASCO Co., Hachioji, Japan). First, 1 mL of the emulsion was extracted with 10 mL of methanol, 
followed by ultrasonication for 20 min. The methanolic extracts were then centrifuged (KN-70, 
KUBOTA Co., Tokyo, Japan) at 5,000 rpm for the first 60 min and at 2,000 rpm for another 15 min. A 
1 mL aliquot of the subnatants was diluted twenty times with methanol and then injected into a quartz 
cell with a 10 mm pass length. The absorbance of L-AA in emulsion extract was measured at 247 nm 
using an appropriate blank. A representative standard curve of absorbance versus concentration gave 
linear least-squares regression with a coefficient of determination (r2) of 0.9996. All experiments were 
repeated in triplicate and mean values were calculated. The retention ratio of L-AA (RAA), defined as 
the ratio of the L-AA concentration measured at a given storage time (CAA) to the initial L-AA 
concentration (CAA,0), was calculated as follows: 
𝑅𝐴𝐴 = (
CAA
𝐶𝐴𝐴,0
)  × 100            (2.5) 
2.3 Results  
Formulation of W/O and W/O/W emulsions loaded with L-AA 
Fig. 2.2a presents a typical example of the droplet size distribution of W/O emulsion formulated at an 
L-AA concentration of 30% (w/v). Its dav,W/O was 2.9 m, and its CVW/O was 15%. The dav,W/O values 
increased slightly with increasing L-AA concentrations in the range applied.  W/O emulsion droplets 
must be smaller than the MC diameter to perform successful MCE. The inner aqueous droplets 
formulated in this study have diameters of less than 4 m (Fig. 2.2a), indicating that they can easily 
pass through MCs with a diameter of 10 m.    
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The freshly formulated W/O emulsions were used for MCE in order to produce W/O/W emulsions. 
After achieving ΔPd,BT, W/O droplets were generated via the asymmetric straight-through MC array. 
Figures 2.3a, b, and c depict the successful generation of uniformly sized W/O droplets from the slot 
outlets at the CR-310 concentration in the oil phase of 4% (w/w) and the L-AA concentration in the 
inner aqueous phase of 30% (w/v). The W/O/W emulsion formulated here had a dav,w/o/w of 30 μm and a 
CVw/o/w of 9.8%, demonstrating the formulation of a monodisperse W/O/W emulsion. 
 
 
(a) 
 
 
(b) 
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(c) 
           
 
Figure 2.2: (a) Droplet size distribution of a W/O emulsion at 30% (w/v) L-AA. (b) Influence of 
CR-310 concentration on the average droplet diameter (dav,W/O) and coefficient of variation 
(CVW/O) of W/O emulsion formulated at 30% (w/v) L-AA. (c) dav of W/O emulsions containing 
different concentrations of L-AA. In (b) and (c), solid keys denote dav,W/O, and open keys denote 
CVW/O. 
 
Effect of CR-310 concentration in the oil phase 
Fig. 2.3c, d, and e illustrate the effect of the CR-310 concentration on the formulation of W/O/W 
emulsions loaded with 30% L-AA in the inner aqueous phase when using the hydrophilic asymmetric 
straight-through MC array. W/O emulsions with dav,W/O of  2.6 m and CVW/O of 13 to 16% were 
successfully formulated using different CR-310 concentrations (4 to 8% (w/w)) in the oil phase (Fig. 
2.2b). Uniformly sized W/O droplets were stably generated from the slot outlets only for 4% (w/w) 
CR-310 (Fig. 2.3c). In contrast, for higher CR-310 concentrations of 6 and 8% (w/w), droplets were not 
stably generated (Figs. 2.3d, e), resulting in the formulation of unstable polydisperse W/O/W emulsions 
with large W/O droplets. At higher CR-310 concentrations, W/O droplets with increasing size and tail-
like and oval shapes emerged from the slot outlets. These different geometrical shapes caused rough 
delayed detachment of W/O droplets from the slots (Figs. 2.3d, e).  These results demonstrate that 
monodisperse W/O/W emulsions loaded with a high concentration of L-AA by MCE could be 
formulated only at a lower hydrophobic emulsifier in the outer aqueous phase. 
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Figure 2.3: Effects of L-ascorbic acid and CR-310 concentrations on W/O droplet generation via 
an asymmetric straight-through MC. (a) 4% (w/w) CR-310 and 10% (w/v) L-AA. (b) 4% (w/w) 
CR-310 and 20% (w/v) L-AA. (c) 4% (w/w) CR-310 and 30% (w/v) L-AA. (d) 6% (w/w) CR-310 
and 30% (w/v) L-AA. (e) 8% (w/w) CR-310 and 30% (w/v) L-ascorbic acid. (f) Optical 
micrograph of uniformly sized W/O droplets for 4% (w/w) CR-310 and 30% (w/v) L-AA. 
 
Effect of L-AA concentration in the inner aqueous phase 
The effect of L-AA concentration on the production of W/O/W emulsions by straight-through MCE 
was also investigated. L-AA content was varied from 10 to 30% (w/v) in the inner aqueous phase 
containing 1% (w/w) magnesium sulfate and 1% (w/v) gelatin, and glucose content was varied from 10 
to 30% (w/v) in the outer aqueous phase containing 1% (w/w) Sunsoft A-12 and 1% (w/w) magnesium 
sulfate. The CR-310 concentration in the oil phase was kept at 4% (w/w). W/O emulsions with dav,W/O 
of  2.6 to 2.9 m and CVW/O of 15 to 17% were successfully formulated using different L-AA 
concentrations in the inner aqueous phase (Fig. 2.2c). The dav of the W/O emulsions is not significantly 
affected by L-AA concentration. The slight increase in droplet size may correspond toward increase in 
concentration of L-AA. The viscosity of dispersed phase increases with increasing the L-AA 
concentration (Table 2.1), providing small area for rotor-starter homogenizer to reduce the dav. As a 
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result, a slight increase in dav of W/O emulsions was obtained when using a high concentration of L-AA. 
On the other hand, the emulsifier concentration have no effect on the dav of the W/O emulsions, which 
may be attributable to complete coverage of the emulsifier molecules at the interface, as clearly seen 
from the interfacial values. Successful MCE that means uniformly sized W/O droplets were generated 
regardless of L-AA concentration (Figs. 2.3a, b, and c). Smooth detachment of W/O droplets from the 
slot outlets was observed. The dav,W/O/W of the formulated W/O/W emulsions, which ranged from 26 to 
33 μm, increased slightly with increasing L-AA concentration. Their CVW/O/W values were less than 
10%, and the droplet size distribution data in Figs. 4a, b, and c demonstrate their monodispersity. 
(a) 
 
(b)  
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(c) 
 
 
Figure 2.4: Size distributions of W/O droplets formulated using MCE. (a) 10% (w/v) L-AA. (b) 
20% (w/v) L-ascorbic acid. (c) 30% (w/v) L-AA. The CR-310 concentration in the oil phase was 
4% (w/w).  
 
Physical and chemical stability of L-AA loaded W/O/W emulsions 
The monodisperse W/O/W emulsions were stored at 4oC for 10 d. Immediately after formulation, 
emulsions with different L-AA concentrations had a whitish turbid appearance with good flowability. 
The appearance of the W/O/W emulsions did not change with time. Fig. 2.5a depicts time changes in 
the dav,W/O/W and CVW/O/W of the formulated W/O/W emulsions loaded with different L-AA 
concentrations. A slight increase in dav,W/O/W was observed, indicating that inner droplets might swell 
due to osmotic pressure difference and high concentration of L-AA. The initial solution preparation 
allows the penetration of oxygen into the system despite of osmotic pressure adjustment by Morse 
equation. The dissolved oxygen tends to increase the osmotic pressure over storage period, which 
slightly increases the dav of W/O/W emulsions. There was an non-significant difference (p > 0.05) in 
dav,W/O/W and CVW/O/W during storage of the W/O/W emulsions containing 10% (w/w) L-AA. In 
contrast, dav,W/O/W and CVW/O/W of the W/O/W emulsions containing 30% (w/w) L-AA slowly increased 
from 30 m to 31.5 µm with CVW/O/W around 10% during storage (Fig. 2.5a).  
The freshly formulated W/O emulsions had an initial retention of more than 90% regardless of L-
AA concentration. Figure 2.5b indicates L-AA retention in the W/O/W emulsions freshly formulated in 
section 3.3. Their initial retention of L-AA exceeded 85%. Their L-AA levels decreased slightly with 
time and exhibited 80% retention after 10 d. 
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(a) 
 
 
 
(b) 
             
Figure 2.5: (a) Effect of L-ascorbic acid concentration on average droplet diameter (dav,W/O/W) and 
coefficient of variation (CVW/O/W) of the collected W/O/W emulsions. denotes dav,W/O/W at 
day 1, and denotes dav,W/O/W at day 10. denotes CVW/O at day 1, and  denotes CVW/O 
at day 10. (b) L-AA retention (R) in the collected W/O/W emulsions at different concentrations. 
denotes 10% (w/v) L-AA,   denotes 20% (w/v) L-AA and  denotes 30% (w/v) L-AA.  
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2.4 Discussion 
The present study was conducted to formulate stable monodisperse W/O/W emulsions loaded with a 
high concentration of L-AA. MCE was adopted to achieve this purpose, as MCE has the ability to 
formulate monodisperse emulsions under considerably mild processing conditions. In this study, some 
physicochemical parameters were also checked to clarify the processing conditions necessary to 
prepare monodisperse W/O/W emulsions.  
Previous studies have encapsulated L-AA in W/O/W and O/W/O emulsions for topical creams and 
other pharmaceutical applications but seldom describe the retention and droplet size distribution of 
primary emulsions 35, 36). The formulated double emulsions rapidly coalesce within a short time, 
resulting in increased polydispersity that limits their use in numerous applications. Moreover, only low 
concentrations of L-AA have been encapsulated in double emulsions including non-food-grade 
materials 27, 35-37). Monodisperse W/O/W emulsions with dav,W/O/W of 40 μm were formulated by MCE 
using symmetric oblong straight-through MCs 19). W/O/W emulsions for drug-delivery systems were 
also formulated by extruding a coarse W/O/W emulsion five times under pressures of 70 to 150 kPa 
through a Shirasu Porous Glass (SPG) membrane 2). These studies focused on production 
characteristics but did not consider any encapsulated bioactive compound. Similarly, these MCE and 
ME studies did not evaluate the stability of formulated W/O/W emulsions. The present study obtained 
new findings regarding the formulation and storage stability of monodisperse W/O/W emulsions 
loaded with a high concentration of L-AA. 
Emulsions prepared from the rotor-starter homogenizers always have border size distribution with 
CV more than 30%. In our study we prepared the W/O emulsions having CV more than 20% with 
boarder size distribution (Fig. 2.2a). The contact area of rotor-starter with emulsions is broader enough 
to generate polydisperse droplets. Moreover, the homogenization speed was mild enough to prepare 
W/O emulsions. The W/O emulsions prepared at this homogenization speed has dav around 4 µm. 
Emulsifier concentration plays a significant role in stabilizing both W/O and W/O/W emulsions, and its 
optimization is very important for successful emulsification using MCs or membrane pores. Hasegawa 
et al. 38) stated that W/O/W emulsions can be formulated using low concentrations of emulsifiers in the 
oil and outer aqueous phases, and that emulsifier type influences the formulation of W/O/W emulsions. 
Kawakatsu et al. 39) stated that the tetraglyerol polyricinoleate (TGPR) concentration in the oil phase 
affects the stability of oil droplets, each containing inner aqueous droplets. At a high TGPR (5% 
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(w/w)) concentration, those containing stable inner aqueous droplets tended to coalesce, destabilizing 
W/O/W emulsions. In our study, stable W/O droplets were generated at a low CR-310 concentration 
(4% (w/w)) (Fig. 2.3c). However, higher CR-310 concentrations (6 and 8% (w/w)) resulted in unstable 
W/O droplet generation, during which the dispersed phase forms an elongated balloon-like shape over 
the slot outlets (Figs. 2.3d, e). Interfacial tension that exceeds other major forces on a micron scale 
plays an important role in droplet generation by MCE 14). Interfacial tensions exceeding threshold level 
(c.a. ~1 mN m-1) are needed to stably formulate monodisperse emulsions 40). Karbstein and Schubert 3) 
demonstrated that dynamic interfacial tension between a vegetable oil and an aqueous solution 
containing an emulsifier is influenced by emulsifier concentration. During W/O droplet generation in 
our study, dynamic interfacial tension of a newly created interface is assumed to decrease more rapidly 
as the CR-310 concentration increases. At CR-310 concentrations exceeding a threshold level, a rapid 
decrease in dynamic interfacial tension may inhibit smooth pinch-off of the interface between the W/O 
emulsion and outer aqueous phases in the slot, resulting in generation of large W/O droplets. There is 
also a possibility that rapid adsorption of CR-310 molecules at the preceding interface has weak 
affinity interactions with the chip surfaces during W/O droplet generation, resulting in rough and 
irregular interfacial motion in the slot. 
In our study, monodisperse W/O/W emulsions loaded with L-AA were successfully formulated 
using MCE, and their dav,W/O/W slightly depended on L-AA concentration. This dependence of dav,W/O/W 
on L-AA concentration is attributed to the variation in  the viscosity of the outer aqueous phase, as the 
viscosity of the oil phase is much higher than the threshold level, below which droplet size becomes 
sensitive in MCE 41). The viscosity of the outer aqueous phase ranged from 1.8 to 2.8 mPa s when the 
L-AA concentration varied (Table 2.1). This viscosity variation is attributed to the difference in the 
glucose concentration necessary to adjust the osmotic pressure in the outer aqueous phase. van Dijke, et 
al. 41) demonstrated that the droplet size of soybean O/W emulsions formulated by MCE increases with 
increasing viscosity of the continuous phase between 0.91 and 68.2 mPa s. The effect of viscosities on 
droplet generation behavior can be described in terms of viscosity ratio. At high viscosity ratios of the 
dispersed and continuous phases, the droplet size is not influenced, while at low viscosity ratios, the 
droplets become larger. There is a viscosity ratio below which successful MCE is not possible. In the 
present study the viscosity ratio was higher than a critical value, demonstrating that the continuous and 
disperse phases have not major effect upon dav. 
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Table 2.1: Physicochemical properties of different phases used to formulate W/O/W emulsions. 
 
 
 
aInternal aqueous phase containing 10 to 30% ( w/v) L-ascorbic acid with 1% (w/w) MgSO4 and 1% 
(w/v) gelatin, b4 to 8% (w/w) tetra glycerin condensed ricinoleic acid esters (CR-310) in soybean oil, 
cViscosity of 4 to 8% (w/w) CR-310 in soybean oil, dViscosity of 10 to 30% (w/v) water-in-oil 
emulsion having 1% (w/w) MgSO4 and 1% (w/v) gelatin, eViscosity of internal water phase having 1% 
(w/w) MgSO4, 10 to 30% (w/v) glucose, and 1% (w/w) Sunsoft A-12, fInterfacial tension between 
internal aqueous phase and oil phase, gInterfacial tension between external aqueous phase and oil 
phase. 
 
L-AA is readily and reversibly oxidized to dehydrascorbic acid, which is present in aqueous media 
as a hydrated hemiketal. The biological activity is lost when the dehydroascorbic acid lactone ring is 
irreversibly opened, giving rise to 2,3-diketogulonic acid. The oxidation of L-AA to dehydroascorbic 
acid and its further degradation products depends on several factors. Oxygen partial pressure, pH, 
temperature, light, and the presence of heavy metal ions are of great importance. The monodisperse 
W/O/W emulsions formulated in our study were stable for more than a week, maintaining whitish 
turbidity, consistency, and flowability. The presence of hypertonic inner aqueous phase causes water 
migration from an outer aqueous phase to an inner aqueous phase, resulting in slow swelling of the 
inner aqueous droplets that may be a possible reason for a slight increase in dav,W/O/W during storage. 
Similar inner aqueous droplet swelling in different food-grade W/O/W emulsions containing sodium 
chloride was reported by Sapei and Rousseau 30). The physical stability of emulsions may also be 
affected by the acidic nature of L-AA. In this study, relatively high concentrations of L-AA are 
Experimental 
systema 
Emulsifierb  Viscositiesc, d, e (mPa s) Interfacial tensionf, g (mN/m) 
 (%) Oil phase Inner aq. 
phase 
Outer aq. 
Phase 
Oil and Inner 
aq. Phases 
Oil and outer 
aq. Phases 
LAA- 10 CR-310- 4 64.8±0.26 1.9±0.01 1.8±0.05 6.2±0.30 1.8±0.40 
LAA- 20 CR-310- 4 64.8±0.26 2.6±0.02 2.2±0.01 6.4±0.10 1.4±0.50 
LAA- 30 CR-310- 4 64.8±0.26 3.0±0.01 2.8±0.01 6.2±0.30 1.6±0.20 
LAA- 10 CR-310- 6 73.0±0.10 1.9±0.01 1.8±0.05 6.2±0.40 2.0±0.20 
LAA- 20 CR-310- 6 73.0±0.10 2.6±0.02 2.2±0.01 6.4±0.20 2.0±0.20 
LAA- 30 CR-310- 6 73.0±0.10 3.0±0.01 2.8±0.01 6.6±0.40 2.1±0.40 
LAA- 10 CR-310- 8 77.4±0.21 1.9±0.01 1.8±0.05 6.6±0.90 1.5±0.40 
LAA- 20 CR-310- 8 77.4±0.21 2.6±0.02 2.2±0.01 6.1±0.50 1.7±0.30 
LAA- 30 CR-310- 8 77.4±0.21 3.0±0.01 2.8±0.01 6.0±0.40 1.6±0.40 
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encapsulated in inner aqueous droplets. At high concentrations of L-AA, the interfacial layer stabilizing 
inner aqueous droplets could be influenced by L-AA molecules, allowing slight swelling to take place 
with the passage of time. Hypertonic conditions promote such swelling, increasing the packing density 
of the inner aqueous droplets. The overall increase in this packaging density may enhance the stability 
and release profile of L-AA encapsulated in the monodisperse W/O/W emulsions. The beneficial effect 
of packaging density in W/O/W emulsions was previously reported by Sapei et al. 31). 
The initial retention of L-AA in this study (Fig. 2.5b) was similar to our previous results for 
W/O/W emulsions loaded with L-AA formulated using conventional two-step emulsification 32). Our 
previous studies on encapsulating L-AA in W/O and W/O/W emulsions demonstrated a decline rate of 
10% with each week of storage time 32, 33). In the present study, we achieve higher L-AA retentions of 
81 to 83% after 15 days of storage. This higher retention can be ascribed to the narrow size distribution 
of the W/O droplets formulated by MCE, as well as very mild W/O droplet generation, since droplet 
generation in MCE was based upon difference in interfacial tension rather than high-energy second-
step homogenization. This low-energy MCE process is considered to increase the retention of L-AA in 
W/O/W emulsions during storage. Previous studies confirmed that L-AA encapsulated in W/O/W 
emulsions is more stable and has good functionality in numerous pharmaceutical products 27, 35, 36, 42).  
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Monodisperse aqueous microspheres encapsulating high 
concentration of L-ascorbic acid: Insights of preparation and stability 
evaluation from straight-through microchannel emulsification* 
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3.1 Introduction 
There are increasing demands for products which are expected to optimize health and target-delivery of 
supplements to the optimum absorption sites in the gastrointestinal tract. During last two decades, 
microspheres have been widely used in food, pharmaceutical and chemical industries1-3). Monodisperse 
microspheres have numerous advantages such as efficient drug delivery, higher bioavailability, high 
dispersibility and fast permeability4-6). Microspheres are generated by different methods including ionic 
gelation,7) cross-linked emulsions,8) sieve methods,9) bio-electro spraying,10) and numerous spray 
drying techniques11). All of these methods have potential advantages such as better particle size 
controllability, better particle morphology and better penetration at target areas.  
Microparticle technology has potential applications in the controlled delivery of bioactives such as 
vitamins, probiotics, small bioactive peptides and antioxidants12). For instance, Ellis and Jacquier13) 
formulated food-grade -carrageenan microspheres with a broad range of functionalities such as 
nutraceutical delivery systems or fat replacers.  Prasertmanakit et al.14) prepared ethyl cellulose 
microcapsules for protection and controlled release of folic acid in foods and supplements. Duclairoir 
et al.15) formulated gliadin nanoparticles as efficient drug carriers for -tocopherol or vitamin E. 
Anionic polysaccharide gels like alginate (ALG) particles have numerous applications for 
encapsulation and delivery systems. Potential applications include encapsulation of drugs16), 
probiotics17), control flavor release18), enzyme protection, and guided delivery of drugs to their target 
organs19). ALGs have an inert nature, high porosity, superior coverage, superior penetration rate, mild 
encapsulation temperature, and biocompatibility with numerous bioactive substances20). 
ALG is a natural, non-toxic, biodegradable, biocompatible, and inert polysaccharide found in 
all species of brown algae21). Chemically, ALG is composed of two types of uronic acids, guluronic (G) 
and mannuronic (M). Monomeric units consisting of G and M are arranged in three types of grouping: 
blocks of alternating M and G residues (MGMG-MGM...), blocks of G (GGGGGGG...), and blocks of 
M (MMM-MMM...)22). Sodium alginate (Na-ALG) is a water-soluble compound that gels in the 
presence of divalent cations21). Such gels can be heat-treated without melting, although they may 
eventually degrade. Gelling depends on ion binding (Ca+2< Zn+2< Sr+2< Ba+2), with the control of 
cation addition being important for producing homogeneous gels22). 
ALG composition is an important parameter in ALG particle formation. At a Na-ALG 
concentration below 1.0%, almost no spherical particles were formed, probably due to the lack of 
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enough carboxyl groups for gelation. Increasing Na-ALG concentration causes higher viscosity of an 
aqueous phase, resulting in larger droplets with a wide distribution22,23). Thus, for a given application, 
the Na-ALG concentration must be controlled in particle size, shape, and size distribution.  
L-ascorbic acid (L-AA) is a water soluble vitamin and regarded as dietary intake of vitamin C24). L-
AA is present in many leafy vegetables and fruits, noticeably in guava, orange, apple, strawberry, kiwi, 
capsicum, pawpaw and cauliflower25). The importance of vitamin C is seen clearly in scurvy, a life-
threatening vitamin C deficiency disease that results in loss of energy, depression, mood disorders, 
poor wound healing, and connective tissue disorders, culminating in death26). Vitamin C plays an 
important role in formation of collagen (in bones, teeth and cartilage) and activation of various 
enzymes related to nervous system, and detoxification of drugs in liver. With a structure similar to 
carbohydrates, vitamin C can uniquely undergo reversible oxidation reactions27). Additionally, the 
chemical properties of vitamin C allow it to react with a wide variety of potentially harmful reactive 
oxygen species. Vitamin C is stable in powder form, while its stability decreases in aqueous 
formulations. Environmental factors that affect the stability include temperature, pH, oxygen, metal 
ion, UV and x-ray 28,29).  
Microchannel emulsification (MCE) is a progressive method that enables preparing monodisperse 
droplets by spontaneous transformation of oil-water interface specifically driven by interfacial tension 
on a micron scale30) and comprehensively reviewed by Vladisavljevic' et al.31) Similarly, this 
emulsification technique allows integration of hundreds of thousands of droplet generation units on a 
single silicon and on the other hand stainless steel chips currently contain fewer number of droplet 
generating units32,33).  Kawakatsu et al.34) introduced MCE and this technology enables the production 
of different emulsions with diameter ranged from 1 m to 500 m. The fabricated microchannel (MC) 
arrays are classified as grooved MC arrays consisting of uniform microgrooves with slit-like terraces 
outside them and straight-through MC arrays having two-dimensionally positioned, symmetric or 
asymmetric micro-through-holes31). These straight-through MC arrays enable the mass production of 
monodisperse droplets, with precise control on processing parameters. 
MCE has been used to produce monodisperse microdispersions including solid lipid 
microspheres,35) gel microbeads36) and giant vesicles37). Many dispersions encapsulating β-carotene,38) 
oleuropein,39) γ-oryzanol,40) L-AA41) and ascorbic acid derivatives 42) have been also prepared using 
MCE. 
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Several research groups have encapsulated L-AA at relatively low concentrations (up to 5%) 
in aqueous droplets using different homogenization techniques43-46). The main objective of this study is 
to formulate different pharmaceutical and food-based products such as energy drinks and fortified 
nutritional supplements containing high concentrations of bioactives. This model study was conducted 
with n-Decane as the continuous phase that can be replaced with appropriate viscosity oil such as, ethyl 
oleate, oleic acid or different types of medium chain triglyceride oils. Moreover, this study was 
conducted to optimize production method for obtaining monodisperse aqueous microspheres 
containing high concentration of L-AA using straight-through MCE. In this study L-AA was 
encapsulated at a concentration of 30% (w/w) in aqueous microspheres along with varying 
concentrations of Na-ALG. The study investigated the optimization of the formation conditions and 
effects of osmotic pressures and varying concentrations of L-AA on MCE. Moreover, the study also 
evaluate the stability of the prepared microspheres and the retention profile of the L-AA encapsulated 
in them. 
3.2 Materials and Methods 
Materials 
L-AA (99.9% purity), anhydrous magnesium sulfate (MgSO4) and sodium alginate (Na-ALG) were 
purchased from Wako Pure Chemical Ind. (Osaka, Japan). All of these chemicals were used for 
preparing a dispersed phase. Milli-Q water with a resistivity of 18 MΩ cm-1 was used to dissolve all the 
above-mentioned chemicals. n-Decane was procured from Wako Pure Chemical Ind. and tetraglycerol 
condensed ricinoleate (TGCR, CR-310) was supplied by Sakamoto Yakuhin Kogyo Co., Ltd. (Osaka, 
Japan). They were used for preparing a continuous phase. Hexamethyldisilazane (LS-7150), purchased 
from Shin-Etsu Chemical Co. Ltd. (Tokyo, Japan), was used for surface hydrophobization of a silicon 
MC array chip and a glass plate. HPLC grade methanol was used to extract L-AA from aqueous 
microspheres. All these chemicals were of analytical grade and used without further purification. 
 
Emulsification Setup for microsphere characterization  
Fig. 3.1a depicts a simplified schematic diagram of the experiment setup used for MCE. A 
hydrophobized silicon MC array plate is tightly attached to a hydrophobized glass plate in the 
emulsification module initially filled with the continuous phase. A syringe pump (Model 11, Harvard 
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Apparatus, Inc., Holliston, USA) was used to supply the continuous phase. The heating system 
provides temperature-controlled water circulation inside the module and outside the reservoir. A 
microscope video system was used to monitor and record droplet formation by MCE47). Fig. 3.1b and c 
depict a dead-end silicon MC array plate (Model MS407, EP Tech., Co. Ltd., Hitachi, Japan) consisting 
of 400 MCs fabricated on four MC arrays. Each channel has terraces outside its inlet and outlet, and 
wells are fabricated outside the terraces. Channel and terrace dimensions are presented in Fig. 3.1(d), 
except for channel and terrace depth (7 m). 
The glass and silicon MC array plates were treated with LS-7150 to make their surfaces 
hydrophobic, so that they became suitable for preparing aqueous liquid microspheres in the continuous 
oil phase. This hydrophobic treatment was performed using slight modification of the procedure by 
Kawakatsu et al.48). Briefly, these plates were surface-oxidized in a plasma reactor (PR500, Yamato 
Scientific Co., Ltd., Tokyo, Japan) for 15 min. The plates were then dipped in LS-7150 for the MC 
array plate or in a mixture of LS-7150 (20% (w/w)) and hexane (80% (w/w)) for the glass plate for two 
nights at room temperature. Finally, the unreacted materials were washed away. 
 
Solutions preparation and emulsification procedure 
Na-ALG solutions at different concentrations of 0.5 to 4.0% (w/w) were prepared by dissolving Na-
ALG powder in Milli-Q water for at least 2 h with constant stirring using a magnetic stirrer at room 
temperature. The solutions at 4±1 oC were stored overnight to ensure complete hydration. They were 
then maintained at 45±1 oC prior to MCE. The disperse aqueous phase used for MCE contains 0.5 to 
4.0% (w/w) Na-ALG, 0 to 2% (w/w) MgSO4, and 5 to 30% (w/w) L-AA. The continuous phase is a 
solution of water-saturated decane containing 5% (w/w) Span 85 or TGCR. To prevent water diffusion 
from the surface of Na-ALG droplets, decane was pre-treated prior to preparing the continuous phase. 
Decane was saturated with water by mixing at a volume ratio of 9:1 (decane:water) for 30 min, after 
which they were separated by centrifugation at 1500 x g for 15 min using a table centrifuge (KN-70, 
Kubota Co., Tokyo, Japan). The decane supernatant part was used as the continuous phase37).  
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Figure 3.1: (a) Simplified schematic of MCE setup. (b) Top and cross-section views of the MC 
array plate (model MS407). (c) Schematic diagram of part of an MC array. (d)  Optical 
micrograph and dimensions of part of an MC array. 
 
The disperse phase in a reservoir was introduced into a module filled with the continuous 
phase by applying pressure using a pumping device (Fig. 3.1a). The module temperature was kept at 
45±1 oC during MCE. Liquid microsphere generation occurred when the disperse phase was forced 
through the MCs into the continuous phase. The resulting microspheres were then swept away by the 
cross-flow of the continuous phase, which was set at 10 to 15 mL h-1. The flows of the disperse and 
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continuous phases were controlled in real time by monitoring liquid microsphere generation via MC 
arrays. 
 
Straight-through MCE 
Asymmetric microchannel array chip 
In this study we used 24 × 24 mm MC array chip (Model WMS1-2) consisting of 10,313 MCs (Fig. 
3.2) in a 10 × 10 mm in the center of the plate and four 1.5 mm diameter holes at the corners of the 
chip. This MC array was fabricated by repeated processes of photolithography and deep-reactive-ion 
etching (DRIE) on 5-inch silicon wafer 49). Each asymmetric MC consisted of a circular microhole (10-
m diameter and 70-m depth) located on the inlet side and a microslot (11×104-m cross section and 
21-m depth) located on the outlet side. The slot aspect ratio of 9.5 was above the threshold value of 3 
for stably generating monodisperse emulsion droplets 50). The fabricated microholes and microslots 
were highly uniform, meeting the criterion for obtaining monodisperse microparticles. Oxygen plasma 
treatment was then performed to grow a hydrophilic silicon dioxide layer on the fabricated plate before 
carrying out hydrophobic treatment. Prior to the first use, the WMS1-2 chips as well as the glass plates 
were hydrophobilized by using LS-7150 (100% concentration for MC array chip, 20% (w/w) in hexane 
for glass plate) and left for two nights at room temperature. Afterwards, the unreacted material was 
washed away by using an ultrasonic bath (VS-100III, As One Co., Osaka, Japan) at a frequency of 100 
kHz. 
 
Preparation of aqueous dispersed phase 
2.0% (w/w) Na-ALG aqueous solution was prepared by dissolving Na-ALG powder in Milli-Q water 
for at least 2 h under constant stirring at room temperature. The solution was stored at 4±1oC overnight 
to ensure complete hydration. The dispersed phase used for straight-through MCE contains 2.0% (w/w) 
Na-ALG, 1% (w/w) MgSO4 and 5-30% (w/w) L-AA. Na-ALG was chosen on the basis of its 
functionality in food systems, since it is a plant-based polysaccharide and easily to handle even at high 
concentration. Moreover, it is widely used for formulation of different types of microspheres. 2.0% 
(w/w) Na-ALG in the dispersed phase was used after optimization, since an optimized viscosity range 
was needed to conduct MCE. At higher viscosity it was difficult to pressurize the dispersed phase from 
the MCs. Moreover, MgSO4 was added to increase the stability of L-AA in the dispersed phase. The 
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continuous phase contains water-saturated decane containing 5% (w/w) TGCR. Water saturation was 
carried out to prevent water diffusion from the surface of Na-ALG microspheres. Decane was water-
saturated by mixing a volume ratio of 9:1 (decane:water) for 30 min, after which they were separated 
by centrifugation at 1500 g for 15 min using a table centrifuge (KN-70, Kubota Co., Tokyo, Japan). 
The decane supernatant part was used as the continuous phase37). All of the phases were maintained at 
45±1oC prior to MCE. 
 
Figure 3.2: Schematic representation of asymmetric straight-through MC array chip used in 
microchannel emulsification. (a) WMS 1-2 silicon chip. (b) Optical micrograph of the bottom-
illuminated chip surface. The circular micrchannels (MCs) are highlighted in dark black color in 
the center of light grey color microslot. (c) Arrangement of asymmetric MCs on the top side of a 
WMS 1-2 chip. Each horizontal row contains alternatively 82 or 83 MCs and vertical rows 
contain alternatively 62 or 63 MCs making the total number of MCs equal to 10,313 = 62 × 82 + 
63 × 83. 
 
 
Emulsification procedure 
Each emulsification experiment was started with degassing of a WMS1-2 chip soaked in the 
continuous phase under ultrasonication at a 100 kHz for 20 min. During module assembly, the 
degassed hydrophobic WMS1-2 chip was mounted in a module compartment previously filled with 
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continuous phase (water saturated decane together with TGCR). Fig. 3.3a shows a simplified schematic 
diagram of the experimental setup used for MCE. A hydrophobized silicon MC array plate is tightly 
attached to hydrophobized glass plate in the emulsification module initially filled with the continuous 
phase.  
 
Figure 3.3: Simplified representation of microchannel emulsification. (a) Experimental set-up 
used in this work for straight-through MCE. (b) Generation process of aqueous microspheres in 
MCE. 
 
A syringe pump (Model 11, Harvard Apparatus Inc., Holliston, USA) was used to supply both 
the continuous and dispersed phases. The heating system provides temperature controlled water 
circulation inside the module and outside the reservoir. The emulsification process was carried out for 
approximately 1 h and monitored through FASTCAM-1024 PCI high speed video system at 250 to 500 
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fps (Photron Ltd., Tokyo, Japan) attached to an inverted metallographic microscope (MS-511B, Seiwa 
Optical Co., Ltd., Tokyo, Japan). 
The module temperature was kept at 45±1oC during MCE. Aqueous microsphere generation 
occurred when the dispersed phase occupies the active surface area of the WMS1-2 chip. The resulting 
microspheres were then swept away by the cross-flow of the continuous phase. The microsphere 
generation process is schematically illustrated in Fig. 3.3b. The dispersed phase flux (Jd) (L m-2 h-1) 
was calculated using the following equation: 
𝐽d =  
𝑄d
𝐴MCA
                              (3.1) 
where Qd is the dispersed phase flow rate (L h-1) and AMCA is the effective area of a straight-through 
MC array (1.0 × 10-4 m2). The average flow velocity of the continuous phase over the plate surface (Uc) 
was calculated with the following equation: 
𝑈c =  
𝑄c
𝐴a,s
                                (3.2) 
where Qc is the continuous phase flow rate (m h-1), and Aa,s (active surface area) is the flow area 
over the chip surface (m2) and is calculated by measuring the dimensions of the spacer placed on  the 
WMS1-2 chip: 
𝐴a,s =   𝑊 × 𝐻                      (3.3) 
where W is the spacer internal width (10-2 m), and H is the spacer thickness (10-3 m).  
 
Measurement and analysis 
The size and size distribution of the W/O aqueous microspheres obtained from straight-through MCE 
were determined as follows. The average droplet diameter (dav) was defined by: 
𝑑av =  ∑ 𝑑i
𝑛
𝑖=1 /𝑛                            (3.4) 
  where di is the diameter of the ith microsphere measured using WinRoof software (Mitani Co., 
Ltd., Fukui, Japan) and n is the number of the microspheres measured (n = 250). The microsphere 
dispersity was expressed as CV, and is defined as: 
CV =  
𝜎
𝑑av
 × 100                           (3.5) 
 where  is the standard deviation and dav is the average microsphere diameter (m). 
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Measurement of fluid properties 
The densities of dispersed and continuous phases were measured using a density meter (DA-130 N, 
Kyoto Electronics Manufacturing Co., Ltd., Kyoto, Japan) at 25±2oC. The viscosities of dispersed and 
continuous phases were measured with a vibro viscometer (SV-10, A&D Co., Ltd., Tokyo, Japan) at 
25±2oC by taking either 10 or 35 mL of samples in a measuring vessel followed by immersion of 
sensor plates in that vessel. Viscosity was measured by detecting the electric current needed to resonate 
the sensor plates. The kinematic viscosity (𝜐) was calculated by following equation: 
         𝜐 =  
𝜂mea
𝜌
                               (3.6) 
where ηmea is the measured viscosity and ρ is the fluid density. The static interfacial tension 
between the oil and aqueous phases was measured with a fully automatic interfacial tensiometer (PD-
W, Kyowa Interface Sciences Co., Ltd., Saitama, Japan) using a pendant drop method. The key 
physical properties of dispersed and continuous phases are presented in Table 3.1. 
 
Table 3.1: Viscosity and interfacial tension data for the liquid phases used for this study. 
 
concentration 
% (w/w) 
Viscosity, a  
(mPas) 
Viscosity,      
b  (mPas) 
Interfacial 
tension,    
c (mN/m) 
Interfacial tension,    
d (mN/m) 
DP composition*     
0.5 1.67±0.02 4.11±0.01 6.5±0.1 6.9±0.2 
1 3.75±0.05 8.85±0.05 6.7±0.5 6.6±0.4 
2 34.9±3.51 59.4±1.80 6.9±0.1 6.7±0.1 
3 112±2.11 334±3.51 7.0±0.5 6.8±0.3 
4 731±6.50 777±8.50 6.2±0.7 6.4±0.6 
DP with L-AA** 
(5-30% (w/w))    
10 40.2±0.40 62.50±1.50 6.9±0.3 6.7±0.3 
20 45.7±0.88 69.21±4.01 7.0±0.2 6.9±0.1 
30 50.6±3.06 73.72±6.32 7.0±0.4 6.8±0.3 
     
CP composition*** 
    
Decane+span 85 0.80±0.005 - - - 
Decane+TGCR 0.84±0.004 - - - 
*Dispersed phase composition, **L-AA, ***Continuous phase composition 
a Viscosity of dispersed phase in presence of 1% (w/w) MgSO4, b Viscosity of dispersed phase in 
presence of 0% (w/w) MgSO4, c Interfacial tension in presence of 1% (w/w) MgSO4, d Interfacial 
tension in presence of 0% (w/w) MgSO4. 
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Physical and chemical stability 
The liquid microspheres encapsulating L-AA formulated through straight-through MCE were observed 
with optical micrographs to evaluate dav, CV, consistency, homogeneity, and coalescence during 10 d 
of storage at 4 °C.    
The amount of L-AA encapsulated in the microspheres was determined spectrophotometrically. All 
spectral measurements of their methanolic extracts were carried out using a UV/VIS/NIR 
spectrophotometer (UV-1700, Shimadzu, Co., Kyoto, Japan). First, 1 mL of the sample containing 
aqueous microspheres was extracted with 9 mL of methanol, followed by ultrasonication for 20 min. 
The methanolic extracts were then centrifuged (Avanti, Beckman Coulter, Miami, USA) at 20,000 g 
for 30 min at 40 °C. A 1 mL aliquot of the supernatant was diluted 50 times with methanol and then 
injected into a quartz cell with a 10 mm pass length. The absorbance of L-AA in extract was measured 
at 245 nm using an appropriate blank. A representative standard curve of absorbance versus 
concentration gave linear least-squares regression with a coefficient of determination (r2) of 0.9996. All 
experiments were repeated in triplicate and mean values were calculated. The encapsulation efficiency 
(EE) of L-AA in samples was calculated with the equation: 
   EEL−AA =  
𝐶L−AA
𝐶L−AA,0
 × 100                             (3.7) 
where CL-AA is the concentration of L-AA at a given storage time and CL-AA,0 is the concentration of 
L-AA initially encapsulated in the microspheres.  
3.3 Results and Discussion 
Effect of MgSO4 concentration on preparation of liquid microspheres 
Salt content is a key factor affecting the interfacial properties of emulsions and their stability 51,52), the 
study investigated the influence of salt content on the preparation of liquid microspheres using MCE 
and their stability. MCE experiments were conducted using varying concentrations of MgSO4 (0 to 2% 
(w/w)) in the disperse phase containing 2% (w/w) Na-ALG and 5% (w/w) L-AA. The disperse phase 
was fed into the module at 15 kPa, while the flow rate of the continuous phase was set at 10 to 15 mL 
h-1. Stable microspheres were generated using the MC array at a MgSO4 concentration of 1% (w/w). 
The generated microspheres detached smoothly from the MC arrays and had a dav of 15.5 µm and a CV 
of 5.0%, demonstrating their monodispersity (Figs. 3.4a and b). Higher MgSO4 concentrations 
produced polydisperse microspheres, and at 2% (w/w) MgSO4 the microspheres first exhibited a high 
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degree of coalescence and then disappeared (burst). This phenomenon leads to unstable microsphere 
generation. The microspheres obtained at 1% (w/w) MgSO4 remained stable for more than 2 h inside 
the module without coalescence. In contrast, the microspheres generated without adding MgSO4 (Fig. 
3.4c) exhibited little coalescence after 30 min in the MC module, indicating that a certain osmotic 
pressure is needed to generate microspheres by MCE. The dav of microspheres containing 2% (w/w) 
MgSO4 increased to 21 µm with a CV of 16%. 
The disperse phase osmotic pressure (d) for the two-phase systems used in this section can 
be calculated using the van’t Hoff equation 53): 
                                                           ∏d = 𝑖𝑀𝑅𝑇                             (3.8) 
where i is the van’t Hoff factor with a value of 1.51 for MgSO4 and 1 for L-ascorbic acid; M is 
the molar concentration of MgSO4 (kmol m-3), L-AA, and Na-ALG; R is a constant with a value of 8.31 
kPa m3 K-1 mol-1; and T is the thermodynamic temperature (K). d in the absence of MgSO4 was 0.74 
MPa, and d in the presence of MgSO4 ranged from 2.52 to 3.65 MPa. Shimizu et al. 54) and Cheng et 
al. 55) reported that the use of disperse phases with d over a threshold value is needed to stably 
produce W/O emulsions with narrow droplet size distributions by ME using surface-modiﬁed Shirasu 
Porous Glass (SPG) membranes. Similar to ME, MCE also has a certain threshold d necessary to 
generate droplets from MCs. Kobayashi, et al.47) demonstrated that d exceeding a certain threshold 
level stably produces monodisperse W/O emulsions with a CV of less than 3%. Similarly, at a higher 
d, the transport of water molecules via the water–oil interface is suppressed because of weak 
interaction between charged hydrophilic groups and emulsifiers at the interface of W/O emulsions 56). 
The generation stability of liquid microspheres via MC arrays in this study might correspond to this 
mechanism. 
 
 
 
 
 
 
 
 
 80 
(a) 
 
 
 
 
Figure 3.4: (a) Effect of the MgSO4 concentration on the average particle diameter (dav) ( ) 
and CV ( ) of the resultant liquid microspheres. (b, c) Optical micrographs of monodisperse 
liquid microspheres of different MgSO4 concentrations.   
 
The aqueous microspheres generated without adding MgSO4 exhibited coalescence just after 
formation, and their in situ stability was quite low. In contrast, the in situ stability of microspheres 
generated in the presence of 0.5 to 1% (w/w) MgSO4 was very high. The generated microspheres 
remained stable for more than 2 h without any coalescence. It has been reported that microgel particles 
containing ionizable groups become deswollen in an aqueous phase containing salt because increased 
ionic strength decreases the Debye screening length on the particle surface and reduces the repulsive 
(b) 1% (w/w)                                   (c) 0% (w/w)  
50 m 
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electrostatic forces between charged groups on the neighboring particles57,58). In our study, the 
electrostatic interactions at low MgSO4 concentrations between the charged groups (MgSO4, water, and 
L-AA) in the liquid microspheres are in the stable range, leading to microsphere stability and 
monodispersity. In contrast, the electrostatic repulsive force in the liquid microspheres at high MgSO4 
concentrations increases due to higher osmotic pressure, which could burst the microspheres and result 
in less monodispersity. 
 
Effect of Na-ALG Concentration on Preparation of Liquid Microspheres 
Fig. 3.5a illustrates the effect of Na-ALG concentration on the preparation of liquid microspheres using 
MCE. The generated aqueous microspheres contained 0.5 to 4% (w/w) Na-ALG, 1% (w/w) MgSO4, 
and 5% (w/w) L-AA. The disperse phase was supplied into the MC module at 15 kPa with the flow rate 
of the continuous phase was maintained at 10 mL h-1. A decrease in dav of microspheres was observed 
with increased concentration of Na-ALG up to a certain concentration (2% (w/w)), whereas further 
increase in the Na-ALG concentration increased the dav of microspheres. Microspheres with the largest 
dav of 24.6 µm and a CV of 10% were observed at a Na-ALG concentration of 4% (w/w). At a low Na-
ALG concentration of 0.5% (w/w), a relatively broader particle size distribution occurred with a dav of 
20 µm and a CV of 12% (Fig. 3.5b). The optimum condition for successful microsphere production 
was 2% (w/w) Na-ALG, since a narrow size distribution was observed with a dav of 15 µm and the 
smallest CV of 5% at this Na-ALG concentration (Fig. 3.5b). As presented in Table 3.1, the viscosity 
of the disperse phase increased sharply at Na-ALG concentrations exceeding 2% (w/w). Such high 
viscosities of the disperse phase (>100 mPa s) impeded crossing the narrow MCs, and only a few MCs 
made microspheres in the whole MC array plate. The viscosity of the disperse phase containing Na-
ALG increased in the presence of MgSO4 (Table 3.1), which plays a key role in the stability of 
microspheres as well as in microsphere generation. 
ALG microspheres have traditionally been produced by extruding Na-ALG solution from a 
needle into a divalent cationic solution 59, 60). These cationic solutions then induce gelation in 
microspheres. Gelling depends on ion binding (Ca2+< Zn2+< Sr2+< Ba2+). Mg2+ salt is also divalent but 
does not completely gelatinize the solution. This soft gel-like structure could modify the structure of 
ALG, as indicated by reduction of the viscosity of the disperse phase in the presence of MgSO4 (Table 
3.1). Furthermore, this soft gel-like structure creates weak linkage of Mg+2 ions with the ALG structure 
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(Fig. 3.6), giving microspheres better stability. Improved stability in the presence of MgSO4 was 
observed in our study. Factors controlling microsphere production include the MC geometry, the 
composition of two liquid phases, and the type of emulsifiers61,62). The viscosity ratio of the dispersed 
phase to the continuous phase was indicated as an important factor affecting the size of emulsion 
droplets generated by MCE63). In our study, the viscosity of the disperse phase containing Na-ALG 
increased with increased Na-ALG concentration, while interfacial tension remained almost unchanged 
at the Na-ALG concentrations applied (Table 3.1). In our study, dav decreased with increasing Na-ALG 
concentrations (0.5 to 2% (w/w)) and increased with increasing Na-ALG concentrations (2 to 5% 
(w/w)). These results at higher Na-ALG concentrations deviate from the previous study of Chuah et 
al.64), who found size reduction in the resultant emulsion droplets with increasing Na-ALG 
concentration. However, these emulsion droplets do not contain any hydrophilic bioactive substance. 
The result presented in Fig. 3.5a correlated well with the previous MCE study of Kobayashi, et al.49), 
who reported that a decrease in the dav of oil-in-water (O/W) emulsion droplets stabilized using sodium 
dodecyl sulfate is influenced by increased viscosity of the disperse phase (silicone oil).   
 
 
 (a) 
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(b) 
 
Figure 3.5: (a) Effect of Na-ALG concentration on dav ( ) and CV ( ) of the resultant liquid 
microspheres. (b) Droplet size distributions of the liquid microspheres of different Na-ALG 
concentrations. 
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Figure 3.6: Potential mechanism representing the soft gel-like structure of Na-ALG in the 
presence of MgSO4.  
 
Effect of Pressure of the Dispersed Phase on Preparation of Liquid Microspheres 
In order to investigate the effect of the hydraulic pressure of the disperse phase on the size and size 
distribution of the resultant microspheres, the disperse phase pressure was varied from 3 to 25 kPa at a 
fixed continuous flow rate of 10 mL h-1. It should be noted that the flow rate of the continuous phase 
hardly affected the dav and CV of the generated microspheres (Fig. 3.7a), which is advantageous for 
stable preparation of monodisperse liquid microspheres. The disperse phase used here contained 1 to 
4% (w/w) Na-ALG, 1% (w/w) MgSO4, and 5% (w/w) L-AA in Milli-Q water. 
Fig. 3.7b illustrates the effect of the disperse phase pressure on the dav and CV of the 
microspheres prepared at different Na-ALG concentrations. The breakthrough pressure ranged from 3 
to 7 kPa with increasing concentration of Na-ALG. The dav of the microsphere decreased with 
increasing disperse phase pressure. A higher disperse phase pressure produced more active MCs 
generating microspheres. Monodisperse liquid microspheres with dav of 15 to 18 m and CV of 4.5 to 
9.5% were prepared at disperse phase pressures of 10 to 15 kPa, regardless of Na-ALG concentration. 
There was a slight effect on their dav and CV at disperse phase pressures exceeding 15 kPa at Na-ALG 
concentrations of 2 and 3% (w/w). At a certain disperse phase pressure, dav depended on the Na-ALG 
concentration. The dav of microspheres increased with increasing concentration of Na-ALG. The 
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microspheres prepared with 4% (w/w) Na-ALG and generated at a disperse phase pressure of 25 kPa 
had a dav of 26 µm and a CV of 10%. The results obtained from this part of the study confirmed the 
existence of a range of optimum disperse phase pressures for successfully preparing monodisperse 
liquid microspheres. 
(a) 
 
(b) 
 
 
Figure 3.7: (a) Effect of the flow rate of the continuous phase (decane containing 5% (w/w) 
TCGR) on dav ( ) and ( ) of the resultant liquid microspheres containing 2% (w/w) Na-
ALG. (b) Effect of the hydraulic pressure of the disperse phase on the dav and CV of the liquid 
microspheres of different Na-ALG concentrations. Na-ALG concentrations are denoted as ( ) 
for 1% (w/w), ( ) for 2% (w/w), ( ) for 3% (w/w), and ( ) for 4% (w/w), while similar 
open keys represents CVs of microspheres at different Na-ALG concentrations. 
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Effect of different operating conditions in straight-through MCE for encapsulation of L-AA in 
microspheres 
The experiments were conducted using the dispersed phase containing 5% (w/w) L-AA together with 
2% (w/w) Na-ALG and 1% (w/w) MgSO4 in water. The continuous phase contains 5% (w/w) TGCR in 
water-saturated decane. The operating conditions and various physical properties of this two-phase 
system are summarized in Table 3.2. Uniformly sized W/O microspheres were generated from the 
asymmetric through holes with a dav of 18.5 m and a CV of 3.5% (Fig. 3.8). The generation of 
aqueous microspheres from asymmetric through-holes was clearly driven by spontaneous 
transformation of the oil-water interface in and over the microslot, following successful MCE process 
65). The generated microspheres detached smoothly without showing any coalescence. Neves et al. 40) 
successfully encapsulated -carotene in monodisperse oil-in-water (O/W) emulsions with a dav of 28.5 
m and a CV of 3.3% by straight-through MCE.  
Table 3.2: Operating conditions and fluid properties of the continuous and dispersed phases. 
 
System component Operating conditions & physical properties 
Continuous phase  
TGCR concentration % (w/w) 5 
Density (kg m-3) 850 
Viscosity (mPa s) 0.84 
Flow velocity (mm s-1) 2.80 
  
Dispersed phase  
Density (kg m-3) 1640 
Viscosity (mPa s) 35.7 
Encapsulated L-AA % (w/w) 5 
L-AA retention (mg L-1) 0.51 
Flux (L m-2 h-1) 5 
Interfacial tension (mN m-1) 6.8 
              TGCR: Tetraglycerol condensed ricinoleate; L-AA: L-ascorbic acid 
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Figure 3.8: Optical micrograph of the experiment for evaluating preparation conditions of 
aqueous microspheres. The generated microspheres contain 5% (w/w) L-AA. 
 
Dispersed phase flux is an important parameter in MCE that correlates with droplet productivity in 
the stable microsphere generation zone. Fig. 3.9a depicts the effect of Jd on the dav and CV of the 
generated aqueous microspheres. The dispersed phase constitute 5% (w/w) L-AA, 2% (w/w)  Na-ALG 
and 1% (w/w) MgSO4 in water, while the continuous phase includes 5% (w/w) TGCR in water-
saturated decane. The straight-through MCE was conducted by maintaining Jd between 5 and 20 L m-2 
h-1, while the continuous phase flow velocity was maintained constantly at 2.8 mm s-1.  
The dav and CV quite slowly increased with increasing Jd until its critical value of 20 L m-2 h-1. 
Outflow of the dispersed phase and unstable microsphere generation were observed after crossing the 
critical Jd of 15 L m-2 h-1 (Fig. 3.9b). The resultant microspheres had dav of 18.7 to 20.7 m and CV of 
3.6 to 6.0%. The average generation frequency per active asymmetric MC (fav,MC) was calculated from 
number of frames taken to generate 20 microspheres. As the number of frames per second for each 
video was already known from the high speed video system and could be used to calculate the 
frequency of microsphere generation: 
𝑓 =   
𝑛𝑓
𝑧
 × 𝑦                         (3.9) 
where 𝑓  is the frequency of microsphere generation (Hz), 𝑛𝑓  is the number of microspheres 
counted, 𝑧 is the number of frames taken to generate 𝑛𝑓 droplets and 𝑦 is the frame rate of the image 
sequence (Hz). The fav,MC increased with increasing Jd only in a narrow range. At Jd above 10 L m-2 h-1, 
there was no further increase in fav,MC (Fig. 3.10). The influence of Jd on the microsphere generation 
   200 m 
Jd = 5 L m-2 h-1 
dav = 18.5m 
CV = 3.3% 
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frequency per MC array chip (fMCA) is also presented in Fig. 3.10. This microsphere generation 
frequency can be estimated by: 
𝑓MCA =  
𝑄d
𝑉av 
=  
6𝑄d
𝜋𝑑av
3                  (3.10) 
where Vav is the average droplet volume. fMCA increased linearly with increasing Qd at Jd of 5 to 15 
L m-2 h-1. The monodisperse microspheres prepared at Jd of 15 L m-2 h-1 had a maximum productivity 
of 10.6×104 s-1. In this case, we observed that 50% of asymmetric MCs generated uniformly sized 
microspheres at fav,MC of 16.2 s-1. The maximum dispersed phase flux for preparing monodisperse 
emulsions usually increases with decreasing the dispersed phase viscosity 66). 
(a) 
 
    
Figure 3.9: (a) The average diameter (dav) and coefficient of variation (CV) of the microspheres 
with increasing dispersed phase flux (Jd). ( ) denotes the dav of the microspheres and ( ) 
indicates their CV. (b) optical micrographs of microsphere generation at Jd of 10 and 20 L m-2 h-
1. 
 
 200 m  200 m 
Jd = 20 L m-2 h-1 Jd = 10 L m-2 h-1 
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Figure 3.10: Effect of dispersed phase flux on microsphere generation Frequency and mean 
productivity containing L-AA. ( ) denotes microsphere generation frequency per each active 
asymmetric microchannel (fMC) and ( ) denote microsphere Generation frequency per 
microchannel array chip (fMCA). 
 
Fig. 3.11a illustrates the effect of L-AA concentration on the dav and CV of the aqueous 
microspheres prepared by straight-through MCE. The L-AA concentration in the dispersed phase varied 
from 5 to 30% (w/w) in the presence of 2% (w/w) Na-ALG solution and 1% (w/w) MgSO4. Successful 
MCE was conducted with different concentrations of L-AA by keeping Jd at 5 L m-2 h-1 and Uc at 2.8 
mm s-1 (Fig. 3.11b). The dav and CV of the resultant microspheres hardly changed up to 20% (w/w) L-
AA. Their CV was below 6%, demonstrating monodispersity of the aqueous microspheres obtained 
here. The dav and CV of microspheres increased to 20.5 m and 10.7% at the L-AA concentration of 
30% (w/w) (Fig. 3.11b). The variation in monodispersity with increasing the L-AA concentration can 
be attributed to the interactions between the MC and terrace surfaces with the dispersed phase 
containing L-AA in the presence of a very thin layer of the continuous phase. Increase of the L-AA 
concentration in the dispersed phase is assumed to cause stronger interactions with MC and terrace 
surfaces, hence leading towards less monodispersity. 
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(a) 
 
(b) 
      
          
Figure 3.11: (a) Effect of L-AA concentration on the average diameter (dav) and coefficient of 
variation (CV) of the microspheres. (b) Optical micrographs showing generation of aqueous 
microspheres with increasing L-AA concentration (5-30% (w/w)). 
 
 200 m  200 m 
5% (w/w) L-AA 10% (w/w) L-AA 
 
20% (w/w) L-AA 
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The results obtained here were comparable with our recent study using a grooved MC array. In that 
study the dav of the aqueous microspheres increased with increasing the L-AA concentration. Our 
previous studies also encapsulated L-AA of high concentration up to 30% (w/w) in W/O and W/O/W 
emulsions with similar compositions in the absence of Na-ALG.41,67,68) Viveros-Contreras et al.69) 
encapsulated 1% (w/w) L-AA in calcium alginate matrix (2% (w/w)). The encapsulation in calcium 
alginate matrix improved the retention, microstructure and micropore volume of the resultant product. 
Devi and Kakati70) also encapsulated L-AA in smart porous microparticles based on gelatin/Na-ALG 
polyelectrolyte complex. These smart microparticles have the potential to improve the stability and 
delivery of L-AA. 
Stability evaluation of aqueous microspheres encapsulating L-AA 
MCE using grooved MC arrays provides useful information regarding the basic behaviors of 
microsphere generation, whereas the drawback lies in low droplet productivity due to the low-density 
arrangement of microgrooves on a chip 71). In contrast, straight-through MCE has much higher through-
put capacity of monodisperse microspheres,66) making it possible to collect microspheres sufficient for 
stability evaluation. 
The monodisperse aqueous microspheres encapsulating 20% (w/w) L-AA were stored at 40±1 oC 
for 10 d. These microspheres were obtained by keeping Jd at 5 L m-2 h-1. Immediately after collection, 
the microsphere-containing dispersion had a light yellowish turbid appearance with good flowability. 
Its appearance did not change with storage time. Fig. 3.12 depicts time changes in the dav and CV of the 
resultant microspheres encapsulating L-AA. There was slight increase in their dav and CV during 
evaluated storage period of 10 d. Their dav and CV after 10 d of storage were 22.3 m and 10%, 
respectively. 
Khalid et al.41) These authors pointed out the increased osmotic pressure as a key factor for 
increased in dav of W/O/W emulsions. 2-20% (w/w) L-AA was encapsulated in solid lipid 
microcapsules using microfluidic approachComunian et al.72) The average diameter of these particles 
varied from 170 to 342 m during 30 d of storage period.  
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(a) 
 
(b) 
 
Figure 3.12: (a) Storage stability of the microspheres during 10 d of storage at 40 oC. ( ) 
denote their average diameter (dav) and ( ) denote their coefficient of variation (CV). (b) 
Optical micrographs at d 1 and 10. Arrows indicate bigger microspheres. 
 
Encapsulation efficiency of L-AA in aqueous microspheres 
The freshly prepared aqueous microspheres containing L-AA had an initial concentration of 2.7 mg 
mL-1 and regarded as 100% encapsulated efficiency (EE), since in MCE it was difficult to maintain the 
volume fraction of the microspheres (MS) with passage of time in comparison to conventional 
emulsification techniques. The MS during MCE corresponds to 0.62%. Fig. 3.13 indicates the retention 
and EE of aqueous microspheres. The EE gradually decreased with storage time and exhibited 71% EE 
of L-AA after 10 d of storage at 40oC. This high EE at 40oC can be ascribed to very mild generation 
 100 m 
Day 1  
 
Day 10 
 
 100 m 
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process of microspheres in straight-through MCE. Moreover, in MCE the generation was based upon 
difference in interfacial tension rather than high energy shear forces. In comparison the conventional 
emulsification methods produce emulsions with larger droplet sizes and have low energy and 
encapsulation efficiencies 73). 
Our results can be considered well when compared to other L-AA encapsulation studies. Farhang et 
al.74) encapsulated L-AA in liposomes and showed that liposomes have EE of 30% L-AA after 7 weeks 
at 25oC. Rozman and Gašperlin75) encapsulated L-AA in W/O microemulsions and reported 60% EE in 
the samples stored at room temperature for 28 d. Khalid et al.68) encapsulated high concentration of L-
AA in food grade W/O emulsions prepared with either soybean or moringa oil and reported EE of 30% 
after 30 d of storage at 25oC.  Comunian et al.76) encapsulated L-AA by the double emulsion followed 
by complex coacervation and obtained EEs in the range of 15-40% for samples stored at 37oC for 60 d. 
Comunian et al.72)   recently encapsulated L-AA in solid lipid microcapsules containing different 
coating agents by glass microfluidic device and obtained EE in the range of 46-96% when stored for 30 
d at 20oC. 
 
Figure 3.13: Encapsulation efficiency and retention of 20% (w/w) L-AA during 10 d of Storage. (
) denotes the L-AA retention in mg mL-1, while ( ) indicates the encapsulation efficiency of 
L-AA in the aqueous microspheres. 
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Chapter 4  
 
Preparation and characterization of water-in-oil emulsions loaded 
with high concentration of L-ascorbic acid* 
 
 
 
 
 
 
 
 
 
 
 
________________________________________________________________________ 
*This chapter has been published as Khalid N, Kobayashi I, Neves MA, Uemura K, Nakajima M. 
Preparation and characterization of water-in- oil emulsions loaded with high concentration of L-
ascorbic acid. LWT-Food Science and Technology.2013, Vol. 51, no. 2, p. 448-454.   
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4.1 Introduction 
Emulsions are defined as dispersions of droplets of one liquid in another, with a droplet diameter 
generally within the range of 0.1-100 μm 1). According to the definition of International Union of Pure 
and Applied Chemistry (IUPAC) (1971), “In an emulsion liquid droplets and/or liquid crystals are 
dispersed in a liquid”. An emulsion consists of at least two immiscible phases such as oil and water, 
with one of the phases dispersed in the other 2). A dispersion consisting of oil droplets dispersed in an 
aqueous phase is called an oil-in-water (O/W) emulsion. O/W food emulsions include mayonnaise, 
milk, soups and sauces. On the other hand, a dispersion consisting of water droplets dispersed in an oil 
phase is called as water-in-oil (W/O) emulsion. Typical examples of W/O food emulsions are 
margarine, butter, and spreads. 
Vitamins are complex organic compounds that the body needs in small quantities and are 
essential in carrying vital functions of human body. These vitamins must be supplied in the diet, as the 
human body cannot synthesize them. One such example is Vitamin C (L-ascorbic acid (L-AA)) which 
can be found in various fruits and leafy vegetables. The exact amount of vitamin C that the body needs 
is unknown, and is thought to be around 45 to 75 mg/day3). L-AA is a white, crystal-shaped organic 
compound, and can be synthesized from glucose or extracted from certain natural sources such as 
orange juice.  
Vitamin C plays a vital role in our body  synthesis of collagen tissue around bones, teeth, 
cartilage, skin, and damaged tissue4). Similarly, this vitamin is needed to activate various enzymes 
related to the nervous system, hormones, and detoxification of drugs  and poison in the liver5). L-AA 
plays a role as antioxidant, as its solubility in water enables it to work as antioxidant within our body 
fluids. Vitamin C increases the rate of absorption of iron, calcium, and folic acid. Vitamin C reduces 
allergic reactions, boosts the immune system, stimulates the formation of bile in the gallbladder, and 
facilitates the excretion of various steroids6).  Because of these favorable effects, vitamin C has been 
used in cosmetics and pharmaceutical applications7). However, its rapid degradation in aqueous 
solutions is still a major drawback to design a variety of functional products. 
Vitamin C is highly soluble in water and alcohol, and is easily oxidized in the solubilized form 
and its oxidation occurs very quickly in an alkaline environment especially at higher temperatures 
(>50oC)8). Similarly, light and heat damage vitamin  C in fruits and vegetables9). Degradation of 
vitamin C proceeds both aerobic and anaerobic pathways and depends upon many factors such as 
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oxygen, heat, light, storage temperature, and storage time10,11). The degradation processes of L-AA are 
very complex and contain a number of oxidation/reduction with some intermolecular 
rearrangements5,12). Fig. 4.1 shows pathway of L-AA degradation in aqueous solution8). Degradation of 
L-AA results in brownish color possibly due to interaction with amino acids5). 
 
Figure 4.1: Degradation pathways of L-AA in aqueous solution (a) represents L-AA, (b) Dehydro-
L-AA, (c) 2,3- diketo-L-gluconic acid and (d) represents L-xylosome (adopted from Lee et al. 5). 
 
L-AA is very unstable in aqueous solution. Encapsulation and emulsification are widely used 
techniques for protection of this vital vitamin13,14). In most cases 1 to 5% of this vitamin is emulsified 
and encapsulated5,13). Both W/O and Water-in-Oil-in-Water (W/O/W) emulsification methods have 
been used for encapsulating vitamin C4,5,13,15,16). In these emulsions the interface acts as a barrier for 
oxygen to prevent encapsulated vitamin C from undergoing oxidation –induced degradation. 
Foreseeing higher biological activity of L-AA, the authors formulated W/O emulsions 
containing high concentration of L-AA. The main purpose of this work is to elucidate that, up to what 
extent stable W/O emulsions can be prepared by incorporating higher amount of L-AA. The effect of 
homogenization speed, concentration of L-AA solubilized in a dispersed phase, stability of prepared 
emulsions, and retention kinetics of L-AA in the prepared emulsions were also investigated. 
4.2 Materials and methods 
Materials 
L-AA (99.9% purity), magnesium sulfate, sodium bicarbonate, acetic acid, 2,6-dichlorophenol 
indophenol, metaphosphoric acid were purchased from Wako Pure Chemical Ind. (Osaka, Japan). All 
of these reagents were of analytical grade. Tetraglycerin monolaurate condensed ricinoleic acid ester 
(CR-310) was supplied by Sakamoto Yakuhin Kogyo (Osaka, Japan). Soybean oil (Wako Pure 
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Chemical Ind.) and Moringa oleifera oil (Yamakei Co., Ltd., Osaka, Japan) were used as continuous-
phase medium. 
 
Preparation of W/O emulsions 
W/O emulsions were prepared from a dispersed aqueous phase and a continuous oil phase. The 
dispersed phase contained (5 to 30 g 100 mL-1) ascorbic acid and (1 g 100-1) magnesium sulfate. The 
magnesium sulfate was added to the dispersed phase to balance the ion-ion interaction and these 
magnesium ions acts as counter ions to stabilize the ascorbic acid by ion shielding effect as previously 
described by Lee et al.5). Soybean oil or Moringa oil, each containing (5 g 100 g-1) CR-310 as 
emulsifier, was used as continuous phase separately. The volume fraction of the dispersed aqueous 
phase (d) was fixed to 30 g 100 g-1. . Thirty mL of dispersed phase were added to seventy mL of 
continuous phase at room temperature (~25oC), followed by emulsification at various rotation speed for 
5 min with a polytron homogenizer (PT-3000 Kinematica-AG, Littace, Switzerland).  
 
Determination of average droplet diameter 
For analysis of prepared W/O emulsions, microscopic observations were made with an optical 
microscope (DM IRM, Leica Microsystems, Wetzler, Germany). From these micrographs droplet size 
was measured and expressed as average droplet diameter (dav). To determine dav, the diameters of 250 
droplets were measured with an image processing software (WinRoof ver. 5.6, Mitani Co., Fukui, 
Japan). Coefficient of variation (CV) was used as an indicator of droplet size distribution of the 
prepared emulsion. The CV (%) was defined as follows: 
𝐶𝑉 = (
𝜎
𝑑𝑎𝑣
)  × 100                  (4.1) 
where  is the standard deviation of the droplet diameter (µm). 
 
Measurement of fluid properties 
Viscosity, density, and interfacial tension between the dispersed and continuous phases were measured 
at 25 oC. Viscosity was measured with a vibro viscometer (SV-10, A&D Co., Ltd., Tokyo, Japan). 
Density was measured with a density meter (DA-130 N, Kyoto Electronics Manufacturing Co., Ltd., 
Kyoto, Japan). The interfacial tension was measured with a Fully Automatic Interfacial Tensiometer 
(PD-W, Kyowa Interface Sciences Co., Ltd., Saitama, Japan) using a pendant drop method. 
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Physical stability of W/O emulsions 
Stability studies were carried out either at 4 or 25 oC. The stability test were carried out for 30 days, 
and emulsions containing 10, 20 and 30 g 100 g-1 L-AA were analyzed with regard to droplet size, 
droplet size distribution, color, and physical state. The droplet size was measured using image 
processing software. Color and physical state were observed qualitatively 15). 
 
Retention kinetics of L-AA in W/O emulsions 
The concentration of vitamin C in W/O emulsions was determined according to 2,6- dichlorophenol 
indophenol titrimetric method No. 967.21 of AOAC17) with slight modification. Briefly 1 g of W/O 
emulsion was mixed with 10 mL of ethanol, and then treated by sonication for 20 min, followed by 
centrifugation for 3 min at 3000 rpm. One mL of supernatant was used to measure L-AA concentration. 
All experiments were repeated in triplicate and mean value were calculated. The retention rate (r) 
calculated by using Eq. 4.2 was defined by the ratio of measured L-AA concentration (CAA) to initial L-
AA concentration (CAA,0). 
𝑟 = (
C𝐴𝐴
C𝐴𝐴,0
)  ×   100                (4.2)                        
 
Statistical analysis 
Analysis of variance (ANOVA) tests were used to analyze the characterization data at a confidence 
level of 95 %. Least significant difference (LSD) test with 95 % confidence level (P<0.05) was used to 
compare dav at different homogenization speed and L-ascorbic acid concentration in the dispersed 
phase. The LSD was calculated using Statistix 8.1 software (Tallahassee, USA) and according to the 
method described by Steel et al.18). 
4.3 Results and discussion 
Effect of homogenization speed on droplet size of W/O emulsions 
Fig. 4.2a shows the effect of homogenization speed on dav and CV of the prepared W/O emulsions 
containing 10 g 100 g-1 L-AA. W/O emulsions were successfully prepared using 5000 rpm or higher, 
whereas lowering homogenization speed resulted in incomplete homogenization with visible phase 
separation. dav of the W/O emulsions prepared gradually decreased from 3.0 to 2.0 m by increasing 
the homogenization speed. There was a significant difference (p<0.05) in their dav with increasing 
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homogenization speed. The CV of the prepared W/O emulsions ranged between 13 % and 22 % with 
polydispersity. 
 
(a) 
        
 
 
 
 
 
(b) 
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(c) 
         
 
Figure 4.2: (a) Effect of homogenization speed on average droplet diameter (dav) and coefficient 
of variation (CV) of W/O emulsions containing 10 g 100 g-1 L-AA. (■) represents soybean oil and 
(□) represents Moringa oil. Different letters (a, b, c, d) represent W/O emulsions (soybean and 
Moringa oil) have significantly difference dav at the 95% confidence level (p=0.05). The symbol 
(●), (○) indicates CV of soybean oil and Moringa oil. (b) Effect of homogenization speed on 
temperature of prepared W/O emulsions. The fitted line had a coefficient of determination (R2) of 
> 0.98. (c) Effect of homogenization speed on L-AA retention in prepared W/O emulsions. AA 
stands for L-AA. (●) represents 10 g 100 g-1, ( ) represents 20 g 100g-1 AA and (■) presents 30g 
100 g-1 L-ascorbic acid. 
 
 
Homogenization at 15000 rpm increased the system temperature to more than 70 oC (Fig. 
4.2b), leading towards reduction in L-AA retention to 82 to 85 g 100 g-1 in prepared W/O emulsions 
(Fig. 4.2c) which agrees well with results of Lee et al.5). The production of emulsion droplets requires 
high energy input. The droplet size of an emulsion produced by rotor-stator homogenization process 
depends on the rotational speed which represents the energy of homogenization. The higher the energy 
applied in the homogenization of emulsion, the smaller the droplet size produced. However, uniformity 
of droplet size distribution depended on the completion of droplet size reduction which required more 
energy 19). W/O emulsions prepared at 7000 rpm incorporated mild heat (42 oC) in the system and 
showed better L-AA retention rate > 95 g 100 g-1. This homogenization speed was considered adequate 
and therefore applied to prepare W/O emulsions in later sections. Increasing the homogenization speed 
results in incorporation of heat in emulsion system, and this heat might result in destruction of L-AA 5). 
 
 
 106 
Effect of L-AA concentration in dispersed phase 
Fig. 4.3 shows the effect of L-AA concentration in the dispersed phase on dav and CV of prepared W/O 
emulsions. There was no significant difference (p>0.05) in their dav with increasing L-AA concentration 
from (5 to 30 g 100 g-1)  in W/O emulsions. The oil type also did not affect droplet size of the prepared 
W/O emulsions. Both the soybean and Moringa oleifera oil has well balanced fatty acid profile (Table 
4.1) with good amount of tocopherols. Their dav ranged from 2.3 to 3.1 µm and slowly increased with 
increasing L-AA concentration. Akhtar et al.15) reported that the oil droplet size of W/O/W emulsions 
containing 1 g 100 g-1 L-AA ranged between 14.8 to 17.0 µm. 4) also reported that the oil droplet size of 
different W/O/W emulsions containing 1 g 100 g-1 L-AA varied from 15.6 to 42.2 µm. These previous 
studies regarding W/O/W emulsions containing L-AA did not mention their internal aqueous droplet 
size. Major factors that affect dav of emulsions are emulsion composition including the amount of 
emulsifier, and processing conditions. They play a vital role in determination of emulsions stability 
5,13,15).  
Table 4.1: Fatty acid composition of soybean and Moringa oil 20, 21). 
 
  
Range (g 100 g-1) 
Fatty acid profile 
 
soybean oil 
 
Moringa oleifera oil 
Myristic (14:0)  
 
0.1 
 
0-0.13 
Palmitic (16:0)  
 
11 
 
5.57-9.26 
Palmitoleic (16:1)  0.1 
 
1-3.7 
Stearic (18:0) 
 
4 
 
2.27-8.3 
Oleic (18:1) 
 
23.4 
 
67.7-76 
Linoleic (18:2)  
 
53.2 
 
0.27-1.29 
Linolenic (18:3)  
 
7.8 
 
0.18-0.45 
Arachidic (20:0)  
 
0.3 
 
1.98-4.7 
Gadoleic (20:1)  
 
- 
 
1.2-2.7 
Behenic (22:0) 
 
0.1 
 
3.72-7.4 
Total PUFA*   57.87 
 
0.4-1.4 
      *Total polyunsaturated fatty acid 
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Figure 4.3: Effect of different concentration of L-AA on average droplet diameter (dav) and 
coefficient of variation (CV) of W/O emulsions prepared at a homogenization speed of 7000 rpm. 
(■) indicates soybean oil and (□) indicates Moringa oil dav. The symbol (●), (○) indicates CV of 
soybean oil and Moringa oil. 
 
 
 
  Viscosity (), viscosity ratio () and interfacial tension () are key fluid properties to 
investigate the droplet size of any emulsion. The soybean oil (c) had viscosity of 63.7 mPa s, while 
Moringa oil (c) had slightly higher viscosity of 68.7 mPa s.  (viscosity ratio) is a dimensionless 
parameter and defined as the ratio of the viscosity of the dispersed phase (d) to the viscosity of 
continuous phase (c), that gives idea about the droplet size under various conditions 22).  in different 
concentrations of W/O emulsions containing L-AA was in between 0.05 to 0.1 (Fig.  4.4a). The gradual 
increase in d and  caused the slow increase in dav of the prepared W/O emulsions (Fig. 4.4).  
between the soybean oil and Milli-Q water containing different concentration of L-AA (5 to 30 g 100 g-
1 ) was in between 4.5 to 6.3 mN m-1 (Fig.  4.4b), whereas it varied between 5.7 to 6.5 mN m-1 with 
increasing L-AA concentration in Moringa oil. The decrease in interfacial tension by hydrophobic 
emulsifier (CR-310) improves the stability of oil/water interface, that results in stable formation of 
W/O emulsions23). 
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(a) 
 
 
(b) 
                              
 
 
Figure 4.4: (a) Variation of viscosity of the dispersed phase, continuous phase and viscosity ratio 
of soybean and Moringa oil as a function of L-AA concentration in the dispersed phase. ηd is the 
viscosity of dispersed phase (●), ηc is the viscosity of continuous phases (black line Moringa oil 
and gray line soybean oil) and ξ is the viscosity ratio (soybean oil (■) and (▲) Moringa oil) 
defined as ηd/ηc (b) Variation of the interfacial tension of soybean oil (●) and Moringa oil (○) 
as a function of L-AA concentration. 
 
 
Physical stability of W/O emulsions containing L-AA at 4 and 25oC 
Preparation of food-grade W/O emulsions containing vegetable oils (e.g., soybean oil and canola oil) is 
a challenging subject due to stability problems 15). The emulsion stability is defined in terms of physical 
and chemical stability of the emulsion.  
Fig. 4.5 shows the stability of W/O emulsions containing 10 to 30 g 100 mL-1 L-AA in the 
dispersed phase upon storage at 4 oC. There was little variation in their droplet size over 30 d of storage 
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period, and their dav remained in the range of 2.3 to 3.0 µm either in case of Moringa oil or soybean oil. 
The oil type did not affect the resultant droplet size, regardless of L-AA concentration. All the W/O 
emulsions stored at 4oC remained stable without any phase separation for more than 30 days. Fig. 4.6 
depicts the stability of W/O emulsions containing 10 to 30 g 100 mL-1 L-AA in the dispersed phase 
stored at 25 oC. Slight increases in dav were seen in all the emulsions upon storage. The W/O emulsions 
stored at 25 oC had dav of 2.5 to 3.4 µm for the soybean oil-containing systems and of 2.6 to 2.9 µm for 
the Moringa oil-containing systems during 30 d of storage period. All emulsions remained stable over 
30 d, followed by a formation of thin aqueous layer at the bottom. Slight increase in CV up to 20 % at 
4 oC and 25 oC was seen in W/O emulsions containing Moringa oil. As for W/O emulsions containing 
soybean oil, their CV varied between 15 and 17 % at 4 oC and 25 oC, respectively. 
 
(a) 
 
(b) 
 
 
Figure 4.5: Stability of W/O emulsions at 4oC. (a) Soybean oil. (b) Moringa oil. The symbols (●) 
indicates 10 g 100 g-1 L-AA, (■) 20 g 100 g-1 L-AA, and (▲) 30 g 100 g-1 L-AA. The symbols (○) 
indicates CV of 10 g 100 g-1 L-AA, (□) 20 g 100 g-1 L-AA and () indicates 30 g 100 g-1 L-AA. 
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(a) 
 
 
 
(b) 
 
 
Figure 4.6: Stability of W/O emulsions at 25oC. (a) Soybean oil. (b) Moringa oil. The symbols (●) 
indicates 10 g 100 g-1 L-AA, (■) 20 g 100 g-1 L-AA, and (▲) 30 g 100 g-1 L-AA. The symbols (○) 
indicates CV of 10 g 100 g-1 L-AA, (□) 20 g 100 g-1 L-AA and () indicates 30 g 100 g-1 L-AA. 
 
 
Organoleptic evaluation plays an important role in checking the physical stability of any 
emulsion15). As for organoleptic evaluation, we qualitatively observed color, physical appearance and 
physical state of prepared W/O emulsions. The emulsions store at 4 oC maintained whitish color for 
more than 30 d of storage, while those stored at 25 oC became first a lightly yellowish color after 17 d, 
followed by yellowish color that indicated destabilization of L-AA in the emulsions. As for physical 
appearance, the W/O emulsions containing soybean oil had flow-like consistency, regardless of storage 
temperature. By contrast, the W/O emulsions containing Moringa oil had solid like consistency at 4 oC 
and flow like consistency at 25 oC. The chemical stability of L-AA encapsulated in the W/O emulsions 
prepared in this study will be described in the next section. 
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Retention kinetics of W/O emulsions containing L-AA 
The degradation of L-AA has been considered one of the major causes of quality and color changes 
during processing and storage of food products. The chemical stability of L-AA encapsulated in 
emulsions and creams has been studied in emulsions and creams by several research groups 4,5,13,24,25). 
L-AA and its derivatives have been used in a variety of food products and cosmetic formulations as an 
antioxidant, pH adjuster, anti-aging and photoprotectant 25). The control of instability of L-AA poses a 
significant challenge in the development of cosmetic and food-grade formulations. Fig. 4.7 shows L-
AA retention in W/O emulsions stored at 4 oC in the presence of light. The prepared W/O emulsions 
containing 10 to 30 g 100 g-1 L-AA exhibited 50 g 100 g-1 retention of L-AA after 30 days of storage. 
There was no significant difference (p>0.05) between two different continuous phases, as they hardly 
affected L-AA retention after each storage period. By contrast, the W/O emulsions containing L-AA 
stored at 25 oC under darkness exhibited 30 g 100 g-1  retention of L-AA after 30 d storage (Fig. 4.7). 
The temperature has a major effect on L-AA degradation 8). The observed retention rates were in 
accordance with a previous study by 5). Those authors concluded that encapsulation of L-AA in W/O/W 
emulsions had beneficial effect on release profile of L-AA 9). demonstrated that rate of oxidative 
degradation in L-AA cream formulation in the dark was about 70 times slower than that in presence of 
light. L-AA retention in Milli-Q water at 25 oC is also presented in Fig. 4.7. The L-AA retention in W/O 
emulsions was higher than that in Milli-Q water during their storage. Rapid ionization in aqueous 
solution results in rapid loss of L-AA 8,26). 
 
(a) 
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(b) 
 
 
Figure 4.7: (a) L-AA retention in W/O emulsions containing soybean oil stored at 4 oC and 25 oC. 
(b) L-AA retention in W/O emulsions containing Moringa oil stored at 4 oC and 25 oC. The 
symbols (●) indicates 10 g 100 g-1 L-AA, (■) 20 g 100 g-1 L-AA, and (▲) 30 g 100 g-1 L-AA in W/O 
emulsions at 4 oC and the symbols (○) indicates 10 g 100 g-1 L-AA, (□) 20 g 100 g-1 L-AA and () 
indicates 30 g 100 g-1 L-AA in W/O emulsions at 25 oC. The symbol (▼) indicates L-AA retention 
in Milli-Q water stored at 25 oC.   
 
  
Fig. 4.8 shows the retention kinetics of L-AA in W/O emulsions during storage. In (A/A0) 
represents the fraction of remaining L-AA in the emulsions, where A is the L-AA concentration after 
storage and A0 is the initial L-AA concentration. The results indicate that the L-AA retention follow 
first order kinetics with respect to time. The retention of L-AA as first-order kinetics was also reported 
by different research groups 27). The retention kinetics of L-AA in W/O emulsions stored at 4 and 25 oC 
was also evaluated by the following first-order kinetics equation: 
𝐴
𝐴0
= exp(−𝑘𝑡)                       (4.3) 
where k is the rate constant and t is the storage time. The rate constant of the first-order 
kinetics was calculated to best-fit the experimental results by the regression function of Microsoft 
Excel 2007. The lines fitted by eq. 2 are presented in Fig. 4.8. The calculated coefficients of 
determination (R2) for all W/O emulsions were > 0.95, indicating that fitting application of the first-
order kinetics is reasonable. Rate constants and half-life of L-AA retention in different W/O emulsions 
are also presented in Table 4.2. There was no significant difference (p>0.05) in the retention kinetics of 
two different continuous phases (soybean oil or Moringa oil). The observed half-life for W/O 
emulsions (soybean oil and Moringa oil) at 4 oC is > 30 d and >19 d for emulsions at 25 oC 
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respectively. The half-time values for the W/O emulsions stored at 4oC show a better stability, 
compared to those stored at 25 oC. 
Table 4.2: Rate constants and half-life of ascorbic acid degradation in different W/O emulsions 
Treatment rate equation R2 
rate 
constant 
k (day)-1 
Average 
value of 
rate 
constant k 
(day)-1 
half life 
(day) 
t1/2=0.693/k 
4°C (Soybean oil), 10 g 100 g-1 ln(A/Ao) = -0.0183t  0.95 0.018 
0.022 31.5 4°C (Soybean oil), 20 g 100 g-1 ln(A/Ao) = -0.0242t   0.96 0.024 
4°C (Soybean oil), 30 g 100 g-1 ln(A/Ao) = -0.0249t   0.98 0.025 
      
25°C (Soybean oil), 10 g 100 g-1 ln(A/Ao) = -0.0361t   0.94 0.036 
0.035 19.8 25°C (Soybean oil), 20 g 100 g-1 ln(A/Ao) = -0.0350t  0.94 0.035 
25°C (Soybean oil), 30 g 100 g-1 ln(A/Ao) = -0.0347t  0.98 0.035 
      
4°C (Moringa oil), 10 g 100 g-1 ln(A/Ao) = -0.0178t   0.95 0.018 
0.023 30.1 4°C (Moringa oil), 20 g 100 g-1 ln(A/Ao) = -0.0247t   0.97 0.025 
4°C (Moringa oil), 30 g 100 g-1 ln(A/Ao) = -0.0247t   0.97 0.025 
      
25°C (Moringa oil), 10 g 100 g-1 ln(A/Ao) = -0.034t   0.95 0.034 
0.035 19.8 25°C (Moringa oil), 20 g 100 g-1 ln(A/Ao) = -0.0346t   0.98 0.035 
25°C (Moringa oil), 30 g 100 g-1 ln(A/Ao) = -0.0352t   0.98 0.035 
 
 
 
 
(a) 
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(b) 
 
 
Figure 4.8: (a) Retention kinetics of W/O emulsions containing soybean oil stored at 4 oC and 25 
oC. Rate constants, coefficients of determination, and half-life are presented in Table 2. (b) 
Retention kinetics of W/O emulsions containing Moringa oil stored at 4 oC and 25 oC . Rate 
constants, coefficients of determination, and half-life are presented in Table 2. The symbols (●) 
indicates 10 g 100 g-1 L-AA, (■) 20 g 100 g-1 L-AA, and (▲) 30 g 100 g-1 L-AA in W/O emulsions at 
4 oC and the symbols (○) indicates 10 g 100 g-1 L-AA, (□) 20 g 100 g-1 L-AA and () indicates 30 g 
100 g-1 L-AA in W/O emulsions at 25 oC. 
 
 
 The photolysis kinetics of L-AA in cream formulations was investigated by Ahmad et al.9). 
They concluded that L-AA retention follows first-order kinetics and this retention is affected by the 
concentration of active ingredients, pH, and viscosity of the medium. Watanabe et al.28) concluded that 
retention of catechins follows first-order kinetics in O/W emulsions containing L-AA. More research is 
needed to completely elucidate the retention profile of L-AA in W/O emulsions containing higher 
concentration of L-AA.  
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Chapter 5  
 
Preparation and characterization of water-in-oil-in-water emulsions 
containing a high concentration of L-ascorbic acid* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
________________________________________________________________________ 
*This chapter has been published as Khalid N, Kobayashi I, Neves M, Uemura K, Nakajima M.  
Preparation and characterization of water-in-oil-in-water emulsions containing a high concentration of 
L-ascorbic acid. 2013. Bioscience, Biotechnology, and Biochemistry. Vol. 77, no. 6, p. 1171-1178. 
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5.1 Introduction  
Double emulsions are categorized as complex dispersion systems and are regarded as emulsions of 
emulsions 1). Double emulsions are further classified into water-in-oil-in-water (W/O/W) and oil-in-
water-in-oil (O/W/O) emulsions. Most industrial applications utilize W/O/W emulsions, whereas the 
applicability of O/W/O emulsions is still limited, mainly due to solubility issues. W/O/W emulsions 
have attracted a great deal of interest for various applications, including foods,2) pharmaceuticals,3) and 
cosmetics.4) For instance, they have been utilized as controlled-release drug-delivery systems (DDS),5) 
as templates for preparing microcapsules with enhanced stability  and controlled release of functional 
food components,6,1) and in the formulation of reduced-calorie food emulsions 7). 
Food-grade W/O/W emulsions are usually prepared by two-step emulsification using conventional 
mechanical emulsification devices (e.g., rotor-stator homogenizers and high-pressure homogenizers). 
They are mostly polydisperse, and structurally heterogeneous. W/O/W emulsions with high 
monodispersity can be prepared by membrane emulsification8, 9) or microchannel emulsification10, 11) as 
the second-step emulsification. In W/O/W emulsions, oil droplets containing inner aqueous droplets as 
dispersed phase are further dispersed in an outer aqueous phase. Compared to single emulsions, 
W/O/W emulsions are capable of encapsulating hydrophilic components with higher entrapment yields 
and stability against degradation 1). These advantages make them useful as dispersion systems for 
encapsulating food-grade hydrophilic components.   
Stabilizing double emulsions is a major challenge for the food, cosmetic, and pharmaceutical 
industries. In general, several major factors (e.g., Ostwald ripening, coalescence, flocculation, and 
creaming) are responsible for destabilizing emulsions. Moreover, the stability of W/O/W emulsions is 
critically influenced by the osmotic pressure balance between the inner and the outer aqueous phase,12) 
the volume ratio balance between the oil and the outer aqueous phase, and the selection of hydrophilic 
and hydrophobic emulsifiers 13,14). 
L-ascorbic acid (vitamin C), an important water-soluble vitamin, is the most widely used vitamin 
supplement in the world.15) It plays an important role in the biosynthesis of collagen, carnitine, and 
neurotransmitters.16) Plants and most animals synthesize L-ascorbic acid (L-AA) for their own 
requirements, but primates and humans are unable to synthesize L-AA due to lack of the enzyme 
gulonolactone oxidase 17). L-AA is a labile molecule, so it can be lost from foods during cooking, 
processing, and preservation 15). Cooking loss of L-AA depends upon many factors (e.g., heating at 
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high temperature, surface area exposed to water, oxygen, pH, and the presence of transition metals) 18). 
Synthetic L-AA is available in a wide variety of supplements in the forms of tablets, capsules, chewable 
tablets, crystalline powder, effervescent tablets, and liquids.  
L-ascorbic and dehydroascorbic acid are the major dietary forms of vitamin C. All forms of L-AA 
are soluble in water, except for ascorbyl palmitate, which is used in commercial antioxidant 
preparations due to its greater lipid solubility 19).  L-AA and its fatty acid esters are used as food 
additives, antioxidants, browning inhibitors, reducing agents, flavor stabilizers, dough modifiers, and 
color stabilizers 20,21). 
Encapsulating L-AA in emulsion systems is highly recommended due to its hydrophilic nature 
and rapid degradation in bulk aqueous systems. Both single- and double-emulsion systems are used to 
encapsulate L-AA. Several research groups have encapsulated L-AA at low concentrations (up to 5%) 
in aqueous droplets using the W/O/W and O/W/O techniques 22-26). Nevertheless, in order to formulate 
food-based products such as high energy drinks, high concentrations of active components are required. 
The primary objective of this study was to prepare stable W/O/W emulsions containing a high 
concentration of L-AA in the inner aqueous phase. The study investigated the effects of type of sugar in 
the outer aqueous phase and the addition of gelatin in the inner aqueous phase on the preparation and 
stability of W/O/W emulsions and the retention kinetics of L-AA in W/O/W emulsions. The W/O/W 
emulsions prepared were also characterized by microscopic analysis, and the results were employed to 
evaluate physical stability. 
5.2 Materials and Methods 
Materials 
 L-AA (> 99.6% purity), refined soybean oil, magnesium sulfate (MgSO4), gelatin, glucose, fructose, 
sucrose, and methanol were purchased from Wako Pure Chemical Industries (Osaka, Japan). Xanthan 
gum was purchased from Tokyo Chemical Industry (Tokyo, Japan).  These reagents were of analytical 
grade. Tetraglycerin monolaurate condensed ricinoleic acid ester (TGCR, CR-310) was from Sakamoto 
Yakuhin Kogyo (Osaka, Japan). Decaglycerol monolaurate (DGM, Sunsoft A-12E) was from Taiyo 
Kagaku (Yokkaichi, Japan). 
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Preparation of W/O/W emulsions 
W/O/W emulsions were prepared by two-step emulsification using a Polytron (rotor-stator) 
homogenizer (PT-3000 Kinematica-AG, Littau, Switzerland) (Fig. 5.1). In W/O/W emulsions, the 
osmotic pressure generated by the presence of electrolytes (e.g., NaCl or MgSO4) in the inner water 
phase can cause swelling and ultimately bursting of the inner aqueous droplets, with negative impact 
on W/O/W emulsion stability. In order to avoid these effects, the concentration of electrolytes must be 
high enough to counteract the Laplace pressure but sufficiently low to avoid osmotic effects 13). 
Osmotic pressure ( can be calculated by the Morse equation: 
Π = 𝑖𝑀𝑅𝑇                              (5.1) 
 Morse equation is a modified form of the van’t Hoff equation,27) where i is the van’t Hoff factor, with a 
value of 2 for MgSO4; M is the molecular concentration of MgSO4, L-AA, and various sugars; R is a 
constant with a value of 8.31KPa m3 K-1mol-1; and T is the thermodynamic temperature (K). The 
osmotic pressure of both the inner and outer aqueous phase was adjusted to 0.17MPa at 25oC (298K). 
Firstly W/O emulsions were prepared using an inner aqueous phase containing L-AA (10 to 30% 
w/v), MgSO4 (1% w/w), and gelatin (0 to 1% w/v), and an oil phase containing a hydrophobic 
emulsifier (TGCR, 5% w/w). Milli-Q water with a resistivity of 18 M cm was used as the medium for 
all the aqueous phases. The volume fraction of the inner aqueous phase (w) was fixed to 30%. Thirty 
mL of the inner aqueous phase was added to 70 mL of the oil phase at room temperature (about 25oC), 
followed by first-step emulsification at 7 000 rpm for 5 min with the Polytron homogenizer. 
Next, W/O/W emulsions were obtained by dispersing the W/O emulsion in an outer aqueous phase 
containing a hydrophilic emulsifier (DGM, 1% w/w), MgSO4 (1% w/w), and a sugar (glucose, fructose, 
or sucrose, 10 to 30% w/w). The volume fraction (w/o) of the W/O emulsion was fixed at 30%. The 
W/O emulsion phase was added to the outer aqueous phase at a total volume of 100 mL at room 
temperature , followed by second-step emulsification at 5 000 rpm for 5 min with the Polytron 
homogenizer. During emulsification, 10 mL of an aqueous solution containing xanthan gum (1% w/v) 
was added to stabilize the W/O droplets that formed.  
 
Determination of average droplet diameter 
Microscopic observations were made with an optical microscope (DM IRM, Leica Microsystems, 
Wetzlar, Germany) to analyze the W/O and W/O/W emulsions prepared. Samples of W/O/W 
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emulsions were diluted 10 times in the outer aqueous phase, prior to analysis. In order to determine the 
average droplet diameter (dav), the diameters of 250 droplets in the micrographs captured were 
manually measured using image analysis software (WinRoof ver. 5.6, Mitani Co., Fukui, Japan). The 
coefficient of variation (CV) was used as an indicator of the droplet size distribution of the emulsions 
prepared: 
𝐶𝑉 = (
𝜎
dav
)  × 100                                           (5.2) 
where  is the standard deviation of the droplet diameter (µm). 
 
 
 
Figure 5.1: Schematic diagram for preparing W/O/W emulsions containing high concentrations 
of L-AA. ϕw denotes the volume fraction of the inner aqueous phase in the W/O emulsion, and 
ϕw/o denotes the volume fraction of the W/O emulsion phase in the W/O/W emulsion. 
 
Measurement of fluid properties 
The viscosity and density of each phase and the interfacial tension between two contacting phases were 
measured at 25oC. Viscosity was measured with a vibroviscometer (SV-10, A&D, Tokyo, Japan). 
Density was measured using a density meter (DA-130 N, Kyoto Electronics Manufacturing, Kyoto, 
Japan). Interfacial tension was measured with a Fully Automatic Interfacial Tensiometer (PD-W, 
Kyowa Interface Sciences, Saitama, Japan) by the pendant drop method. Table 5.1 lists the major fluid 
properties of the three-phase systems used to prepare the W/O/W emulsions. 
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Stability of W/O/W emulsions 
The W/O/W emulsions prepared were observed in order to evaluate consistency, color, homogeneity, 
and eventually phase separation during 35 d of storage under refrigeration at 4°C. All samples (10-g 
aliquots) were centrifuged at 3,000 rpm for 30 min using a laboratory centrifuge (KN-70, Kubota, 
Tokyo). After centrifugation, samples were inspected for eventual phase separation. Testing was 
replicated at time intervals previously determined. 
 
 Retention kinetics of L-AA in W/O/W emulsions 
L-AA encapsulated in the W/O/W emulsions was determined by the spectrophotometric method 
reported by Zeng et al.,28) which was originally used to measure L-AA solubilized in aqueous solution. 
All spectral measurements of methanolic extracts of W/O/W emulsions were carried out with a 
UV/VIS/NIR spectrophotometer (V-570, Jasco, Hachioji, Japan). Next, 1 mL of W/O/W emulsion was 
extracted with 10 mL of methanol, followed by ultrasonication for 20 min. The methanolic extract was 
then centrifuged (KN-70, Kubota) at 2 000 rpm for 15 min. A 1 mL aliquot of the supernatant was 
diluted to 20 mL with methanol, and the diluted solution was then injected into a quartz cell with a 10-
mm pass length. The absorbance of L-AA in this solution was measured at 247 nm using an appropriate 
blank. A representative standard curve of absorbance versus concentration gave linear least-squares 
regression with a coefficient of determination (r2) of 0.9996. All experiments were repeated in triplicate 
and mean values were calculated. The retention ratio, defined as: 
𝑅 = (
𝐶AA
CAA,0
)  ×  100                                         (5.3) 
  
 Where CAA is the measured L-AA concentration at a given storage time and CAA,0 is the initial 
L-AA concentration. 
 
Statistical analysis 
Analysis of variance (ANOVA) tests were used to analyze the characterization data at a confidence 
level of 95% (p < 0.05). A least-significant difference (LSD) test was used to compare the effect of 
adding gelatin on the average oil droplet diameter of the W/O/W emulsions and the effect of storage 
time on the droplet diameter of  the W/O and W/O/W emulsions. LSD was calculated by the method 
described by Steel et al.29) 
 123 
5.3 Results and Discussion 
Effects of the compositions of aqueous phases on the preparation of W/O/W emulsions  
Osmotic pressure plays a very important role in the stability of W/O/W emulsions, and Laplace 
pressure works against the stability of W/O emulsions.30) The addition of a small quantity of electrolyte 
to the disperse phase has a stabilizing effect on W/O emulsions, by counteracting the Laplace pressure 
effect. Kanouni et al.12) found that stabilization of W/O/W emulsions required a balance between the 
osmotic pressures of the outer and the inner aqueous phase. Considering these results, the outcomes of 
adding various sugars in the outer aqueous phase and adding gelatin in the inner aqueous phase were 
investigated. 
 
Effects of adding sugars in the outer aqueous phase  
A well-balanced composition of aqueous phases is needed in order to prepare stable W/O/W emulsions. 
Fig. 5.2 indicates the variation in the average W/O droplet diameters (dav,w/o/w) of freshly prepared 
W/O/W emulsions in the presence and the absence of a sugar (fructose, sucrose, or glucose) containing 
L-AA (10 % w/v) in the inner aqueous droplets. The W/O emulsions prepared by first-step 
homogenization had an average aqueous droplet diameter (dav,w/o) of 2.5 m and a CVw/o of 20%.  The 
W/O droplets of the resulting W/O/W emulsions had a dav,w/o/w of 12 to 20 m and a CVw/o/w of 20 to 
25%. Adding sugar caused a 20 to 30% reduction in the dav,w/o/w value. These CV values for the W/O/W 
emulsions containing fructose or sucrose were somewhat greater than the values for those containing 
glucose and no sugar. Freshly prepared W/O/W emulsions containing no sugar or glucose did not 
undergo creaming for 2 d but those containing sucrose and fructose underwent rapid creaming soon 
after preparation (Fig. 5.3a). This creaming may have occurred due to considerable flocculation of the 
W/O droplets, which causes much faster creaming of aggregated droplets (flocs). The micrographs in 
Fig. 5.3b depict aggregation of W/O droplets in the outer aqueous phase containing fructose or sucrose. 
Stokes’ law gives a good description of the terminal creaming rate of isolated emulsion droplets and 
flocs, provided that there is little movement of the liquid within the droplets 31). This condition is 
fulfilled when the viscosity of the droplets (the dispersed phase) is significantly greater than that of the 
continuous phase, or when the droplets are surrounded by an emulsifier membrane that resists 
deformation 31). The terminal creaming rate of an individual droplet is defined as: 
𝜈dr =  
𝑔𝑑dr
2 Δ𝜌
18𝜂𝑐
                                           (5.3) 
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and that of a floc is defined as: 
𝜈floc =  
−𝑔𝑑floc
2 Δ𝜌
18𝜂𝑐
                                      (5.3) 
where g is gravitational acceleration, ddr is droplet diameter, dfloc is floc diameter,  is the density 
difference between the droplet or floc and the continuous phase, and c is the viscosity of the 
continuous phase. The formation of flocs caused by droplet aggregation greatly increases the creaming 
rate of emulsions. 
Adding glucose leads to increased molecular movement, interfacial film formation, and the setting 
up of physical barriers with components due to the non-Newtonian behavior of emulsions32,33. 
Creaming and oiling-off are the results of a variety of physicochemical mechanisms that occur within 
W/O/W emulsions, including gravitational separation, flocculation, and coalescence. Schmidts et al.34 
reported that it was difficult to obtain physically stable W/O/W emulsions using hydrophilic sucrose 
esters in the continuous aqueous phase. Added fructose or sucrose in the continuous aqueous phase can 
interact with the hydrophobic emulsifier at the oil-water phase and weaken the repulsive interaction 
between the adjacent interfacial films that prevents rapid creaming.  
 
(a) 
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(b) 
             
 
Figure 5.2: Effects of sugars on the average droplet diameters and coefficients of variation of the 
W/O and W/O/W emulsions prepared. (a) The average aqueous droplet diameter (dav,w/o) and 
coefficient of variation (CVw/o) of the W/O emulsions prepared. (b) The average oil droplet 
diameter (dav,w/o/w) and CVw/o/w of the W/O/W emulsions prepared. Gray bars indicate the dav,w/o 
and dav,w/o/w of the W/O/W emulsions, and (○) indicates CV of emulsions. 
 
 
 
(a) 
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(b) 
 
 
Figure 5.3: Photographs and optical micrographs of the W/O/W emulsions prepared in the 
presence and absence of a sugar in the continuous aqueous phase. (a) Photographs. (b) Symbols: 
A, no sugar, B with fructose, C with sucrose, and D with glucose. 
 
 
Effects of adding gelatin to the inner aqueous phase  
The effects of adding gelatin to the inner aqueous phase on the droplet size and droplet size distribution 
of the W/O/W emulsions prepared is depicted in Fig. 5.2. Adding gelatin did not significantly affect (p 
> 0.05) the dav,w/o of the W/O emulsions (Fig. 5.2a). The dav,w/o/w of the W/O/W emulsion in the 
presence of gelatin was greater than that of the W/O/W emulsion in the absence of gelatin, whereas the 
CV of the W/O/W emulsions was unaffected by added  gelatin. The W/O/W emulsion containing 
gelatin had smooth mobility with a good organoleptic profile in terms of color, flowability, and 
stability in comparison to that without gelatin. The W/O/W emulsion prepared in the presence of 
gelatin had better stability against creaming than that in the absence of gelatin.  
Adding gelatin to the aqueous phase of the W/O emulsions resulted in a narrow size distribution 
with improved stability and a good organoleptic profile 35). Evison et al.36) have reported that adding 
1% (w/w) gelatin in the inner aqueous phase of W/O/W emulsions led to a substantial increase in the 
yield of an encapsulated compound and better stability against the coalescence of both inner aqueous 
and oil droplets. Biopolymers such as gelatin that are incorporated in W/O/W emulsions also act as 
 127 
chelating agents that can reduce the release rate of encapsulated compounds 2, 37). In our study, this 
gelation and chelating action of gelatin were assumed to be responsible for increasing the stability of 
the W/O/W emulsions against sedimentation and creaming. The additional gelatin can also act as a 
buffer to balance the effect of a high concentration of L-AA in W/O/W emulsions.   
 
Effects of L-AA concentration on the preparation of W/O/W emulsions  
Fig. 5.4 presents the average diameters (dav,w/o and dav,w/o/w) and CV of the oil droplets and inner 
aqueous droplets in prepared W/O/W emulsions containing various concentrations of L-AA. The 
concentration of L-AA in the inner aqueous phase was varied from 10 to 30% (w/v), and gelatin was 
added to all the inner aqueous phase solutions at a concentration of 1% (w/v). The concentration of 
glucose in the outer aqueous phase was also varied from 10 to 30% (w/v), depending on the preceding 
L-AA concentration. The W/O emulsions, with a w of 30%, used in second-step homogenization, had 
a dav,w/o of 2.3 to 2.8 m and a CV of 10 to 16%. The dav,w/o value increased slightly with increasing L-
AA concentrations, probably due to the increased viscosity of the inner aqueous phase (Table 5.1). The 
interfacial tension between the inner aqueous phase and the oil phase was independent of the L-AA 
concentration (Table 5.1). W/O/W emulsions were successfully prepared regardless of the L-AA 
concentration applied. The dav,w/o/w of the resulting  W/O/W emulsions increased gradually from 12 to 
18 μm as the concentration of L-AA increased. The increase in dav,w/o/w of the W/O/W emulsions 
corresponds to an increase in the viscosity of the outer aqueous phase (Table 5.1), as the interfacial 
tension between the oil phase and the continuous aqueous phase was unaffected by the L-AA 
concentration. The results shown in Fig. 5.4 indicate the successful preparation of W/O/W emulsions 
containing a high concentration of L-AA (up to 30% w/v) in the inner aqueous phase, considerably 
higher than those previously reported.22,24) 
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(a) 
 
(b) 
                
Figure 5.4: Effects of concentration of L-AA on the average droplet diameter and coefficient of 
variation of the W/O and W/O/W emulsions. (a) dav,w/o and CVw/o of  the W/O emulsions. (b) 
dav,w/o/w and CVw/o/w of W/O/W emulsions. All emulsions contained 1% (w/v) gelatin in the inner 
aqueous phase. ● dav,w/o and dav,w/o/w of emulsions; and ○ indicates CV of emulsions. 
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Table 5.1: Fluid properties of three-phase systems containing high concentrations of L-AA, 
glucose, and gelatin used for preparing W/O/W emulsions. 
 
 
Viscosity (mPa s) Interfacial tension (mN/m) 
L-ascorbic acid 
concentrationa 
% (w/v) 
Inner aq. 
phaseb 
Oil phasec 
Outer aq. 
phased 
Oil and inner aq. 
phases 
W/O and outer 
aq. phases 
10 2.0 ± 0.01 66.1 ± 0.10 1.9 ± 0.05 6.2 ± 0.4 1.6 ± 0.2 
20 2.8 ± 0.02 66.1 ± 0.10 2.7 ± 0.01 6.4 ± 0.2 1.6 ± 0.2 
30 3.3 ± 0.01 66.1 ± 0.10 3.1 ± 0.01 6.6 ± 0.4 1.6 ± 0.4 
      
 
aInitial concentration of L-AA in the inner aqueous phase., bcontaining 10-30% (w/v) L- AA with 1% 
(w/w) MgSO4 and gelatin 1% (w/v)., ccontaining TGCR 5% (w/w) in soybean oil., dcontaining MgSO4 
1% (w/w), glucose 10-30% (w/v), and DGM 1% (w/w). 
 
Stability of W/O/W emulsions containing high concentrations of L-AA 
Physical stability of the W/O/W emulsions  
The W/O/W emulsion samples were stored at 4oC for 35 d. Immediately after preparation, those 
containing concentrations of L-AA were whitish in color and showed good flowability. In addition, the 
W/O/W emulsions did not exhibit any change in physical appearance or homogeneity during the 
storage period, confirming increased stability. A centrifugation test indicated no phase separation in the 
W/O/W emulsions containing gelatin in the inner aqueous phase even after 30 d of storage. In contrast, 
those without gelatin resulted in phase separation after 36 h of storage as indicated by the 
centrifugation test. This suggests a beneficial effect of gelatin on the stabilization of W/O/W emulsions 
containing 30% (w/v) L-AA. 
Fig. 5.5 indicates the time changes in the dav,w/o and CVw/o of the inner aqueous droplets and in 
the dav,w/o/w and CVW/O/W of the oil droplets in the prepared W/O/W emulsions containing 
concentrations of L-AA. There was a non-significant difference (p > 0.05) in dav,w/o  during storage, 
which can be attributed to the migration of L-AA from the inner aqueous droplets to the continuous 
aqueous phase. Their CVw/o increased from 19 to 25% (Fig. 5.5a). For the resulting W/O/W emulsions, 
there was a non-significant difference in dav,w/o/w and almost no change in CVw/o/w between days 1 and 
35 (Fig. 5.5b). The variation in dav,w/o/w can be ascribed to coalescence of the W/O droplets and/or an 
osmotic pressure effect that becomes important after a certain duration. 
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(a) 
 
 
(b) 
 
 
Figure 5.5: Time changes in average droplet diameter and coefficient of variation of the W/O and 
W/O/W emulsions. (a) dav,w/o and CVw/o of the W/O emulsions containing 10 to 30% (w/v) L-
ascorbic acid in the inner aqueous phase. (b) The dav,w/o/w and CVw/o/w of the W/O/W emulsions. ● 
their dav,W/O, and ○ their CVW/O. CAA,0 initial concentration of L-AA in the inner aqueous phase. 
Time change of dav,w/o/w of W/O/W emulsions with CAA,0 of 10% is indicated by ●, 20 % by ■, and 
30 % by ▲, whereas, their CV is represented by ○ for 10 %, □ for 20, % and, by  for 30%. 
Similar letters (a, b, c, d) indicate that the W/O and W/O/W emulsions had shown non-significant 
differences in dav at the 95% confidence level (p = 0.05). 
 
 
Retention kinetics of L-AA in the W/O/W emulsions  
Fig. 5.6 shows L-AA retention in the W/O/W emulsions during storage under refrigeration at 4oC. The 
freshly prepared W/O/W emulsions had an initial retention of L-AA (10-30% w/v) of higher than 90%. 
The L-AA levels in the W/O/W emulsions decreased gradually with time and exhibited about 40% 
retention at day 28. The L-AA in a bulk Milli-Q water stored at 4oC had retention of < 5% at day 28, as 
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rapid ionization in aqueous solutions results in a rapid loss of L-AA. Lee et al.25) encapsulated 5% 
(w/w) L-AA in W/O/W emulsions using electrolytes, and concluded that W/O/W emulsions were 
revealed as efficient tool for improving L-AA stability. The prepared W/O/W emulsions had L-AA 
concentrations (R) of 3.88 g/100 mL, 8.02 g/100 mL and 12.06 g/100 mL at 10, 20, and 30% (w/v), 
after 30 d of storage time. They were subjected to centrifugation at 15 000 rpm for 20 min to determine 
the amounts of phase separation. There was hardly any phase separation in them during 30 d of storage, 
and the degradation of L-AA took place with a rate constant of 0.03 (0.75%)  (Table 5.2). The 
formation of an oil-emulsifier interface across the inner aqueous phase containing L-AA may protect 
the linkage of L-AA to the outer aqueous phase. Similarly, L-AA also appear to act as a pro-antioxidant 
protecting against L-AA leakage and enhancing the stability W/O/W emulsions.     
 
 
 
Figure 5.6: Time change of L-AA retention (R) in the W/O/W prepared emulsions and in bulk 
Milli-Q water. The samples containing L-AA were stored at 4oC. CAA,0 initial concentration of L-
AA in the inner aqueous phase. CAA,0 of 10 % is indicated by ●, 20 % by ■, and, 30 % by ▲. (♦) 
CAA,0  in Milli-Q water. 
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Table 5.2: Rate constants and half-life of L-AA retention in various W/O/W emulsions 
L-ascorbic acid  
concentration   
% (w/v) 
Rate equationa 
Coefficient of 
determination 
(r2) 
Rate constant  
k (d-1) 
Half-life (d) 
t1/2 = 0.693/k 
10 lnCAA/CAA,0 = -0.0298t 0.96 0.03 23.7 
20 lnCAA/CAA,0= -0.0292t 0.97 0.029 23.8 
30 lnCAA/CAA,0= -0.0292t 0.97 0.029 23.9 
 
aCAA, L-AA concentration at a given time; CAA,0, initial L-AA concentration. 
 
The retention kinetics of L-AA in the W/O/W emulsions stored at 4oC was also evaluated as: 
In
𝐶AA
𝐶AA,0
=  −𝑘𝑡                                    (5.4) 
 where k is the rate constant and t is the storage time. The rate constant of first-order kinetics was 
calculated by applying the regression function of Microsoft Excel 2010, obtaining best-fit results. The 
lines fitted by the retention kinetics equation are presented in Fig. 5.7. The calculated r2 values for all 
the W/O/W emulsions were > 0.95, indicating that the fitting application of the first-order kinetics is 
plausible. The observed half-life for W/O/W emulsions containing high concentrations of L-AA at 4oC 
was about 24 d (Table 5.2). Our results indicate that the L-AA retention kinetics depended on the 
composition of the external aqueous phase used in the W/O/W emulsion preparation. Diffusion of L-
AA across the interface can play an important role in retention kinetics. The diffusive transfer of L-AA 
through the oil phase is a very complex process and its origin remains controversial. Based on first-
order kinetics, it can be stated that L-AA transfer involves various steps, and that interfacial and 
aqueous phase composition have an influence on the release rate. This behavior have been reported by 
different research groups for O/W emulsions containing L-AA in the outer aqueous phase 38). The 
factors affecting the retention kinetics of L-AA in different systems include the concentration of L-AA 
(active ingredient), the pH and viscosity of the liquid phase and the preparation process. The release 
pattern of L-AA follows zero-order kinetics in W/O and O/W/O emulsions 23). In most food matrices 
(juices and fruits) and in water, L-AA oxidation and decomposition follow first-order kinetic 39). 
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Figure 5.7: Retention kinetics of L-AA in the W/O/W emulsions stored at 4 oC. Rate constants, 
coefficients of determination, and half-life of the fitted lines are presented in Table 5.2. CAA,0 
initial concentration of L-AA in the inner aqueous phase. CAA,0 of 10% is indicated by ●, 20% by 
■ and, 3% by ▲. 
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Chapter 6  
The preparation characteristics and stability evaluation of oil-in-
water emulsions loaded with ergocalciferol by microchannel 
emulsification* 
 
 
 
 
 
 
 
 
________________________________________________________________________ 
*This chapter is to be published as Khalid N, Kobayashi I, Wang Z, Neves M, Uemura K, Nakajima 
M, Nabetani H. The Preparation characteristics and stability evaluation of oil-in-water emulsions 
loaded with ergocalciferol by microchannel emulsification. RCS Advances 
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6.1 Introduction 
Vitamin D plays a vital role in maintaining and developing healthy skeletal system, since it maintains 
calcium level in the body. Deficiency of vitamin D results in increased risk of diabetes, hypertension, 
cancer and autoimmune diseases 1-4). Broad spectrum deficiencies of vitamin D includes rickets in 
children, osteomalacia in adults and osteoporosis in women, all of these lead to softening and 
weakening of bones 5-7).   Nutritional and cultural factors leading to vitamin D deficiency include 
insufficient fortified food consumption, sunblock usage, limited body exposure to sun and fear for 
excessive intake of vitamin D 7,8). Vitamin D is synthesized in the skin and involves the phytochemical 
conversion of provitamin D by the action of ultra-violet (UV-B) rays. This process takes place if the 
UV-B rays fall between 290-315 nm of spectrum. These rays are only emitted in the regions that lie 
below 35o latitude and includes Northern Africa and Los Angeles 9,10). 
The terminology and classification related to vitamin D is confusing and can be classified into 
5 different forms and metabolites, among these vitamin D2 (ergocalciferol) and D3 (cholecalciferol) are 
important (Fig. 6.1) 11,12). Vitamin D2 is naturally present in some plants and is produced commercially 
by irradiation of yeast. Vitamin D2 is substantially used for fortification and supplementation in food 
and pharmaceutical industries 12). Several researchers pointed out rapid metabolism of vitamin D2 in 
comparison to vitamin D3, but if taken daily the action become bioequivalent 13, 14). Both forms of 
vitamin D are converted to 25-hydoxyvitamin [25-(OH)D] in the liver. The quantification of 25-(OH)D 
in blood gives the quantitation of vitamin D status. A cutoff value of 30 ng/mL is sometimes used for 
optimal vitamin status 12). Ergocalciferol was produced in 1920s through UV-B exposure of foods, and 
resulted in the formation of first medicinal preparation called Viosterol 15). Ergocalciferol has limited 
natural sources and the most significant source is wild mushrooms 16). Ergocalciferol is prone to 
oxidation and is also isomerized to isotachysterol in the presence of sunlight and mostly under acidic 
conditions 16,17). Erogcalciferol is mostly supplemented and fortified in fat based products due to its fat 
soluble nature.  
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Figure 6.1: Chemical structures of important forms of vitamin D. (a) ergocalciferol and (b) 
cholecalciferol. 
 
Emulsification technologies play an important role in the production of encapsulated foods, 
pharmaceuticals, cosmetics and chemicals 18,19). The produced emulsions are either simple (O/W and 
W/O) emulsions, multiple emulsions (W/O/W and O/W/O), nanoparticles or core shell micelles 19). 
These different emulsification processes are either carried by conventional devices (colloidal mills, 
high pressure homogenizers and rotor stator) and modern devices like microfluidic devices (Lab-on-a-
chip), membrane emulsification and microchannel emulsification (MCE) 19,20). The conventional 
devices produce emulsions with broader size distribution and polydispersity in system, these in term 
reduces the stability and functionality of system. Microfabricated emulsification devices have potential 
to produce monodisperse emulsions with droplet size variation less than 10% with membrane 
emulsification and around 5% with other microfluidic devices 20).  
MCE is a progressive method that produce monodisperse droplets by spontaneous 
transformation of oil-water interface specifically driven by interfacial tension on a micron scale 21) and 
comprehensively reviewed by Vladisavljevic, et al. 20) and Vladisavljevic' et al. 22). Similarly, this 
emulsification technique allow integration of hundreds of thousands of droplet forming units on a 
single silicon or stainless steel chips 23,24).  MCE produces O/W, W/O and W/O/W emulsions with 
diameter ranged from 1 m to 550 m 22). Based on microfabrication design, the MCE devices can 
either be categorized into grooved MC arrays consisting of uniform microgrooves and a slit-like terrace 
and straight-through MC arrays having uniform, symmetric or asymmetric microholes together with 
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microslots 22). Grooved type MCs are further classified into either dead end type and cross flow 
grooved MCs. Cross flow grooved MC modules are more suited for higher droplet production with low 
flow rates around 1.5 mL h-1 25). Grooved MC arrays are designed to study the droplet generation 
process, droplet characterization and to observe the interface movement around microchannels 26). On 
the other hand, straight-through MC arrays are designed to increase the throughput capacity of 
emulsions and to work with low viscosity fluids. The straight-through MC arrays has ability to increase 
the production capacity up to 2000 L m-2 h-1 with monodisperse droplets having CV less than 2% 22).  
MCE has been used to produce monodisperse microdispersions (e.g., solid lipid microspheres 
27), gel microbeads 28), and giant vesicles 29)). MC emulsification has promising potential for producing 
uniformly sized oil droplets containing such functional lipids as β-carotene 30), γ-oryzanol 31), L-
ascorbic acid 32), ascorbic acid derivatives 33) and oleuropein 34). Different food grade materials (e.g., 
refined vegetable oils, a medium-chain triglyceride oil, hydrophilic and hydrophilic emulsifiers, 
proteins, and hydrocolloids) were utilized to produce monodisperse O/W, W/O, W/O/W emulsions and 
microparticles by MCE.  
In this study, ergocalciferol loaded O/W emulsions were prepared with MCE. The basic 
characterization and optimization of these emulsions were performed on grooved type MCs. The effect 
of dispersed and continuous phase flux together with stability and release profile were carried out with 
straight-though MCE. Moreover, in this research, the effect of different vegetable oils and emulsifiers 
on production characteristics of O/W emulsions were evaluated. The results of this research will help to 
prepare and optimized new aqueous based functional foods. 
6.2 Material and methods 
Chemicals 
Ergocalciferol (396.66 g/mol), soybean and olive oil were purchased from Wako Pure Chemical Ind. 
(Osaka, Japan). Medium chain triacylglycerol (MCT, sunsoft MCT-8) with a fatty acid residue 
composition of 75% caprylic acid and 25% capric acid was procured from Taiyo Kagaku Co. Ltd. 
(Mie, Japan). Safflower oil was purchased from MP biomedicals (lllkirch, France).  All of above 
mentioned chemicals were used as dispersed phase. Polyoxyethylene (20) sorbitan monolaurate 
(Tween 20) was purchased from Wako Pure Chemical Ind. (Osaka, Japan), β-lactoglobulin (-lg) from 
bovine milk (>90% purity) was purchased from Sigma Aldrich (St. Louis, Mo., USA) and decaglycerol 
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monolaurate (Sunsoft A-12, HLB: 12) was supplied by Taiyo Kagaku Co., Ltd. (Yokkaichi, Japan). 
Tween 20, -lg and Sunsoft A-12 were used as emulsifiers in this study. These emulsifiers were 
separately dissolved in Milli-Q water with a resistivity of 18MΩ cm and served as continuous phase. 
All other chemicals used in this study were of analytical grade and used as received.  
Preparation of solutions 
The continuous phase was prepared by dissolving either 1-2% (w/w) Tween 20, 1% (w/w) Sunsoft A-
12 or 1% (w/w) -lg in Milli-Q water. The dispersed phase was prepared by dissolving 0.2-1.0% (w/w) 
ergocalciferol in preheated MCT, soybean, olive or safflower oil at 85 ± 3oC for 20 min and afterwards 
cooling at room temperature for 2 h before storage at 4 ± 1oC. During storage, we expected that 
dissolved ergocalciferol molecules would form nuclei that would grow and eventually form crystals 
large enough to sediment. Before initiating experiments, the samples were therefore shaken slightly to 
resuspend any ergocalciferol crystals if present. Although no crystallization was observed during 
storage at 4 ± 1oC. 
Silicon chips  
The experiments have been carried out by using silicon 24 × 24 mm and 25 × 28 mm MC plates (model 
WMS 11-1 and CMS 6-2, manufactured by EP. Tech Co., Ltd., Hitachi, Japan). WMS 11-1 contain 
27,400 active MCs arranged within a 10 × 10 mm square region in the center of MC plate, and CMS 6-
2 contain 540 parallel channels on 10 consecutive MC arrays. WMS 11-1 and CMS 6-2 were etched to 
100 m in all directions. The MC plates were microfabricated by photolithography and deep reactive 
ion etching. 
Fig. 6.2a is a schematic representation of a silicon CMS 6-2 plate, each MC array contain 54 
parallel channels with a depth of 5 m, with a width of 18 m and a length of 140 m and a terrace 
depth of 5 m and a length of 60 m. Each continuous-phase channel outside the terrace outlet has a 
depth of 100 m. Fig. 6.2b shows the schematic representation of WMS 11-1. Each MC consisted of a 
cylindrical 10 m diameter straight microhole with a depth of 200 m and a 10 x 80 m microslot with 
a depth of 40 m. The slot aspect ratio of 8 was above the threshold value of 3 for monodisperse 
emulsion droplets. The distance between the two adjacent MCs in the vertical was 105 m and the 
distance between the centers of MCs in the adjacent rows was 70 m. 
The MC plates were subjected for plasma oxidation in plasma reactor (PR41, Yamato Science 
Co. Ltd., Tokyo, Japan) to develop a silicon dioxide layer on the surface of MC plates. The silicon 
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dioxide layer maintain the hydrophilicity of silicon during MCE. After each experiment the MC plates 
were cleaned in three steps. In the first step the MC plates were washed with neutral detergent together 
with Milli-Q water in an ultrasonic bath (VS-100 III, As One Co., Osaka, Japan) for 20 min, afterwards 
treatment with 50% Milli-Q water and 50% ethanol in an ultrasonic bath, lastly cleaned in an ultrasonic 
bath with Milli-Q water and stored in 50 mL of Milli-Q water prior to reuse for MC emulsification. 
(a) 
 
 
(b) 
 
Figure 6.2: (a) Schematic drawings of the MC array chip (CMS 6-2) and part of an MC array 
together with different dimensions. (b)  Schematic drawings of the MC array (WMS 11-1) and 
MCs dimensions. All dimensions were presented in micrometers. 
 
Experimental procedure for MCE 
At the initiation of experiment, MC plates were degassed in continuous phase (emulsifier in Milli-Q 
water) by ultrasonic bath for 20 min. For grooved type MCE, the setup consists of MC module, a 10 
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mL liquid chamber that contain the disperse phase and a syringe pump (Model 11, Harvard Apparatus 
Inc., Holliston, USA) that feeds the continuous phase with a 50 mL glass syringe (Fig. 6.3a). The 
emulsification process was carried out for approximately 3 h and monitored through inverted 
metallographic microscope (MD-300EF; Nikon Co., Tokyo, Japan) equipped with an objective lens of 
2.5x to 20x and a CCD camera (KP-C550; Hitachi, Tokyo, Japan). The whole process was recorded 
with a video recorder (RDR-HX67; Sony Co., Tokyo, Japan). 
Droplet-generation experiments were performed with the grooved type MCE setup depicted in 
Fig. 6.3b. The module was initially filled with continuous phase before mounting the CMS 6-2 plate. 
The pressurized dispersed phase was introduced into the module. The pressure applied to the dispersed 
phase (Pd) was gradually increased. Pd can be given by 
∆𝑃d =  𝜌d∆ℎd𝑔                        (6.1) 
where d is the dispersed-phase density, hd is the difference in the hydraulic heads between 
the chamber containing the dispersed phase and the channels of the module, and g is the acceleration 
due to gravity. To generate droplets, the dispersed phase was forced through the MCs onto the terrace 
and into the continuous phase channel. 
(a) 
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(b) 
 
Figure 6.3: (a) Schematic drawing of the experiment setup for grooved type MCE. (b)  Schematic 
drawing of droplet generation via part of an MC array having 5 m depth. 
 
For straight-through MCE, the setup consists of MC module (comprising of 6 steel parts, two 
glass plate of different dimensions and rubber seals) and a syringe pumps (Model 11, Harvard 
Apparatus Inc., Holliston, USA) that feeds the continuous phase and dispersed phase (Fig. 6.4a). The 
emulsification process was carried out for approximately 1 h and monitored through FASTCAM-1024 
PCI high speed video system at 250 to 500 fps (Photron, Tokyo, Japan) attached to an inverted 
metallographic microscope (MD-300EF; Nikon Co., Tokyo, Japan). 
The droplet generation process was observed by injecting the disperse phase through a syringe 
pump (Model 11, Harvard Apparatus Inc., Holliston, USA) at the flow rate ranging from 0.5 to 2.0 mL 
h-1 (flux (Jd); 5 to 20 L m-2 h-1). The generated droplets were removed by supplying continuous phase 
ranging from 100 to 500 mL h-1 through the gap between the MC plate and the gap. The shear stress 
(at the WMS 11-1 plate is given by  
                                     𝜏 = 
3𝑄cnc
2ℎ2𝑊
                                (6.2) 
Where h =1 mm is the gap height and W = 12 mm is the gap width, Qc is the continuous phase 
flow rate (m3 sec-1) and c is the continuous phase viscosity (Pa. sec). had a negligible value of 0.011 
to 0.021 Pa at 250 to 500 mL h-1. 
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(a) 
 
(b) 
 
 
Figure 6.4: (a) Schematic representation of an asymmetric straight through MCE setup. (b) 
Droplet generation representation through straight through MC arrays. 
 
 
Measurement and analysis 
The size and size distribution of the resultant O/W emulsion droplets from grooved MC emulsification 
were determined as follows. The average droplet diameter (dav) was defined by: 
𝑑𝑎𝑣 =  ∑ 𝑑𝑖
𝑛
𝑖=1 /𝑛                       (6.3) 
where di is the diameter of the ith droplet measured using WinRoof software (Mitani Co., Ltd., 
Fukui, Japan) and n is the number of the droplets measured (n= 250). The droplet dispersity (droplet 
size distribution) was expressed as CV, and is defined as: where  is the standard deviation and dav is 
the average droplet diameter (m). 
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CV =  
𝜎
𝑑𝑎𝑣
 × 100          (6.4) 
The particle size distribution of O/W emulsions from straight-through MC emulsification was 
measured by using light scattering instrument, that work on the principle of Polorization Intensity 
Differential Scattering Technology (Beckman Coulter LS 13 320, Miami, USA). This instrument have 
ability to measure the size ranging from 0.04 to 2000 m with a resolution of 116 particle size 
channels. The mean droplet size was expressed as Sauter mean diameter (d3,2) i.e. the diameter of a 
droplet having the same area per unit volume as that of the total collection of droplets in emulsions. 
The width of droplet size distribution was expressed as relative span factor (RSF) and is defined as: 
RSF =  
𝐷𝑣0.9−𝐷𝑣0.1
𝐷𝑣0.5
        (6.5) 
Where Dv0.9 and Dv0.1 are the representative diameters where 90%, 10% and 50% of the total 
volume of the liquid is made up of droplets with diameters smaller than or equal to the stated value. 
While Dv0.5 is the representative diameter where 50% of the total volume of the liquid is made up of 
droplets with diameters larger than the stated value and 50% is made up of droplets with diameters 
smaller than the stated value. 
 
Measurement of fluid properties  
The densities of dispersed and continuous phases were measured using a density meter (DA-130 N, 
Kyoto Electronics Manufacturing Co., Ltd., Kyoto, Japan) at 25 ± 2oC. The viscosities of dispersed and 
continuous phases were measured with a vibro viscometer (SV-10, A&D Co., Ltd., Tokyo, Japan) at 25 
± 2oC by taking either 10 or 35 mL of samples in a measuring vessel followed by immersion of sensor 
plates in that vessel. Viscosity was measured by detecting the electric current needed to resonate the 
sensor plates. The absolute viscosity (η) was calculated by 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑣𝑖𝑠𝑐𝑜𝑠𝑖𝑡𝑦 =  
𝑛mea
𝜌
             (6.6) 
where ηmea is the measured fluid viscosity and ρ is the fluid density. The static interfacial tension 
between the oil and the aqueous phases was measured with a fully automatic interfacial tensiometer 
(PD-W, Kyowa Interface Sciences Co., Ltd., Saitama, Japan) using a pendant drop method. The key 
physical properties of dispersed and continuous phase were presented in Table 6.1. 
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Physical and chemical stability of O/W emulsions  
The O/W emulsions loaded with ergocalciferol formulated through straight-through MCE were 
observed with light scattering Bechman Coulter Counter to evaluate d3,2, RSF, consistency, 
homogeneity, and coalescence during 15d of refrigerated storage at 4 °C.    
The amount of ergocalciferol encapsulated in the O/W emulsions was determined 
spectrophotometrically. All spectral measurements of ethanolic extracts of O/W emulsions were carried 
out using a UV/VIS/NIR spectrophotometer (UV-1700, Shimadzu Co., Japan). First, 1 mL of the 
emulsion was extracted with 9 mL of ethanol, followed by ultrasonication for 20 min. The ethanolic 
extracts were then centrifuged (Avanti HP-25, Beckman Coulter, Miami, USA) at 20,000 g for 15 min. 
A 1 mL aliquot of the subnatants was diluted ten times with ethanol and then injected into a quartz cell 
with a 10 mm pass length. The absorbance of ergocalciferol in emulsion extract was measured at 310 
nm using an appropriate blank. A representative standard curve of absorbance versus concentration 
gave linear least-squares regression with a coefficient of determination (r2) of 0.9996. All experiments 
were repeated in triplicate and mean values were calculated. The Beer’s law was obeyed in the 
concentration range of 0.1-0.5 mg mL-1 and the sensitivity of measurement has relative standard 
deviation of 0.85% (n=15). The Molar absorptivity (Ɛ) for ergocalciferol during this study was 2.52 
mM-1 cm-1. The encapsulation efficiency of ergocalciferol in samples were calculated with the 
equation: 
   𝐸𝐸𝑣𝑖𝑡𝑎𝐷2 =  
𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑓𝑟𝑒𝑒 𝑣𝑖𝑡𝑎𝑚𝑖𝑛𝐷2
𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑒𝑛𝑐𝑎𝑝𝑠𝑢𝑙𝑎𝑡𝑒𝑑 𝑣𝑖𝑡𝑎𝑚𝑖𝑛𝐷2
 × 100        (6.7) 
 
6.3 Results and discussion 
Basic characterization through grooved type MCE 
Effect of disperse phase composition on O/W emulsions 
Fig. 6.5a illustrates the effect of different oils on dav and CV of O/W emulsions. The grooved MC 
emulsification was carried out by dissolving 0.5% (w/w) ergocalciferol in MCT, soybean, olive and 
safflower oil, while the continuous phase constitutes 1% (w/w) Tween 20 in Milli-Q water. The 
dispersed phase was introduced into MC module by head on pressure (Pd) difference. A gradual 
increase in Pd caused the dispersed phase to enter the terrace in front of the MC inlets. When Pd 
reached the break-through pressure (Pd,bt = 3.0 kPa), the dispersed phase started to pass through the 
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MCs, leading to the periodic generation of aqueous droplets. The MC emulsification was performed at 
slightly above break-through pressure of 3.2 kPa. The continuous phase flow rate was fixed at 2 mL h-1 
throughout the experiment. Successful emulsification was conducted with different oil types. The dav of 
resultant emulsions ranged between 28.3 to 30.0 m with CV between 3.6 to 6.1%. More narrow size 
droplet distribution was seen in emulsions prepared with slightly higher viscous oils like olive oil and 
soybean oil in comparison to MCT (Fig. 6.5b). The O/W emulsions prepared with MCT have CV more 
than 6%. The dav of emulsions prepared with 5 m channel depth was higher than 18-20 m previously 
reported by Fujiu et al. 35) that only contain Milli-Q water droplets in water saturated decane. The 
results of this study was well in line with Souilem, et al. 34). They encapsulated oleuropein in W/O/W 
emulsions and produced W/O droplets with dav around 27 m with channel depth of 5 m and width of 
about 18 m. More narrow size droplet formation take place in MCE, if the inflow of the continuous 
phase is sufficiently fast compared to the outflow of the liquid that is forming the droplet (dispersed 
phase) 36). The viscosity ratio (d/c) is one the key factor determining the monodispersity of 
emulsions 36). The viscosity ratio of all vegetable oils in this study were sufficiently high (Table 6.1) 
leading to successful monodisperse emulsion droplets encapsulating ergocalciferol. The slightly higher 
dav of olive oil emulsions might corresponds toward higher viscosity (62.1 mPa s) in comparison to 
other oils, this high viscosity have no impact on monodispersity and droplet size distribution, more 
narrow size distribution was observed in olive oil emulsions in comparison to MCT, soybean and 
safflower oil. The possible interpretation of above mention reason is the higher viscosity of olive oil 
that leads toward more monodisperse droplets.  
(a) 
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Figure 6.5: (a) Effect of different dispersed phase composition on dav and CV of O/W emulsions. 
( ) denote MCT, ( ) soybean oil, ( ) olive oil and ( ) denote safflower oil, while there open 
keys denote CV. (b) Typical generation behaviors of O/W emulsions droplets encapsulating 
ergocalciferol by using different dispersed phase oils. 

Effect of different emulsifiers on O/W emulsions loaded with ergocalciferol 
The effect of the emulsifiers on oil droplet formation from the grooved MC was also investigated. Food 
grade emulsifiers (Tween 20, Sunsoft A-12 and -lg) with a noticeable ability to prepare O/W 
emulsions were used at a concentration of 1% (w/w) in the Milli-Q water. These aqueous emulsifier 
solutions were used as continuous phase. All of these emulsifier solutions exhibited successful 
emulsification with smooth detachment of droplets at the interface (Fig. 6.6a(i-iii)). Uniform emulsion 
droplets were stably generated from the MCs especially in the presence of Tween 20 and Sunsoft A-12. 
There was neither the formation of bigger droplets nor a continuous out flow of dispersed phase. Fig. 
6.6b illustrate the effect of emulsifiers on dav and CV of O/W emulsions. The dav and CV of the 
resultant emulsion droplets were 28.5 µm and 5.9% for Tween 20 and 28.1 µm and 6.6% for Sunsoft 
A-12. Although droplet generation and detachment process was quite stable with -lg with smallest 
droplet diameter (26.6 m) but after 5 min few droplets start sticking at the terrace of MC plate (Fig. 
6.6b(iii)) and grow in size with passage of time, as a result the CV of emulsion droplets increased to 
7.2%. 
 Kobayashi and Nakajima 37) investigated the effect of emulsifiers on droplet generation 
characteristics by using a straight-through extrusion filter. They pointed Tween 20 and polyglycerol 
50 µm 
MCT Soybean oil 
Olive oil Safflower oil 
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fatty acid ester as optimum food grade emulsifiers for MCE. Similarly, in another study by Patel and 
San Martin-Gonzalez 17) demonstrate successful preparation of solid lipid nanoparticles loaded with 
ergocalciferol stabilized by Tween 20. The results of above section demonstrate that Tween 20 and 
Sunsoft A-12 as potential emulsifiers for generating ergocalciferol loaded O/W emulsions, either with 
conventional homogenization techniques (data not shown) or MCE.  
 
 
(a) 
    
 
 
 
(b) 
 
 
 
 
 
 
Tween 20 Sunsoft A-12 -lg 
i ii iii 
100 m 
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(c) 
 
Figure 6.6: Effect of different emulsifiers on droplet generation behavior in grooved type MC 
emulsification. (a) Droplet generation with (i) Tween 20, (ii) Sunsoft A-12 and (ii) -lactoglubulin. 
(b) Effect of different emulsifiers on dav and CV of O/W emulsions, ( ) denote Tween 20, ( ) 
Sunsoft A-12 and ( ) -lactoglubulin. (c) Typical droplet generation characteristics with -
lactoglubulin as emulsifier. 
 
 
Effect of concentration of ergocalciferol on O/W emulsions 
Fig. 6.7 illustrates the effect of concentration of ergocalciferol on dav and CV of O/W emulsions. The 
concentration of ergocalciferol varied from 0.2% to 1.0% (w/w) in soybean oil.  According to US 
Pharmacopeia, ergocalciferol can sparingly soluble in different oils, and have maximum solubility in 
organic solvents except hexane. In our study, we noticed maximum solubility of 1% (w/w) 
ergocalciferol in different oils at 85 ± 2oC with no solubility at room temperature. Successful MCE was 
conducted with different concentrations of ergocalciferol by keeping dispersed phase pressure at 3.2 
kPa and continuous phase flow rate around 2 mL h-1. In this section we also evaluated the effect of 
Tween 20 and Sunsoft A-12 with different concentrations of ergocalciferol in soybean oil. The dav of 
O/W emulsions increased linearly with increasing concentration of ergocalciferol when emulsified with 
1% (w/w) Tween 20. The resultant droplet diameter ranged between 23.8 to 28.5 m with CV between 
5.9 to 6.2%. 
 Comparatively similar results were obtained with Sunsoft A-12 (Fig. 6.7). The emulsions 
stabilized with 1% (w/w) Sunsoft A-12 have dav ranged between 24.5 to 27.5 m and have CV in 
between 6.5 to 8.4%. More monodisperse droplet size distribution were seen in emulsions emulsified 
with Tween 20 in comparison to Sunsoft A-12 (Fig. 6.6). Monodispersity of droplets stabilized with 
1% (w/w) Tween 20 were previously reported by Kobayashi et al. 38) and Kobayashi et al. 39) in MCE.  
100 m 
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Figure 6.7: Effect of ergocalciferol concentration in soybean oil on dav and CV of O/W emulsions 
either stabilized by 1% (w/w) Tween 20 or Sunsoft A-12.  
Effect of dispersed phase flow rate on O/W emulsions encapsulating erogcalciferol 
Dispersed phase flow rate is an important parameter in MCE that correlates with droplet productivity at 
sable droplet generation rate. Fig. 6.8a depicts the effect of dispersed phase (Qd) flow rate on the dav 
and CV of the generated droplets. Qd constitute 0.5% (w/w) ergocalciferol in soybean oil, while 
continuous phase (Qc) includes 1% (w/w) Tween 20 in Milli-Q water. 
At the lowest Qd of 2 × 10-3 mL h–1, the resultant droplets had a dav of 23.5 m and a CV of 
5.4%. They also had a monomodal and very narrow size distribution. When Qd was increased stepwise, 
monodisperse emulsions with CV of 4 to 7% were produced at Qd of 9 × 10-2 mL h–1 or less. In this Qd 
range, dav of the resultant droplets ranged from 23.7 m to 29.0 m. The microscopic observations 
during MCE confirmed that the resultant droplet size hardly changed between Qc of 0 mL h-1 and 5.0 
mL h-1. The generation of droplets even without continuous flow rate depicts the unique spontaneous 
transformation of interface in MCE.  In contrast, at Qd of > 0.1 mL h-1, the dav and CV of O/W 
emulsions dramatically increased to > 33.4 m with CV values more than 10%, moreover the droplet 
size distribution became wider and lead towards large droplet size area (Fig. 6.8a). The MC plate (CMS 
6-2) used in this study enabled the production of O/W emulsions with uniform fine droplets at a critical 
Qd of 9 × 10-2 mL h–1, which was slightly higher than a maximum Qd (5 ×10-3 mL h-1) for the 
previously reported studies from MC emulsification 40).  
After reaching the critical Qd, some of the dispersed phase that passed through a MCs 
expanded instead of generating droplets, suggesting that the flow state of the dispersed phase was 
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affected by the dispersed-phase velocity inside the MC. Sugiura, et al. 21) reported that the droplet  
generation behavior inside MCs are significant to the capillary number of the dispersed phase that 
flows inside a MCs. The capillary number (Ca), indicates the balance between viscous force and 
interfacial force, can be determined by:  
                                           𝐶𝑎 =  𝑛d𝑈d/𝛾         (6.8) 
where d is the dynamic viscosity (Pa.s) of the dispersed phase, Ud is the dispersed phase 
velocity (m sec-1) and  is the interfacial tension between the two phases (N m-1). Ca at the critical Qd 
of 9 × 10-2 mL h–1 was 0.019. The observed Ca was similar to the pervious findings with grooved type 
MCE 21, 41) 
 The influence of Qd on the droplet generation frequency per MC plate (active area; f) was 
presented in Fig. 6.8b) can be estimated by: 
𝑓 =  
𝑄d
𝑉av
=  
6𝑄d
𝜋𝑑av
3          (6.9) 
 Where Vav is the average droplet volume. The f increased with increasing Qd in the range of 
0.3 mL h–1 or less. The further increase in Qd lowered the f, uniform fine droplets were generated at a 
maximum f of 144.8 144.8 × 105 h-1 (Fig. 6.8b). 
 
(a) 
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Figure 6.8: (a) Influence of Qd on dav and CV of the O/W emulsions encapsulating ergocalciferol 
produced using the CMS 6-2 MC array. (b) Influence of Qd on the droplet generation frequency 
per hour. 
Stability evaluation of O/W emulsions through straight through MCE 
Grooved type MCE provides useful information regarding basic characterization of droplets but the 
drawback lies in low droplet productivity up to 1.5 × 10-3 l h-1 25). In comparison straight-through MCE 
can increase the through-put capacity of droplets and work even at Qd of 0.27 l h-1 with uniform droplet 
productivity 26). These asymmetric MC arrays comprises of straight-through microholes can 
accommodate >104 MCs per 1 cm3 42). This part of wok focused on the stability and encapsulation 
efficiency of ergocalciferol loaded O/W emulsions. 
Emulsifier concentration on stability of O/W emulsions 
The most effective emulsifiers are non-ionic surfactants (Tween 20 etc.) that can be used emulsify O/W 
or W/O emulsions. In addition, they can stabilize the emulsion against flocculation and coalescence. 
The effect of Tween 20 concentration in the continuous phase has been investigated over a 
concentration range between 0.5 and 2.0% (w/w) using 0.5% (w/w) ergocalciferol in soybean oil as a 
dispersed phase. As shown in Fig.6.9a and b, uniform droplet production were obtained with a span of 
particle size distribution in the range of 0.204-0.208 up to the concentration range of 0.5 to 1.5% 
(w/w), although droplet generation was quite stable with 2% (w/w) Tween 20 but the distribution was 
fairly larger and have span width of about 0.237 with d3,2 of 35.7 m.  
The production of uniform droplets even at low emulsifier concentration could be clarified by 
the presence of surface active agents in soybean oil, like free fatty acid (e.g., linoleic and linolenic 
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acid). The production of these free fatty acid might increase during mixing of ergocalciferol at 85 oC. 
The other factor that promote successful droplet generation at low emulsifier concentration is the 
asymmetric structure of MCs that enhance the droplet formation and increase monodispersity. At 
higher Tween 20 concentration (2% (w/w)) significant amount of droplets were attached to the plate 
surface during emulsification and after generation. This attachment process might be due to high 
interfacial forces that prevails over the tangential drag force generated by cross flow and slightly 
increased the steric hindrance effect and decrease the monodispersity (Fig. 6.10b) in comparison such 
steric hindrance effect was not observed with low concentration of Tween 20 (Fig. 6.10a).  
(a) 
 
(b) 
 
 
Figure 6.9: (a) Particle size distribution of the generated soybean oil droplets encapsulating 
ergocalciferol at the constant flux of 5 L m-2 h-1 for four different Tween 20 concentration (0.5-
2.0% (w/w)). (b) Effect of Tween 20 concentration in the aqueous phase on the mean size of 
ergocalciferol loaded emulsions at Jd = 5 L m-2 h-1. 
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Figure 6.10: (a) Generation of ergocalciferol loaded droplets at low Tween 20 concentration 
(0.5% (w/w)). The droplets detached smoothly from the plate surface as soon as they formed 
(higher magnification). (b) Generation of droplets at high Tween 20 concentration (2.0% (w/w)). 
The droplet remains attached to plate surface for some time, before they detached from the 
microslots (higher magnification). 
 
Vladisavljevic et al. 43) reported the observed effect at low concentration of SDS (0.01-0.1%) 
in straight-through MCE. This deviation might attributed with the emulsifier nature, since SDS is the 
strong ionic emulsifier in comparison to non-ionic nature of Tween 20. At 0.5-1.5% (w/w) Tween 20, 
the mean droplet diameter (d3,2) was in between 33.7-34.1 m (Fig. 6.9b). The mean droplet/channel 
size ratio lies in between 3.37 to 3.41 and fairly smaller than other membrane emulsification devices 
44). The d3,2 value of 33.7-34.1 m is significantly higher than dav of 24.5 m reported in straight-
through MC emulsification for the system containing 1% (w/w) Tween 20 and argan oil using a 
symmetric MC plate with 10 × 50 m channels 45). The results of successful emulsification at low 
(a) (b) 
200 m 200 m 
 50 m 50 m 
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Tween 20 concentration are well in line with the previous study of El-Abbassi et al. 45). They 
formulated argan oil stabilized O/W emulsions with low concentration of Tween 20 (1-6%).    
    
Effect of dispersed phase flux and storage stability of O/W emulsions 
Fig. 6.11a shows the effect of ergocalciferol loaded soybean oil flux on the d3,2 and the size 
distribution. The dispersed phase flux (Jd) is the useful indicator of droplet productivity via MCs as 
well as other microfluidic devices. Jd is defined as: 
𝐽d =  
𝑄d
𝐴MCA
                           (6.10) 
 Where AMCA is the total active area of the MC arrays (10 × 10 mm). The maximum Qd used 
here was 2 mLh-1 which corresponds to Jd of 20 L m-2 h-1 and it was the critical flux in this study, after 
crossing this flux there was continuous outflow of dispersed phase and leading to unstable droplet 
production. There was continuous increase in d3,2 of produced emulsions with increasing dispersed 
phase flux (Fig. 6.11a). The d3,2 with increasing flux ranged in between 33.9 to 35.4 m, 
correspondingly there span width (indicator of droplet dispersity) also increased with increasing 
dispersed phase flux. The droplet production behavior with increasing flux was presented in Fig. 6.11b. 
There was smooth detachment of droplets with increasing flux before reaching critical Jd. 
The results of Jd on ergocalciferol loaded O/W emulsions deviates with previous findings of 
Vladisavljevic, et al. 26). They reported size stable zone of soybean oil loaded emulsions in between 0-
50 L m-2 h-1, moreover they reported critical Jd of 260 L m-2 h-1 for soybean oil loaded emulsions 
without loading any bioactive. The results are somewhat similar to the findings of 31), they formulated 
polyunsaturated fatty acid (PUFA) loaded O/W emulsions and observed increase in dav of emulsions as 
a function of Jd. They reported critical Jd of 80 L m-2 h-1. 
The monodisperse O/W emulsions encapsulating 0.5% (w/w) ergocalciferol formulated with 
1% (w/w) Tween 20 were stored at 4 ± 1oC for 15 d. These emulsions were formulated by keeping Jd at 
5 L m-2 h-1 and continuous phase flow rate at 150 mL h-1. Immediately after formulation, emulsions 
with ergocalciferol had a colorless turbid appearance with good flowability. The appearance of the 
O/W emulsions did not change with storage time. Fig. 6.10 depicts time changes in the d3,2 and span 
values of the formulated O/W emulsions encapsulating ergocalciferol. There was hardly any increase in 
d3,2 of emulsion during evaluated storage time, indicating high physical stability of O/W emulsions. 
The d3,2 of emulsions remain  in range of 33.9 mm with span width between 0.203 to 0.208 (Fig. 6.12). 
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(a) 
 
(b) 
 
        
        
Figure 6.11: (a) Effect of Jd on mean droplet diameter and span width of O/W emulsions 
encapsulating ergocaliferol. (b) Typical droplet generation behavior at (i) low flux of 5 L m-2h-1 
and (ii) critical flux of 20 L m-2h-1. 
(i) (ii) 
100 m 100 m 
 50 m 50 m 
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Figure 6.12: Storage stability of O/W emulsions encapsulating ergocalfierol stored at 4 ±1oC. The 
data was presented in term of mean droplet diameter and span width. 
 
Encapsulation efficiency of ergocalciferol in O/W emulsions 
The freshly formulated O/W emulsions had an initial retention of 0.06 mg mL-1 and regarded as 100% 
encapsulated efficiency, since in MC emulsification it was difficult to maintain the volume fraction 
with passage of time in comparison to conventional emulsification procedures. Fig. 6.13 indicates the 
retention and encapsulation efficiency (EE) of O/W emulsions. The EE slightly decreased with storage 
time and exhibited 76% retention of ergocalciferol after 15 d of storage at 4 oC.  The results are 
comparable with EE of previously encapsulated bioactives in MC emulsification. The EE of L-ascorbic 
acid in W/O/W emulsions prepared through MC emulsification was more 80% after 10 d of storage 
period 32). This higher retention can be ascribed to the narrow size distribution of the O/W droplets 
formulated by MCE, since the generation of droplets in MCE was based upon difference in interfacial 
tension rather than high-energy homogenization procedures. Semo et al. 46) and Ron et al. 47) 
encapsulated ergocalciferol in casein and -lactoglobulin and observed that reduction rate of 
encapsulated ergocalciferol was slower than solved ergocalciferol in ethanol-water mixture. 
Encapsulated ergocalciferol in mentioned studies perform better against oxygen diffusion, interaction 
with oxidizing agents and harmful effects of UV radiations. The evaluation of these mechanisms are 
beyond the scope of present study.  
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Figure 6.13: Encapsulating efficiencies and retention profile of O/W emulsions with storage time. 
The emulsions were prepared at Jd of 5 L m-2 h-1 and the data was presented over 15 days of 
storage time 
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Table 6.1: Fluid properties of systems containing ergocalciferol together with different oils used for preparing O/W emulsions 
 
 
 
 * Dispersed phase contains 0.5% (w/w) ergocalciferol and interfacial tension was observed in the presence of 1% (w/w) Tween 20 in Milli-Q water, ** 
Viscosity ratio () was defined as the ratio of to-be-dispersed phase viscosity over the continuous phase viscosity. 
 Dispersed phase  Continuous phase 
  d (mPa s) d (kg m-3) d (mN m-1)  Emulsifiers 
in Milli-Q water 
d (mPa s) d (kg m-3) d (mN m-1) 
*MCT 22.5±0.3 946.9±0.2 5.3±0.4 24.7 0.5% Tween 20 0.89±0.1 997.3±0.6 5.1±0.2 
*Soybean oil 53.0±0.1 921.9±0.4 5.6±0.1 58.2 1.0% Tween 20 0.91±0.1 998.4±0.6 5.2±0.1 
*Olive oil 68.2±0.1 911.9±0.2 6.2±0.2 75.0 1.5% Tween 20 0.96±0.1 999.1±0.8 5.2±0.2 
*Safflower oil 53.2±0.1 918.9±0.1 5.3±0.2 58.5 2.0% Tween 20 0.99±0.1 1000.1±0.1 5.4±0.3 
     1.0% -lg 0.95±0.1 999.9±0.2 12.6±0.9 
     1.0% Sunsoft A-12 0.97±0.1 998.5±0.6 4.8±0.2 
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Chapter 7  
 
Formulation of monodisperse O/W emulsions loaded with ergocalciferol 
and cholecalciferol by microchannel emulsification: Insights of 
production characteristics and stability* 
 
 
 
 
 
 
________________________________________________________________________ 
*This chapter is published as Khalid N, Kobayashi I, Wang Z, Neves M, Uemura K, Nakajima M, 
Nabetani H. Formulation of monodisperse O/W emulsions loaded with ergocalciferol and cholecalciferol 
by microchannel emulsification: Insights of production characteristics and stability. 2015. International 
Journal of Food Science and Technology. In Press. DOI:10.1111/ijfs.12832. 
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7.1 Introduction 
There are an estimated one billion people worldwide who are either vitamin D deficient or have insufficient 
vitamin D intake 1). This deficiency can be addressed by food fortification and supplementation.  Vitamin D 
is a hydrophobic bioactive and has numerous uses in various industries including cosmetics, foods and 
pharmaceutics. Vitamin D is basically a seco-steroid hormone that possesses two active forms namely 
ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3) 2). Vitamin D3 is produced intradermally in the 
skin upon exposure to light and has many structural forms 3), while vitamin D2 is formed by the irradiation 
of ergosterol 4). 
After release from the food matrix, vitamin D is included to mixed micelle and enters the 
enterocytes via passive diffusion through unsaturable mechanism. Afterwards, it is included in 
chylomicrons and is activated by liver 5). The liver converts vitamin D to calcidiol [25(OH)D], the inactive 
blood circulating form or more precisely the indicator of vitamin D status in living bodies 5, 6). Calcidiol is 
converted to calcitriol [1, 25(OH)2D] in the kidneys, and afterwards controls bone metabolism, calcium and 
phosphorus hemostasis, renal calcium reabsorption, blood pressure in addition to intestinal transport and 
insulin secretion 1, 2, 6).  
The recommended daily intake of vitamin D is around 5 g day-1 2). Most researchers define 
vitamin D deficiency as a serum calcidiol concentration less than 50 nmol L-1, insufficiency as a 
concentration of less than 80 nmol L-1 and toxicity as a concentration of  greater than 375 nmol L-1 1, 6).  
Most dietary products are poor source of vitamin D, including breast milk 7). Vitamin D intake is found to 
be low in vegetarians and vegans 8, 9). The high phytate and fiber content of vegetarian diets may also 
reduce the vitamin D absorption, while consumption of fish at least four times a week (wild fatty fish) helps 
prevent vitamin D deficiency 10). Similarly, vitamin D deficiency occurs due to lack of exposure of sun 
light, extensive use of UV protecting creams, lactose intolerance, and so on 11-13). 
Kawakatsu et al. 14) proposed microchannel emulsification (MCE) capable of generating 
monodisperse emulsion droplets by using microchannel (MC) arrays precisely fabricated on a single-crystal 
silicon microchip. These MC arrays have also been fabricated on polymer 15) and stainless steel chips 16). 
On MC array chips, numerous droplets can be generated simultaneously from a maximum of hundreds or 
thousands of parallel MCs 17). These MC arrays are either fabricated onto the chip surface as microgrooves 
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(grooved MC array) or straight-through holes (straight-through MC array) 18). MCE enables formulating 
monodisperse emulsions by forcing a dispersed phase into a continuous phase through uniformly sized 
channels of well-defined geometry. The droplet generation process in MCE was comprehensively reviewed 
by Vladisavljevic et al. 19). Monodisperse emulsions with droplet diameters of 1 to 500 m and the smallest 
coefficient of variation below 5% have been successfully formulated through MCE 18).  
MCE is a useful technique for many fundamental studies on emulsions, e.g., emulsion stability 20) 
and crystallization behavior of emulsion droplets 21). This technique has been used to prepare 
microdispersions such as solid lipid microspheres 22), coacervate microcapsules 23) gel microbeads 24) and 
giant vesicles 25). Similarly, previous studies have demonstrated the formulation of microdispersions 
encapsulating bioactives such as β-carotene 26), oleuropein 27), γ-oryzanol 28), L-ascorbic acid 29) and 
ascorbic acid derivatives 30).  
There is a considerable interest in fortifying food and beverage products with vitamin D, while 
fortifying foods with vitamin D is not straightforward due to its high hydrophobicity in food matrixes 31), 
degradability at high temperatures 32), better efficacy at higher pH 33), oxidation 34) and variable oral 
bioavailability 11). There was no pervious study describing the encapsulation of both active forms of 
vitamin D. Encapsulation of both forms of vitamin D have synergetic effect on retention of vitamin D in 
body for longer period of time 35,36). Keeping this idea in mind the present study was conducted to 
formulate oil-in-water (O/W) emulsions containing both ergocalciferol (VD2) and cholecalciferol (VD3) by 
using straight-through MCE. We investigated the effect of sodium cholate as potential emulsifier on 
stabilization of these emulsions. We also evaluate the physical and chemical stability of the O/W emulsions 
containing VD2 and VD3 formulated from MCE. 
7.2 Material and methods 
Chemicals 
Ergocalciferol, cholecalciferol, soybean oil, olive oil and polyoxyethylene (20) sorbitan monolaurate 
(Tween 20) were purchased from Wako Pure Chemical Ind. (Osaka, Japan). Medium chain triacylglycerol 
(MCT, sunsoft MCT-7) with a fatty acid residue composition of 75% caprylic acid and 25% capric acid 
was procured from Taiyo Kagaku Co. Ltd. (Mie, Japan). Sodium salt of colic acid (Na-cholate, > 97% 
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purity) was purchased from Sigma Aldrich (St. Louis, USA). Milli-Q water with a resistivity of 18 MΩ cm 
(pH 7.1) was used to dissolve the emulsifiers and served as continuous phase. All other chemicals used in 
this study were of analytical grade and used as received.  
 
Microchannel array chip 
In this study we used a 24×24-mm MC array chip (Model WMS 1-2) consisting of 10,313 MCs (Fig. 7.1) 
in a 10-mm2 in the center of the chip and two 1.5 mm diameter holes at the corners of the chip. This MC 
array chip was fabricated by repeated processes of photolithography and deep-reactive-ion etching (DRIE) 
on 5 in. silicon wafer. Each MC consisted of a circular microhole (10 m diameter and 70 m depth) 
located on the inlet side and a microslot (11 × 104 m cross section and 30 m depth) located on the outlet 
side. The slot aspect ratio of 9.5 was above the threshold value of 3 for successfully formulating 
monodisperse emulsions 37). Oxygen plasma treatment (PR41, Yamato Science Co. Ltd., Tokyo, Japan) was 
then performed to grow a hydrophilic silicon dioxide layer on the fabricated plate before carrying out the 
emulsification.  
 
Preparation of dispersed and continuous phases 
0.5% (w/w) VD2 was dissolved in soybean oil, olive oil and MCT heated to 75±2oC for 20 min and then 
quickly cooled to room temperature. Afterwards, 0.5% (w/w) VD3 was added to each oil solution pre-
loaded with VD2 at ambient temperature, and the oil solution loaded with VD2 and VD3 were stirred for 20 
min for proper dissolution. The influence of temperature on VD2 solubility in different oils was ascertained 
by measuring the turbidity as a function of temperature. Briefly, a known concentration of VD2 was 
dispersed in different oils (0.5 mg mL-1) at room temperature, which leads to the formation of turbid 
suspensions. The turbidity of these samples was then measured as function of temperature from 25 to 
100oC by using an UV/VIS/NIR spectrophotometer (V-570, Jasco Co., Hachioji, Japan) at 600 nm. As this 
experiment showed that the samples above 70oC become clear (original oil color), we chose 75oC as 
optimum temperature to dissolve VD2 in different oils. The continuous phase contained 1% (w/w) Na-
cholate or 1% (w/w) Tween 20 in Milli-Q water and used as such during MCE. The pH of the continuous 
phase during MCE was 7.1. 
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Figure 7.1: Schematic representation of microchannel (MC) array chip used in microchannel 
emulsification. (a) WMS 1-2 silicon chip. (b) Optical micrograph of the bottom-illuminated chip 
surface. The microholes are highlighted in dark black color in the center of light grey color microslot. 
(c) Arrangement of channels on the top side of a WMS 1-2 chip. Each horizontal row contains 
alternatively 82 or 83 channels and vertical rows contain alternatively 62 or 63 channels. 
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Emulsification procedure  
Each emulsification experiment was started with degassing of a WMS 1-2 chip soaked in the continuous 
phase under ultrasonication (VS-100III, As One Co., Osaka, Japan) at 100 kHz for 20 min. During module 
assembly, the degassed MC array chip was mounted in a module compartment previously filled with the 
continuous phase. Fig. 7.2a shows a simplified schematic diagram of the experimental setup used for MCE. 
A syringe pump (Model 11, Harvard Apparatus Inc., Holliston, USA) was used to supply both the 
continuous and dispersed phases. The emulsification process was carried out for approximately 1 h at 
ambient temperature and monitored through a high speed video system at 250 to 500 fps (FASTCAM-1024 
PCI, Photron Ltd., Tokyo, Japan) attached to an inverted metallographic microscope (MS-511B, Seiwa 
Kougaku Sesakusho Ltd., Tokyo, Japan). The droplet generation process during MCE is illustrated in Fig. 
7.2b. The dispersed phase flux (Jd) (L m-2 h-1) during emulsification was calculated using the following 
equation: 
𝐽d =  
𝑄d
𝐴MCA
                                          (7.1) 
where Qd is the dispersed phase flow rate (L h-1) and AMCA is the effective area of the MC array (10-4 m2). 
The average flow velocity of the continuous phase along the plate surface (Vc) (m h-1) was calculated with 
the following equation: 
𝑉c =  
𝑄c
𝐴a,s
                                        (7.2) 
where Qc is the continuous phase flow rate (L h-1), and Aa,s is the flow area along the plate surface (m2) and 
is calculated by measuring the dimensions of the spacer between the MC array chip and glass plate: 
𝐴a,s =   𝑊 × 𝐻                           (7.3) 
where W is the spacer internal width (10-2 m), and H is the spacer thickness (10-3 m). The Jd was varied 
between 5 to 120 L m-2 h-1. The Vc was set between 6.9 to 27.8 mm s-1. After experiments, the MC array 
chip was cleaned using an ultrasonic bath at a frequency of 100 kHz based on the following sequences: an 
MC array chip was cleaned in an aqueous solution of non-ionic detergent for 20 min, afterwards, the chip 
was again cleaned in Milli-Q water containing ethanol (1:1 v/v proportion) for the next 20 min and another 
round of cleaning with Milli-Q water for the final 20 min.  
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Measurement and analysis 
The size distribution of the O/W emulsion droplets containing VD2 and VD3 was measured by using a laser 
light scattering instrument which works on the principle of Polorization Intensity Differential Scattering 
Technology (LS13320, Beckman Coulter, Fullerton, USA). This instrument has ability to measure the size 
ranging from 0.04 to 2000 m with a resolution of 116 particle size channels. The mean droplet size was 
expressed as Sauter mean diameter (d3,2); i.e., the diameter of a droplet having the same area per unit 
volume as that of the total collection of droplets in emulsions. The width of droplet size distribution was 
expressed as relative span factor (RSF) and is defined as: 
RSF =  
𝑑v90−𝑑v10
𝑑v50
                   (7.4) 
where dv90 and dv10 are the representative diameters where 90% and 10% of the total volume of the liquid is 
made up of droplets with diameters smaller than or equal to the stated value. dv50 is the representative 
diameter where 50% of the total volume of the liquid is made up of droplets with diameters larger than the 
stated value and 50% is made up of droplets with diameters smaller than the stated value. 
 
Measurement of fluid properties  
The densities of dispersed and continuous phases were measured using a density meter (DA-130 N, Kyoto 
Electronics Manufacturing Co., Ltd., Kyoto, Japan) at 25±2oC. The viscosities of dispersed and continuous 
phases were measured with a sine wave vibro viscometer (SV-10, A&D Co., Ltd., Tokyo, Japan) at 25±2oC 
by taking 10 samples in a measuring vessel followed by immersion of sensor plates in that vessel. This 
viscometer uses a frequency of 30 Hz which is maintained at a constant amplitude. Viscosity was measured 
by detecting the electric current needed to resonate the sensor plates. The absolute viscosity (η) was 
calculated by 
𝜂 =  
𝜂mea
𝜌
                     (7.5) 
where ηmea is the measured fluid viscosity and ρ is the fluid density. The static interfacial tension between 
the oil and aqueous phases was measured with a fully automatic interfacial tensiometer (PD-W, Kyowa 
Interface Sciences Co., Ltd., Saitama, Japan) using a pendant drop method. The key physical properties of 
the continuous and dispersed phases are presented in Table 7.1. 
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Figure 7.2: Simplified representation of microchannel emulsification (MCE). (a) Experimental set-up 
used in this work for straight-through MCE. (b) Generation of O/W emulsion droplets in MCE. 
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Table 7.1: Fluid properties of the two-phase systems containing ergocalciferol (VD2) and 
chorecalciferol (VD3) together with different oils used for formulating O/W emulsions. 
 
Emulsion phase 
Density 
(kg m-3) 
Viscosity (mPa s) 
Interfacial 
tension 
(mN m-1) 
Dispersed phase* 918.23 ± 0.55 51.06 ± 0.20 - 
Continuous phase** 
(1% (w/w) Tween 20) 
998.90 ± 0.10 0.86 ± 0.01 5.30 ±0.30 
Continuous phase** 
(1% (w/w) Na-cholate) 
999.20 ± 0.30 1.29 ± 0.01 10.80 ± 0.30 
* Dispersed phase contains 0.5% (w/w) ergocalciferol and cholecalciferol in soybean oil; **Interfacial 
tension was measured between 1% (w/w) Tween 20 or 1% (w/w) Na-cholate in Milli-Q water and 0.5% 
(w/w) ergocalciferol and cholecalciferol in soybean oil 
 
Physical and chemical stability of O/W emulsions encapsulating VD2 and VD3 
The physical stability of the O/W emulsion droplets encapsulating VD2 and VD3 was evaluated according 
to the method described in an earlier section. The d3,2, RSF, consistency and coalescence during 30 days of 
storage were observed at 4±1 and 25±1°C.  The chemical stability of VD2 and VD3 in the emulsion droplets 
was determined spectrophotometrically. All spectral measurements of ethanol and hexane extracts of the 
preceding O/W emulsions were carried out using a UV/VIS/NIR spectrophotometer (UV-1700, Shimadzu, 
Co., Kyoto, Japan). First, 1 mL of the emulsion was extracted either with 9 mL of ethanol or hexane, 
followed by ultrasonication at 100 kHz for 20 min. The extracts were then centrifuged (Avanti HP-25, 
Beckman Coulter) at 20,000 g for 15 min. A 1 mL aliquot of the supernatant was diluted five times with 
ethanol (VD2) and hexane (VD3) and then injected into a quartz cell with a 10 mm pass length. The 
absorbance of VD2 and VD3 in emulsion extract was measured at 310 nm using an appropriate blank 
(ethanol and hexane). A representative standard curve of absorbance versus concentration gave linear least-
squares regression with a coefficient of determination (r2) of 0.999. All experiments were repeated in 
triplicate, and mean values were calculated. The Beer’s law was obeyed in the concentration range of 0.01-
0.5 mg mL-1 for VD2 and VD3, and the sensitivity of measurement has relative standard deviation of 0.85% 
(n=15). The molar absorptivity (Ɛ) for VD2 during this study was 0.61 mM-1 cm-1 and for VD3 was 0.4 mM-
1 cm-1. The encapsulation efficiency of VD2 and VD3 in samples n samples was calculated using the 
following equations, respectively: 
                𝐸𝐸VD2 =  
𝑊VD2,t 
𝑊VD2,0
 × 100               (7.6) 
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               𝐸𝐸VD3 =
𝑊VD3,t 
𝑊VD3,0
 × 100                (7.7) 
 where WVD2,t is the total amount of VD2 in the O/W emulsions and WVD2,0 is the total amount of  
VD2 added initially during preparation. Similarly, WVD3,t is the total amount of VD3 in the O/W emulsions 
and WVD3,0 is the total amount of VD3 added initially during emulsion preparation. 
7.3 Results and discussion 
Effect of different oils of the disperse phase on droplet generation characteristics 
The formulation characteristics of O/W emulsions encapsulating VD2 and VD3 were evaluated by using 
three different oils as the dispersed phase: soybean oil, olive oil and MCT. The continuous phase included 
either 1% (w/w) Tween 20 or 1% (w/w) Na-cholate in Milli-Q water. The dispersed phase was injected into 
the module at Qd of 2 mL h-1, while Qc was maintained at 250 mL h-1. Uniformly sized oil droplets 
encapsulating VD2 and VD3 were stably generated from the slot outlets without any significant wetting, 
regardless of the types of oils and emulsifiers used. Moreover, this droplet generation was completely based 
on spontaneous transformation of the oil-water interface in and over the slots (Fig. 7.3a), which is quite 
similar to previous studies on encapsulating -carotene in O/W emulsions and L-ascorbic acid in W/O/W 
emulsions with straight-through MCE 28, 29). 
Fig. 7.3b shows the d3,2 and RSF width of the formulated O/W emulsion droplets encapsulating 
VD2 and VD3 in different oils. Their d3,2 for Tween 20 ranged between 26.4 to 29.0 m with RSF width 
less than 0.3. In contrast, their d3,2 and RSF for Na-cholate had greater values and ranged between 30.9 to 
31.5 m with RSF width less than 0.6. Many past studies reported RSF of <0.5 as indictor of 
monodispersity in microfluidic devices 38, 39). Although narrower droplet size distributions were observed 
when using soybean oil and MCT rather than olive oil, the resultant emulsions containing olive oil droplets 
maintained monodispersity with RSF <0.5 (Figs. 7.3c and d). This finding might be attributed to the 
difference in fatty acid composition and free fatty acids of olive oil and soybean oil. As shown in Figs. 7.3c 
and 4d narrower droplet size distributions were observed for the O/W emulsions stabilized by Tween 20 in 
comparison to Na-cholate. Na-cholate is a biological surfactant extensively used for the formulation of 
mixed micelles and plays important role in many physiological processes; however, its efficiency to 
stabilize the emulsion interfaces is far less in comparison to Tween 20 due to low aggregation number 40). 
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Tween 20 has fatty acid ester moiety that could provide extra stability during emulsification process 
together with long-term stability 41).  
(a)  
                                                                              
 
(b)  
 
 
 
 
 
 200 µm  200 µm 
Jd = 10 L m-2 h-1 Jd = 10 L m-2 h-1 (i) (ii) 
 175 
(c) 
 
(d) 
   
Figure 7.3: (a) Typical generation behaviors of O/W emulsion droplets containing VD2 and VD3 
stabilized by 1% (w/w) Na-cholate (i) and Tween 20 (ii). (b) Effect of different dispersed phase 
composition on mean droplet diameter (d3,2) and RSF width of O/W emulsions. (c) Droplet size 
distribution of different disperse phases stabilized by Na-cholate. (d) Droplet size distribution of 
dispersed phases stabilized by Tween 20. ( ) MCT, ( ) soybean oil and ( ) denote olive oil in 
both Na-cholate and Tween 20. 
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Effect of dispersed phase flux on droplet generation characteristics  
Droplet productivity in MCE is directly related with Jd, being considered as important parameter in scaling 
up microfluidic devices. Fig. 7.4a depicts the effect of Jd on the d3,2 and RSF width of the resultant droplets 
stabilized either with Tween 20 or Na-cholate. The dispersed phase constitutes 0.5% (w/w) VD2 and VD3 in 
soybean oil. MCE was conducted by varying Jd in between 5 and 100 L m-2 h-1, while Vc was varied 
between 6.9 and 19.4 mm s-1. In Fig, 7.4a, the O/W emulsion droplets stabilized by Tween 20 have size 
stable zone between 10 and 40 L m-2 h-1. In this stable zone the d3,2 varies between 29.3 to 29.7 m with 
RSF width <0.25. In comparison the emulsions stabilized with Na-cholate have size stable zone in Jd of 10 
to 30 L m-2 h-1. The d3,2 in size stable zone remain in range from 30.3 to 30.7 m with RSF width below 
0.25. After crossing the size stable zone, the d3,2 slowly increased with increasing Jd in its range of 50 to 80 
L m-2 h-1 for Tween 20 and 40 to 60 L m-2 h-1 for Na-cholate. In this case, the RSF was kept below 0.25 for 
Tween 20 but gradually increased for Na-cholate. Further increase in Jd resulted in steeper increase in the 
d3,2 for both emulsifiers, and the d3,2 ranged between 35.4 to 37.4 m with RSF above 0.5 at Jd  of 100 L m-
2 h-1. 
The influence of Jd on the droplet generation frequency per MC array chip (f) is presented in Fig. 
7.4b. f can be estimated by:  
𝑓 =  
𝑄d
𝑉av 
=  
6𝑄d
𝜋𝑑3,2
3                    (7.8) 
where Vav is the average droplet volume (m3).  The monodisperse droplets produced had a maximum 
productivity of 4.9×105 h-1 at Jd of 80 L m-2 h-1 for Tween 20, and 2.8×105 h-1 at Jd of 50 L m-2 h-1 for Na-
cholate. During MCE, we observed the generation of uniformly sized oil droplets from more than 90% of 
the whole channels at Jd of 80 L m-2 h-1 in emulsions stabilized with Tween 20. In comparison, uniformly 
sized oil droplets from more than 90% of the whole channels were observed at Jd of 50 L m-2 h-1 in 
emulsions stabilized with Na-cholate. In MCE the droplet generation from the channel is depended on the 
capillary number (Ca) defined as the ratio of the viscous force to the interfacial tension force and is 
expressed as: 
Ca =  
𝜂d𝑈d,ch
𝛾
                     (7.9) 
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where ηd is the viscosity of the dispersed phase (Pa s), 𝑈d,ch is the average flow velocity of the dispersed 
phase in the channel (m s-1), and γ is the interfacial tension between the dispersed and continuous phases (N 
m-1). 𝑈d,ch can be estimated by the following equation: 
𝑈d,ch =  
4𝑄d
𝑑2𝜋 𝑁ch
                 (7.10) 
where dch is the hydraulic diameter of each channel and Nch is the total number of channels (10, 313). 
Monodisperse emulsion droplets were generated from the channels below the critical Ca, where the 
interfacial tension force was dominant for droplet generation 42). The soybean oil loaded with VD2 and VD3 
had a ηd of 50.2 mPa s, but γ for the two-phase system containing Na-cholate (10.8 mN m-1) was much 
higher than that containing Tween 20 (4.5 mN m-1). At the critical 𝑈d,MC (1.4 mm s-1), the calculated critical 
Ca value was 1.8×10-2 in emulsions stabilized by Tween 20. The emulsions stabilized by Na-cholate have 
much lower critical Ca value of 8.8×10-3 at 𝑈d,MC of 1.0 mm s-1. 
 
 
(a) 
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(b) 
                        
Figure 7.4: (a) Effect of dispersed phase flux on mean droplet diameter (d3,2) and RSF width of O/W 
emulsions stabilized by Na-cholate and Tween 20. ( ) denote Tween 20 and ( ) denote Na-cholate, 
while same open keys represent RSF width of O/W emulsions. (b) Effect of dispersed phase flux on 
droplet productivity. ( ) denote Tween 20 and ( ) denote Na-cholate. 
 
Stability evaluation of O/W emulsion droplets encapsulating VD2 and VD3  
The monodisperse O/W emulsions encapsulating 0.5% (w/w) VD2 and VD3 formulated at Jd of 10 L m-2 h-1 
were stored at 4±1 and 25±1oC for 30 days. Immediately after formulation, the collected emulsions 
containing VD2 and VD3 had a light turbid appearance with good flowability and consistency. Their 
physical appearance did not change with storage time. Fig. 7.5 depicts time changes in the d3,2 and RSF 
width of the monodisperse O/W emulsions encapsulating VD2 and VD3. There was no difference in their 
d3,2 and RSF width for Tween 20 at 4 and 25oC and Na-cholate only at 25oC. On the contrary, 
destabilization was observed in emulsions stabilized by Na-cholate stored at 4oC after 15 days of storage. 
There was gradual increases in the d3,2 and RSF of emulsions stabilized by Na-cholate stored at 4oC. 
Initially there was slight increase in the d3,2 up to 15 days from 29.7 to 31.7 m with RSF of <1.0. After 15 
days there was sharp increase in the d3,2 of emulsions and the droplet size reached to 65.3 m with RSF of 
>1.7. This sharp increase in d3,2 indicates weaker emulsifier layer around the droplets. In comparison the 
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d3,2 slightly increased from 29.5 to 31.8 m at 4 and 25oC in emulsions stabilized by Tween 20 and 28.3 to 
31.5 m at 25oC in emulsions stabilized by Na-cholate.  
The steep increase in d3,2 of the O/W emulsions stabilized by Na-cholate at 4oC can be well 
explained by low aggregation number (average number of molecules in a micelle) of Na-cholate. The 
aggregation number of pure Na-cholate (3 to 16) is highly influenced by the environmental parameters 43, 
44). At low temperature some of the Na-cholate aggregates may crystallize the droplet surface and 
destabilize the emulsions, which could cause the increase in their d3,2. In contrast, such destabilization was 
not observed at ambient temperature. Tween 20 has higher aggregation number (<60) and also has strong 
hydrophobic moiety that stabilized the oil-water interfaces for longer period of time in comparison to ionic 
emulsifiers 45). Recently, Guttoff et al. 46) formulated nanoemulsions encapsulating vitamin D that were 
physically stable for one month at ambient temperature, whereas they were susceptible to droplet growth 
when exposed to elevated temperatures. Similarly, Ziani et al. 47) prepared food-grade O/W emulsions 
loaded with VD3 by running a blend of 10% (w/w) oil and 90% (w/w) water containing 1% (w/w) of non-
ionic emulsifiers (Tweens) over cycles in the high pressure homogenizer. The resulting emulsion had an 
average droplet size of around 0.22 m and was resistant to particle growth after formulation. To our 
knowledge, there are no previous reports describing the encapsulation of both forms of vitamin D using 
either conventional or microfluidic approaches. We used extremely mild emulsification procedure, which 
produced O/W emulsions with precise monodispersity.   
(a)  
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(b) 
                                 
Figure 7.5: Storage stability of O/W emulsions encapsulating VD2 and VD3 stored at 4±1 and 25±1oC. 
The data was presented in term of mean droplet diameter (d3,2) and RSF width. (a) Storage stability 
of emulsion droplets stabilized by Tween 20. ( ) denote stability at 4oC and ( ) denote stability 
at 25oC, while same open keys denote RSF width. (b) Storage stability of emulsion droplets stabilized 
by Na-cholate. ( ) denote stability at 4oC and ( ) denote stability at 25oC, while same open 
keys denote RSF width. 
 
Encapsulation efficiency of VD2 and VD3 in O/W emulsion droplets  
The freshly formulated O/W emulsions containing VD2 and VD3 had initial concentrations of 59.3 µg mL-1 
for VD2 and 62.1 µg mL-1 for VD3 regarded as 100% EE, since in MCE it was difficult to maintain the 
dispersed phase volume fraction (d) in these emulsions with passage of time in comparison to 
conventional emulsification procedures. The calculated d at the end of emulsification corresponds to 
0.79%. Fig. 7.6a depicts the EE of the VD2 and VD3 kept in the resultant O/W emulsions stabilized with 
1% (w/w) Tween 20. The EE slowly decreased with storage time and exhibited 75.7% for VD2 and 77.1% 
for VD3 at 4oC and 66.2% for VD2 and 69.1% for VD3 after 15 days of storage at 25oC. In comparison the 
O/W emulsions stabilized with 1% (w/w) Na-cholate exhibited only 49.5% for VD2 and 51.21% for VD3 at 
4oC after 15 days of storage (Fig. 7.6b). The emulsions stored at 25oC had EE of 68.2% for VD2 and 70.1% 
for VD3 after 15 days of storage. 
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The present study correlates well with the previously reported EEs of bioactives in MCE. For 
instance, the EE of L-ascorbic acid in the monodisperse W/O/W emulsions prepared through MCE was 
more than 80% after 10 d of storage at 4oC 29). Semo et al. 48) and Ron et al. 49) encapsulated VD2 in casein 
and -lactoglobulin micelles and observed that reduction rate of encapsulated VD2 was slower than VD2 
solubilized in ethanol-water mixture. Recently, Almouazen et al. 50) encapsulated VD3 in polymeric 
nanoparticles for potential applications in chemotherapy and found its EE of around 90% with sustained 
release over a period of 7 days. The EE of VD3 in poly(lactic-co-glycolic acid)-coated nanoparticles was 
around 74.8% 51). Tippetts et al. 52) fortified milk with different emulsions containing VD3, and the 
retention profile was observed in cheese curd. The emulsified cheese curd showed higher EE of VD3 (74-
78%) in comparison to non-emulsified cheese curd.  
 
(a) 
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(b) 
                            
Figure 7.6: Encapsulating efficiencies (EEs) of ergocalciferol (VD2) and chorecalciferol (VD3) in the 
resultant O/W emulsions as a function of storage time. These emulsions were formulated at Jd of 5 L 
m-2 h-1 and the data are presented over 15 days of storage time. (a) EEs of Tween 20 stabilized 
emulsions and (b) EEs of Na-cholate stabilized emulsions. ( ) denote EE of VD2 at 4oC, ( ) EE 
of VD3 at 4oC, ( ) EE of VD2 at 25oC and ( ) denote EE of VD3 at 25oC. 
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Chapter 8  
 
Formulation and characterization of food grade oil-in-water emulsions 
encapsulating mixture of cholcalciferol and ergocalciferol by different 
homogenization techniques* 
 
 
 
 
 
 
 
________________________________________________________________________ 
*This chapter is to be submitted as Khalid N, Kobayashi I, Wang Z, Neves M, Uemura K, Nakajima M, 
Nabetani H. Formulation and characterization of food grade oil-in-water emulsions encapsulating mixture 
of cholcalciferol and ergocalciferol by different homogenization techniques. Food Science and Technology 
Research 
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8.1 Introduction 
Vitamin D is called the antirachitic vitamin, since it counteracts rickets, helps to breaking-down mineral 
substance in fully grown bones (Osteodistrophy), bone and joint deformations and spontaneous brittleness 
of bones 1). The term vitamin D refers to a pair of biologically inactive precursors; these are vitamin D3, 
also known as cholecalciferol, and vitamin D2 known as ergocalciferol. Cholecalciferol (D3) is produced in 
the skin by a photoreaction on exposure to UV light from the sun (wavelength 290 to 320nm), while 
ergocalciferol (D2) is produced in plants and enters human diet through consumption of plant sources 2, 3). 
Vitamin D2 and D3 forms are inactive but once present in the circulation enter the liver and kidneys where 
they are hydroxylated to form active forms of D2 and D3 4).  
Vitamin D2 and D3 plays an important part in human and animal nutrition. It regulates the 
absorption, metabolism and excretion of calcium and phosphorus from the intestine and kidneys. Further it 
controls the incorporation of calcium and phosphorus in the skeleton 4). The recommended daily intake of 
vitamin D is around 5 g/day 5).  Most dietary products are poor source of vitamin D, including breast milk 
6). Vitamin D intake is found to be low in vegetarians and vegans 7, 8). The high phytate and fiber content of 
vegetarian diets may also reduce the vitamin D absorption, in contrast consumption of fish at least four 
times a week (wild fatty fish) helps prevent vitamin D deficiency 9). Similarly, vitamin D deficiency occurs 
due to lack of exposure of sun light, extensive use of UV protecting creams, lactose intolerance and 
religious restrictions 10-12). 
Low fat or reduced fat products are highly desirable in human nutrition, but the processing of low 
fat products resulted in reduction of several micronutrients like fat soluble vitamins. Enrichment of low fat 
products with vital micronutrients is the challenging task in food industries. Encapsulation, emulsification, 
salting out, solvent evaporation and polymerization are the popular enrichment methods frequently used in 
food industries 13, 14). All of these methods have positive and negative aspects, but in general each delivery 
system must be speciﬁcally designed for each application depending on the characteristics of the active 
agent to be encapsulated, e.g., solubility, physical and chemical stability. Previously, vitamin D is 
encapsulated in numerous systems like spontaneous emulsification 15), nanoparticles 16), casein micelles 17) 
and Poly(D, L)Lactic acid (PLA) nanoparticles prepared from nanoprecipitation method 18).  
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Fat soluble bioactives in its pure form, can be handled only with difficulty or not at all, because it 
is oxidation-sensitive substance. Furthermore, a fine dispersion of the fat soluble bioactive is advantageous 
for optimal absorbability and as well as bioavailability. These substances are therefore often supplied in the 
form of emulsions or in the dry powders or as solution in physiologically tolerated oil or embedded in a 
fine dispersion in a protective colloid. The challenges associated with vitamin D fortiﬁcation are: poor 
water solubility; chemical degradation when exposed to light, oxygen, or elevated temperatures; and 
variable oral bioavailability 10,15). In the current study, we aimed to formulate oil-in-water (O/W) emulsion-
based delivery systems for vitamin D containing a mixture of both vitamin D2 and D3 by using a simple 
rotar-stator homogenizer and high pressure homogenization techniques. Moreover, we conducted 
comparative studies with both techniques on stability and release profile of vitamin D loaded emulsions. 
8.2 Material and methods 
Chemicals 
Cholecalciferol (VD3), ergocalciferol (VD2), soybean oil, olive oil, disodium hydrogen phosphate 
dodecahydrate (sodium phosphate, dibasic), sodium dihydrogen phosphate dehydrate and polyoxyethylene 
(20) sorbitan monolaurate (Tween 20) were purchased from Wako Pure Chemical Ind. (Osaka, Japan). 
Medium chain triacylglycerol (MCT, sunsoft MCT-7) with a fatty acid residue composition of 75% 
caprylic acid and 25% capric acid was procured from Taiyo Kagaku Co. Ltd. (Mie, Japan). Milli-Q water 
with a resistivity of 18MΩ cm (pH 7.1) was used to dissolve the emulsifiers and served as continuous 
phase. All other chemicals used in this study were of analytical grade and used as received.  
 
Dispersed and continuous phase preparation 
0.5% (w/w) VD2 was dissolved in heated soybean oil, olive oil and MCT at 75± 2oC and quickly cooled to 
room temperature. Afterwards, 0.5% (w/w) VD3 was added to pre-loaded VD2 solutions (soybean oil, olive 
oil and MCT) and stirred for 20 min for proper dissolution. The influence of temperature on VD2 solubility 
in different oils was ascertained by measuring the turbidity as a function of temperature. Briefly, a known 
concentration of VD2 was dispersed in different oils (0.5 mg mL-1) at room temperature, which lead to the 
formation of turbid suspension. The turbidity of these samples was then measured as function of 
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temperature from 25 to 100oC by using an UV/VIS/NIR spectrophotometer (V-570, Jasco, Hachioji, Japan) 
at 600 nm. This experiment shows that the samples above 70oC become clear (original oil color), and so we 
choose 75oC as optimum temperature to dissolve VD2 in different oils. The continuous phase comprises 1% 
(w/w) Tween 20 in Milli-Q water and used as such during emulsification. The pH of continuous phase 
during emulsification was 7.1. 
 
Preparation of O/W through rotar-stator homogenization 
The O/W emulsions were prepared from a dispersed oil and continuous phase. The dispersed phase 
constitutes 0.5% (w/w) VD2 and VD3 in soybean oil, olive oil or MCT, while the continuous phase contain 
1% (w/w) Tween 20 in Milli-Q water. The volume fraction of the dispersed aqueous phase (d) was fixed to 
30 g 100 g-1. Thirty mL of dispersed phase were added to seventy mL of continuous phase at room 
temperature (~25oC), followed by emulsification at various rotation speed (5000 to 20,000 rpm) for 5 min 
with a polytron homogenizer (PT-3000 Kinematica-AG, Littace, Switzerland). 
  
Preparation of O/W through high-pressure homogenization 
Two step homogenization technique was adopted to prepare O/W emulsions with high pressure 
homogenizer. In the first step a premix emulsions were obtain by homogenizing dispersed and continuous 
phases at 7,000 rpm for 5 min by using polytron homogenizer (PT-3000 Kinematica-AG, Littace, 
Switzerland), and immediately followed by high-pressure homogenization (Microfluidizer Processor Model 
M-110EH, Microfluidics Corporation, Newton, ME, USA) in a single pass at 100 MPa. The pH of all 
prepared O/W emulsions was 7.1. 
 
Physicochemical properties of the continuous and dispersed phases  
The densities of the liquid phases were measured with a digital density meter (DA-130 N, Kyoto 
Electronics Manufacturing Co., Ltd., Kyoto, Japan) at 25 ± 2oC. The viscosities of the emulsified fluids 
were measured with a vibro viscometer (SV-10, A&D Co., Ltd., Tokyo, Japan) at 25 ± 2oC by taking 35 
mL of samples in a measuring vessel followed by immersion of sensor plates in that vessel. The frequency 
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and amplitude of the resonating gold plates were maintained at 30 Hz during measurement. Absolute 
viscosity (η) was then calculated from the real viscosities of fluids by 
𝜂 =  
𝜂mea
𝜌
                      (8.1) 
where ηmea is the measured fluid viscosity and ρ is the fluid density. The static interfacial tension between 
the two emulsified phases were measured with a fully automatic interfacial tensiometer (PD-W, Kyowa 
Interface Sciences Co., Ltd., Saitama, Japan) using a pendant drop method. The key physical properties of 
liquid phases were presented in Table 8.1. 
 
Droplet size determination and -potential measurements  
The particle size distribution of sub-micron O/W emulsion droplets encapsulating VD2 and VD3 was 
measured by using laser diffraction particle size analyzer, that works on the principle of Polorization 
Intensity Differential Scattering (PIDS) Technology (Beckman Coulter LS 13 320, Miami, FL, USA). This 
instrument has ability to measure the size ranging from 0.04 to 2000 m. The mean droplet size was 
expressed as volume mean diameter (d4,3) i.e. the diameter of a droplet having the same volume in total 
weight of emulsions and expressed as: 
𝑑4,3 =  
∑ 𝑛𝑖 𝑑𝑖
4
∑ 𝑛𝑖𝑑𝑖
3                      (8.2) 
where ni is the number of droplets of diameter di. The width of droplet size distribution was 
expressed as relative span factor (RSF) and is defined as: 
RSF =  
𝐷𝑣0.9−𝐷𝑣0.1
𝐷𝑣0.5
                  (8.3) 
Where Dv0.9 and Dv0.1 are the representative diameters where 90%, 10% and 50% of the total 
volume of the liquid is made up of droplets with diameters smaller than or equal to the stated value. While 
Dv0.5 is the representative diameter where 50% of the total volume of the liquid is made up of droplets with 
diameters larger than the stated value and 50% is made up of droplets with diameters smaller than the 
stated value. 
The -potential of O/W emulsions encapsulating VD2 and VD3 was measured by Dynamic Light 
Scattering (Zetasizer Nano ZS, Malvern Instruments Ltd., Worcestershire, UK). All measurements were 
recorded in triplicate and reported as the average and standard deviation. 
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Physical and chemical stability of O/W emulsions  
The physical stability of O/W emulsions encapsulating 0.5% (w/w) VD2 and VD3 were observed by using 
laser diffraction particle size analyzer as described in section 2.5 to evaluate d4,3, RSF, consistency and 
coalescence during 30 d of storage at 4 ± 1°C. The chemical stability of emulsion extracts either in ethanol 
or hexane was determined spectrophotometrically using a UV/VIS/NIR spectrophotometer (UV-1700, 
Shimazdu, Co. Japan).  
The 1 mL of the emulsion was extracted either with 9 mL of ethanol or hexane and followed by 
ultrasonication for 20 min. The extracts were then centrifuged (Avanti HP-25, Beckman Coulter, Miami, 
FL) at 20,000 g for 15 min. 1 mL aliquot of the subnatants was diluted five times with ethanol for 
quantification of VD2 and hexane for quantification of VD3. Afterwards, 3 mL of aliquot was injected into 
a quartz cell with a 10 mm pass length. The absorbance of VD2 and VD3 in emulsion extract was measured 
at 310 nm using an appropriate blank.  
A representative standard curve of absorbance versus concentration gave linear least-squares 
regression with a coefficient of determination (r2) of 0.999. All experiments were repeated in triplicate and 
mean values were calculated. The Beer’s law was obeyed in the concentration range of 0.01-0.5 mg mL-1 
for VD2 and VD3 the sensitivity of measurement has relative standard deviation of 0.85% (n=15). The 
Molar absorptivity (Ɛ) for VD2 during this study was 0.61 mM-1 cm-1 and for VD3 was 0.4 mM-1 cm-1. The 
encapsulation efficiency of VD2 and VD3 in samples was calculated with the equation: 
   𝐸𝐸𝑣𝑖𝑡𝑎𝐷2 =  
𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑓𝑟𝑒𝑒 𝑣𝑖𝑡𝑎𝑚𝑖𝑛𝐷2  
𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑒𝑛𝑐𝑎𝑝𝑠𝑢𝑙𝑎𝑡𝑒𝑑 𝑣𝑖𝑡𝑎𝑚𝑖𝑛𝐷2 
 × 100             (8.4) 
               𝐸𝐸𝑣𝑖𝑡𝑎𝐷3 =  
𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑓𝑟𝑒𝑒 𝑣𝑖𝑡𝑎𝑚𝑖𝑛𝐷3  
𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑒𝑛𝑐𝑎𝑝𝑠𝑢𝑙𝑎𝑡𝑒𝑑 𝑣𝑖𝑡𝑎𝑚𝑖𝑛𝐷3 
 × 100             (8.5) 
 
8.3 Results and discussion 
Effect of emulsifying techniques on preparation of O/W emulsions  
 
Rotar-stator homogenization  
 
Fig. 8.1 shows the effect of homogenization speed on d4,3 and span width of O/W emulsions containing 
0.5% (w/w) VD2 and VD3. The O/W emulsions were successfully prepared at 5,000 rpm or higher, whereas 
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lower speed of homogenization resulted in incomplete homogenization and phase separation in short time. 
d4,3 of resultant emulsions gradually decreased from 28.34 µm to 6.86 µm by increasing speed of 
homogenization form  5,000 to 20,000 rpm.  The O/W emulsions prepared at 5,000 and 7,000 rpm 
completely phase separated within 2 h of formation, while all other emulsions remained stable without any 
prominent phase separation or physical deformation. The span width of O/W emulsions was in between 
1.03 to 3.40. The higher span width indicates polydispersity in formulated emulsions.  
 
 
Figure 8.1: Effect of rotor-stator homogenization speed on d4,3 and span width of O/W emulsions 
encapsulating vitamin D2 and D3. Grey bar denote d4,3 of emulsions and ( ) span width of O/W 
emulsions. 
 
Homogenization at 20,000 rpm slightly increased the temperature to more than 40.2oC in 
comparison to 28-35oC in emulsions produced at low speed of homogenization. However, such variation in 
temperature has no prominent effect on encapsulation efficiencies (EE) of VD2 and VD3 (Fig. 8.2). The 
initial EEs of VD2 and VD3 were more than 80% just after emulsification with different speed of 
homogenization. Moreover, a slightly higher yield of VD2 was observed in emulsions in companion to 
VD3. The higher yield of VD2 was in order of 3-4% in comparison to VD3. 
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Figure 8.2: Encapsulation efficiencies (EEs) of O/W emulsions produced from rotor-stator and high 
pressure homogenization techniques. The EEs were quantified in soybean oil by two step extraction 
process. Black bars denote EEs of VD2, while grey bars present EEs of VD3. 
 
The production of emulsions with rotar-stator homogenizer (RSH) depends upon the rotational 
speed of shaft, which can easily be co-related with energy of homogenization. The higher the input energy, 
the smaller will be the droplet size. However, uniformity of droplet size distribution depends upon the type 
of emulsion (O/W or W/O) formulated and the strength of emulsifier 19, 20). High emulsion stability for O/W 
emulsions is obtained by using emulsifiers having hydrophilic and lipophilic balance (HLB) greater than 10 
21). In our study we used polyoxyethylene (20) sorbitan monolaurate as emulsifier and have HLB value 
around 16.7. The high HLB value reduces the interfacial tension and gives extra stability to O/W emulsions 
even at low speed of homogenization.  
 
High-pressure homogenization 
 
To conduct a comparative study with RSH, O/W emulsions were also prepared with high pressure 
homogenization (HPH). A premix emulsion (d = 30%) was prepared with RSH at 7,000 rpm for 5 min and 
immediately carried out HPH at 100 MPa in a single pass. This treatment resulted in a well stable O/W 
emulsion having smooth consistency with bright whitish color. Fig. 8.3 shows droplet size distribution of 
premix and high pressure treated O/W emulsions. The normal distributed curve in emulsions treated with 
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HPH shows monodispersity in emulsion system in comparison to RSH. The high pressure treated 
emulsions have d4,3 of 0.40 µm with span width  < 1.  
 
Figure 8.3: Droplet size distribution of premix O/W emulsion at 7,000 rpm and high pressure 
homogenized O/W emulsion at 100 MPa in single pass. The dispersed phase contains vitamin D2 and 
D3 in soybean oil. ( ) denote droplet size distribution of premix O/W emulsion and ( ) denote 
droplet size distribution of high pressure homogenized O/W emulsion.  
 
HPH has no marked effect on EEs of VD2 and VD3 (Fig. 8.2). The initial EEs of VD2 and VD3 
were more than 80% in both premix and high pressure treated O/W emulsions. HPH is a non-thermal 
technology capable of producing O/W and W/O emulsions on sub-micron scale and have potential benefit 
in food industries. The narrow size droplet distribution with HPH have marked influence on shelf life and 
texture of different emulsion systems 22). Recently, Ziani et al. 23) formulated VD3 loaded O/W emulsions 
by using blend of 10% (w/w) oil and 90% (w/w) aqueous phase containing 1% (w/w) non-ionic surfactants 
over 5 cycles in the high pressure homogenizer at 62 MPa. The obtained O/W emulsion was resistant to 
particle growth and had average particle size of around 0.2 µm. 
 
Effect of oil type on droplet sizes of O/W emulsions prepared from RSH and HPH 
The ability of different oils to encapsulate VD2 and VD3 in O/W emulsions prepared with RSH was 
investigated by using soybean oil, olive oil and MCT. These oils were selected on the basis of functionality. 
Soybean and olive oil contain varieties of phospholipids, sterols and fatty acids, while MCT comprises only 
of caprylic and capric acid. Successful emulsification was conducted with different oil type from 5,000 to 
20,000 rpm for 5 min. Fig. 8.4 shows the d4,3 of different O/W emulsions in relation to oil type and speed of 
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homogenization. The droplet size decreases with speed of homogenization in all oil types. The smallest d4,3 
was obtained with soybean oil in comparison to olive oil and MCT. The prepared emulsions at low speed of 
homogenization phase separated quickly, while emulsions prepared at 10,000 and 20,000 rpm remain stable 
for more than 30 days without showing any physical deformity. Emulsions prepared at low speed of 
homogenization phase separated probably due to Ostwald ripening. Ostwald ripening leads to droplet 
growth due to mass transport of oil molecules, from smaller to larger droplets, since RSH produce 
emulsions with polydisperse droplets and normally has span width greater than 1.5 22).  Fig. 8.5 shows the 
optical micrographs of O/W emulsions prepared with different oil types. The presence of large droplets 
clearly reflect polydisperse emulsions, while at higher speed of homogenization, relatively monodisperse 
droplets were seen in MCT oil type, the possible reason for such monodispersity is the low viscosity of 
MCT in comparison to soybean and olive oil. The generation of smaller droplets during homogenization 
depends upon the ratio of viscosity of the dispersed phase to that of the continuous phase 24) 
 
 
Figure 8.4: Effect of rotor-stator homogenization speed on d4,3 of O/W emulsions containing different 
oil types. ( ) shows O/W emulsions containing soybean oil, ( ) denote olive oil and ( ) denote 
O/W emulsions containing MCT.  
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Figure 8.5: Optical micrographs of O/W emulsions with different oil types prepared with rotor-stator 
homogenizer at 10,000 and 20,000 rpm and with high pressure homogenizer at 100 MPa in single 
pass.  
 
The premix O/W emulsions prepared with MCT, soybean and olive oil at 7,000 rpm for 5 min was 
subject to HPH at 100 MPa. Significant reduction in d4,3 was observed with all oil types. Among them the 
smallest d4,3 was obtained with soybean oil (0.40 µm) followed by olive oil (0.77 µm) and MCT (0.85 µm). 
Similarly, monomodal droplet size distribution was observed with soybean oil (Fig. 8.6) in comparison to 
olive oil and MCT. Olive oil and MCT has distant bimodal peaks, indicating droplet growth even after 
HPH. An increased d4,3 with olive oil can be attributed to the high viscosity of the oil phase (Table 8.1), the 
high viscosity makes droplet distribution with in HPH more difficult 22, 24).  The above results slightly 
deviates from previous study of Ziani, et al. 23), they obtained monomodal peak of O/W emulsions 
encapsulating VD3 in MCT with average droplet size diameter around 220 nm. However, they pointed 
100 µm 
Soybean oil Olive oil MCT 
10,000 rpm 
20,000 rpm 
100 MPa 
10,000 rpm 10,000 rpm 
20,000 rpm 20,000 rpm 
100 MPa 100 MPa 
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bimodal distribution of droplets with viscous oil loaded with vitamin E and the above findings correlated 
with their results 23). 
Table 8.1: Fluid properties of two-phase system containing vitamin D2 and D3 used for preparing 
O/W emulsions 
 
Emulsion phase Density 
(Kg m-3) 
Viscosity 
(mPa s) 
Interfacial tension 
(mN m-1) 
Zeta potential  
(-mV) 
Dispersed phase*     
Soybean oil 917.8 ± 0.55 52.9 ± 0.06 5.5 ± 0.40 -56.5 ± 0.09 
Olive oil 929.5 ± 0.23 62.2 ± 0.10 6.2 ± 0.20 -51.5 ± 1.63 
MCT 943.8 ± 0.26 22.1 ± 0.10 5.2 ± 0.40 -55.3 ± 0.21 
Continuous phase**     
1% (w/w) Tween 20 999.0 ± 0.20 0.87 ± 0.01   
 
*Dispersed phase contains 0.5% (w/w) ergocalciferol and cholecalciferol in different oil types 
**Continuous phase includes 1% (w/w) Tween 20 in phosphate buffer (pH 7.0)  
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Figure 8.6: Droplet size distribution of emulsions formulated with different oil types with high 
pressure homogenizer at 100 MPa. ( ) shows emulsions containing soybean oil, ( ) denote olive 
oil and ( ) denote O/W emulsions containing MCT.  
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Figure 8.7: Storage stabilities of O/W emulsions with different oil types for a period of 30 days. (a) 
Soybean oil stability ( ) denotes emulsions formulated at 10,000 rpm, ( ) denote emulsions 
formulated at 20,000 rpm and ( ) denotes emulsions formulated at 100 MPa. b) Olive oil stability, (  ) 
denotes emulsions formulated at 10,000 rpm, ( ) denote emulsions formulated at 20,000 rpm and ( ) 
denotes emulsions formulated at 100 MPa. (c) MCT stability, ( ) denotes emulsions formulated at 
10,000 rpm, ( ) denote emulsions formulated at 20,000 rpm and ( ) denotes emulsions formulated at 
100 MPa. 
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Encapsulation efficiency of O/W emulsions encapsulating vitamin D2 and D3 
 
Fig. 8.8 shows encapsulation efficiencies (EEs) VD2 in different O/W emulsions. The freshly prepared 
rotor-stator homogenized emulsions with soybean oil have EE over 85 and 87% at 10,000 and 20,000 rpm 
respectively. The olive oil containing emulsions have EE over 71 and 67.5% at 10,000 and 20,000 rpm, 
while MCT containing emulsions retains about 42% VD2 at 10,000 and 20,000 rpm respectively. There was 
significant reduction in EEs of VD2 in O/W emulsions with storage time. At day 30, soybean oil retains 
<10%, olive oil <3% and MCT <23% VD2 respectively. Polydisperse droplet size distribution and diffusion 
of oil droplets to aqueous phase resulted in significant loss of VD2 from O/W emulsions.  
Slightly higher initial EEs were observed in emulsions prepared with HPH.  The initial EE with 
soybean oil was 87%, 65% with olive oil and 57% with MCT. These emulsions retain about 50% VD2 after 
15 days of storage at 4oC. Afterwards, there was sharp decline in EEs and at day 30; the EEs were in order 
of 2%, 6% and 23.3% with soybean, olive oil and MCT respectively. Dahan and Hoffman 30) evaluated the 
impact of short (C2triacetin), medium (C8-10, glyceryl tricaprylate/caprate) and long chain (C18, peanut oil) 
triglyceride (SCT. MCT and LCT respectively) on VD3 absorption. The bioavailability (in vitro lipolysis) 
indicated a rank order of MCT > LCT > SCT, but the in vivo bioavailability followed LCT > MCT > SCT. 
A slightly higher retention in MCT in our studies correlated with the study of Dahan and Hoffman 30). 
Fig. 8.9 shows EEs of VD3 in different O/W emulsions. The freshly prepared emulsions from RSH 
containing soybean oil have EE of 83 and 73% at 10,000 and 20,000 rpm. A slightly lower EE of 70% was 
observed with olive oil at 10,000 and 20,000 rpm respectively. In contrast, MCT containing emulsions have 
higher EEs of 91 and 94% at 10,000 and 20,000 rpm. All of these emulsions retains good amount of VD3 
up to 7 days of storage, after then there was sharp decline in EEs of VD3 the trend can more obvious in 
olive oil and MCT in comparison to soybean oil emulsions. After 30 days of storage the retention was 
about 10% in all O/W emulsions prepared with RSH. The initial EEs with HPH were more than 80% in all 
emulsions containing soybean, olive oil and MCT. Soybean oil retains about 70% VD3 after 10 days of 
storage, whereas olive oil retains 39% and MCT 50% after same storage period. The Sharpe decline in EEs 
were also observed in emulsion prepared with HPH and follows the order olive oil > MCT > soybean oil. 
The possible interpretation of sharp decline can be deduced from two reasons, firstly the prepared 
emulsions either with RSH or HPH contains polydisperse droplets. This polydisperity allows the small 
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droplets to grow with time due to Oswald ripening; moreover this process is accelerated due to viscosity 
difference between oil and aqueous phases 22). Secondly, vitamin D might migrate to the interface of O/W 
emulsions with respect to storage time that resulted in rapid decline in EEs of emulsions. VD2 has a 
predicted intrinsic solubility value of log S = -5.96, which indicate that part of the molecule possess 
hydrophilic characters due to its OH groups 31). Menéndez-Aguirre, et al. 17) encapsulated VD2 in casein 
micelles with application of high pressure treatments. They concluded that application of high pressure 
treatment with a slow release rate increased VD2 retention, while fast release of pressure reduces the 
retention of VD2. The lower stability of vitamin D loaded emulsions were also reported by Ziani, et al. 23) 
and the addition of co-surfactant might increase the thermal stability of vitamin D loaded emulsions 23).  
 
 202 
 
Figure 8.8: Encapsulation efficiencies (EEs) of O/W emulsions encapsulating ergocalciferol (VD2). (a) 
Soybean oil containing emulsions, ( ) denotes emulsions formulated at 10,000 rpm, ( ) denote 
emulsions formulated at 20,000 rpm and ( ) denotes emulsions formulated at 100 MPa. (b) Olive 
oil emulsions, (  ) denotes emulsions formulated at 10,000 rpm, ( ) denote emulsions 
formulated at 20,000 rpm and ( ) denotes emulsions formulated at 100 MPa. (c) MCT containing 
O/W emulsions, ( ) denotes emulsions formulated at 10,000 rpm, ( ) denote emulsions 
formulated at 20,000 rpm and ( ) denotes emulsions formulated at 100 MPa. 
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Figure 8.9: Encapsulation efficiencies (EEs) of O/W emulsions encapsulating cholecalciferol (VD3). (a) 
Soybean oil containing emulsions, ( ) denotes 10,000 rpm, ( ) denote e 20,000 rpm and ( ) denotes 
100 MPa. (b) Olive oil emulsions, (  ) denotes 10,000 rpm, ( ) denote 20,000 rpm and ( ) denotes 
100 MPa. (c) MCT containing O/W emulsions, ( ) denotes emulsions formulated at 10,000 rpm, ( ) 
denote emulsions formulated at 20,000 rpm and ( ) denotes emulsions formulated at 100 MPa. 
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Chapter 9  
Oil-in-water emulsions encapsulating quercetin using microchannel 
emulsification: Effect of different emulsifiers on generation 
characteristics and stability* 
 
 
 
 
 
 
 
________________________________________________________________________ 
*This chapter is to be submitted as Khalid N, Kobayashi I, Neves M, Uemura K, Nakajima M, Nabetani H. 
Oil-in-water emulsions encapsulating quercetin using microchannel emulsification: Effect of different 
emulsifiers on generation characteristics and stability. Innovative Food Science and Emerging 
Technologies 
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9.1 Introduction 
 
Quercetin is categorized as a flavonol and belongs to the family of flavonoids. The International Union of 
Pure and Applied Chemistry (IUPAC) nomenclature for quercetin is 3,3’,4’,5,7 –pentahydroxyflavanone 1). 
By definition quercetin is an aglycone (lacking an attached sugar) having brilliant citron yellow color and is 
entirely insoluble in water, sparingly souble in oil medium and readily soluble in variety of polar solvents 
2).  The solubility of quercetin can greatly be improved by attaching glycosyl group at hydroxyl positions 3).  
Flavonols are present in variety of fruits, vegetables, seeds, flowers and nuts 4). These are also abundant in 
variety of medicinal plants like Ginko bioloba, Solanum trilobatum and many others 2). The estimated daily 
intake of flavonols is in the range of 20-50 mg. day-1. Most of the dietary intake is as flavonol glycosides of 
quercetin, kaempferol and myricetin 5).  
Quercetin exhibit a wide range of biological activities, including anti-oxidant, anti-cancer, anti-
toxic, anti-thrombotic, anti-aging, metal chelating and anti-microbial activities 2, 6-8). Similarly, it has impact 
on obesity, sleep and mood disorders 2,9). Recently, quercetin is used in many sport supplements in order to 
reduce post-exercise immune system perturbations 10). The bioavailability and absorption of quercetin 
depends upon the nature of attached sugar, solubility modifications and type of emulsifiers used in different 
systems 11). Despites of great biological activities, quercetin has very poor oral bioavailability.  The main 
disadvantages of using quercetin in therapeutics and functional foods are, poor solubility in aqueous and oil 
medium, crystallization behavior at ambient and body temperatures, poor permeability and low 
bioavailability 12-14). To overcome these disadvantages, it is necessary to develop an efficient delivery 
system for quercetin that improves the stability and release of quercetin at appropriate target site. 
A wide variety of colloidal systems have been developed to encapsulate vital lipophilic 
compounds, including micro and nano-emulsions, solid lipid micro and nano-particles, filled hydrogel 
particles and polymeric nanoparticles 15,16). These colloidal delivery systems were formulated either with 
conventional emulsification tools or microfluidic devices17). In this study we used microchannel 
emulsification (MCE) to encapsulate quercetin in different oil-in-water (O/W) emulsions. MCE is a 
promising technique to generate extremely monodisperse emulsion droplets with droplet size variation less 
than 5% 18). MCE chips consist of either MC arrays with parallel microgrooves and a terrace, or many 
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straight-through holes 18,19). The distinguishing features of MCE involves no shear forces during droplet 
generation process, size of the droplets is determined by the microchannel geometry and composition of 
dispersed phase and flow rate 20). In MCE, droplet generation is driven by spontaneous transformation of 
dispersed phase that passed through the microchannels and is further driven by interfacial tension 21). MCE 
has been successfully applied for preparation of simple and multiple emulsions, microspheres and 
microcapsules. Many hydrophilic and lipophilic compounds were encapsulated in these systems like  β-
carotene, 22) oleuropein, 23) γ-oryzanol, 24), L-ascorbic acid 25, 26) and ascorbic acid derivatives 27).  
The aim of this study was to design food grade O/W emulsions encapsulating quercetin using 
straight-through MCE. The present study investigates the effect of different emulsifiers on generation 
characteristics and stability of O/W emulsions encapsulating quercetin. Moreover, the study investigates 
the effect of different dispersed phase composition on quercetin encapsulation, together with storage 
stability and encapsulation efficiency of formulated O/W emulsions. The output of this research improves 
the understanding of different factors that influence the formation, stabilization and utilization of crystalline 
bioactive compounds in food, cosmetics and pharmaceutical products. 
9.2 Material and methods  
Chemicals 
3,3’,4’,5,7 –pentahydroxyflavanone (quercetin) was procured from Nacalai Tesque, Inc. (Kyoto, Japan). 
Soybean oil, sesame oil, dimethyl sulfoxide, bovine serum albumin (BSA) and polyoxyethylene (20) 
sorbitan monolaurate (Tween 20) were purchased from Wako Pure Chemical Ind. (Osaka, Japan). 
Safflower oil was purchased from MP biomedicals (lllkirch, France). Medium chain triacylglycerol (MCT, 
sunsoft MCT-7) with a fatty acid residue composition of 75% caprylic acid and 25% capric acid and 
polyglyceryl-5-laurate (Sunsoft A-12E, HLB 15.6) were procured from Taiyo Kagaku Co. Ltd. (Mie, 
Japan). Sodium salt of colic acid (Na-cholate > 97% purity) was purchased from Sigma Aldrich (St. Louis, 
Mo., USA). Decaglycerol monolaurate (ML-750, HLB 14.8) was procured from Sakamoto Yakuhin Kogyo 
Co., Ltd (Osaka, Japan). Milli-Q water with a resistivity of 18MΩ cm was used to dissolve the emulsifiers 
and served as continuous phase. All other chemicals used in this study were of analytical grade and used as 
received.  
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Dispersed and continuous phase preparation 
A continuous phase was prepared by dissolving either 1% (w/w) Tween 20, Na-cholate, ML-750, Sunsoft 
A-12E or BSA in Milli-Q water at ambient temperature, stirring for 20 min and stored for 60 min before 
using as continuous phase. A disperse phase was prepared by dispersing quercetin (0.1-0.6 mg mL-1) either 
into soybean oil, MCT, mixture of MCT and soybean oil (50:50% (v/v)), sesame oil or safflower oil at 
ambient temperature, then heating the mixture under water bath at 90oC (with stirring for 40 min, ultra-
sonication (VS-100III, As One Co., Osaka, Japan) at 45kHz for 10 min, again heating for 40 min, followed 
by ultra-sonication for 10 min and lastly storage for 40 min at ambient temperature).  
 
 Silicon microchannel chip 
The encapsulation experiment has been conducted using silicon 24 × 24-mm MC array chip (Model WMS 
1-2; EP. Tech Co., Ltd., Hitachi, Japan) containing 10,313 MCs arranged within a 10-mm2 central region. 
The MC chip was 500 m thick, but it was thinned to 100 m in the central region (Fig. 9.1a). The four 
1.5-mm diameter holes at the corner of chip permit a disperse phase to flow beneath the plate. The MC 
plate and MC arrays were fabricated by repeated processes of photolithography and deep-reactive-ion 
etching (DRIE) on 5-in. silicon wafer. Dimension wise each MC consisted of a circular microhole (10-m 
diameter and 70-m depth) located on the outlet side and a microslot (11 × 104-m cross section and 21-
m depth, an aspect ratio = 9) located on the inner side (Fig. 9.1b). Before first usage, the MC chip was 
plasma oxidized in a plasma reactor (PR41, Yamato Science Co. Ltd., Tokyo, Japan) to grow a hydrophilic 
silicon dioxide layer on the surface. After each experiment, the MC chip was cleaned with neutral detergent 
and ethanol using an ultrasonic bath (VS-100III, As One Co., Osaka, Japan) at a frequency of 100 kHz and 
later stored in Milli-Q water. 
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Figure 9.1: Schematic representation of MC chip used in MCE. (a) WMS 1-2 silicon chip. (b) 
Arrangement of  MCs in WMS 1-2 chip. Each horizontal row contains alternatively 82 or 83 
channels and vertical rows contain alternatively 62 or 63 channels.  
 
Emulsification procedure  
Before conducting each experiment, the MC chip was degassed in the continuous phase under ultra-
sonication at a 100 kHz for 20 min. The degassed MC chip was mounted in a MC module compartment 
previously filled with continuous phase. Fig. 9.2a shows a simplified schematic diagram of the 
experimental setup used for MCE. The dispersed phase was injected through the MCs by a syringe pump 
(Model 11, Harvard Apparatus Inc., Holliston, USA) using a 10 mL glass syringe at the flux ranging (Jd)  
from 10 to 300 L m-2h-1, while continuous phase was delivered from an elevated reservoir through the gap 
between the MC chip and cover slip. The emulsification process was carried out for approximately 1 h and 
monitored through FASTCAM-1024 PCI high speed video system at 250 to 1000 fps (Photron Ltd., Tokyo, 
Japan) attached to an inverted metallographic microscope (MS-511B, Seiwa Kougaku Sesakusho Ltd., 
Tokyo, Japan). The droplets generation process during MCE is illustrated in Fig. 9.2b.  
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Figure 9.2:  Schematic presentation of MCE used for encapsulation of quercetin. (a) Experimental 
set-up used for quercetin encapsulation. (b) O/W emulsion droplets generation process in MCE. 
 
Measurement and analysis 
The particle size distribution of the resultant O/W emulsions encapsulating quercetin was measured by 
using a light scattering instrument (LS 13 320, Beckman Coulter, Fullerton, USA). This instrument works 
on the principle of Polorization Intensity Differential Scattering Technology and has ability to measure the 
size ranging from 0.04 to 2000 m with a resolution of 116 particle size channels. The mean droplet size 
was expressed as Sauter mean diameter (d3,2), which is the diameter of a droplet having the same area per 
unit volume as that of the total collection of droplets in emulsions. The width of droplet size distribution 
was expressed as relative span factor (RSF) and is defined as: 
RSF =  
𝑑𝑣0.9−𝑑𝑣0.1
𝑑𝑣0.5
                   (9.1) 
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where dv0.9 and dv0.1 are the representative diameters where 90% and 10% of the total volume of the liquid 
is made up of droplets with diameters smaller than or equal to the stated value. dv0.5 is the representative 
diameter where 50% of the total volume of the liquid is made up of droplets with diameters larger than the 
stated value and 50% is made up of droplets with diameters smaller than the stated value. 
 
Measurement of fluid properties  
The densities of dispersed and continuous phases were measured using a density meter (DA-130 N, Kyoto 
Electronics Manufacturing Co., Ltd., Kyoto, Japan) at 25±2oC, while the viscosities of dispersed and 
continuous phases were measured with a sine wave vibro viscometer (SV-10, A&D Co., Ltd., Tokyo, 
Japan) at 25±2oC by taking 35 mL samples in a measuring vessel followed by immersion of sensor plates 
vibrating at constant frequency and amplitude in that vessel. The absolute viscosity (η) was calculated by 
𝜂 =  
𝜂mea
𝜌
                     (9.2) 
where ηmea is the measured fluid viscosity and ρ is the fluid density. The static interfacial tension between 
the oil and aqueous phases was measured with a fully automatic interfacial tensiometer (PD-W, Kyowa 
Interface Sciences Co., Ltd., Saitama, Japan) using a pendant drop method. The key physical properties of 
the continuous and dispersed phases are presented in Table 9.1. 
 
Physical and chemical stability of O/W emulsions encapsulating quercetin 
The physical stability in terms of consistency and coalescence was observed at 4 and 25 ± 1°C with 
microscopic observations using an optical microscope (DM IRM, Leica Microsystems, Wetzlar, Germany), 
while the particle size distribution and RSF with storage period was measured by using a light scattering 
instrument (LS 13 320, Beckman Coulter, Fullerton, USA).  
The amount of quercetin present in O/W emulsions and dispersed phases was quantified using 
UV/VIS/NIR spectrophotometry (V-570, Jasco, Hachioji, Japan). Standard curves were made by using a 1 
mM quercetin solution as a stock solution and dimethyl sulfoxide (DMSO) as a blank. Calibration curves 
were linear (r2 > 0.996) over the quercetin concentration (1-10 g mL-1). The slope of best-fit line was 
0.066 ± 0.020 cm-1 (g mL-1)-1 and the intercept was 0.016 ± 0.004 cm-1. The Molar absorptivity (Ɛ) for 
quercetin during this study was 21.86 mM-1 cm-1. 
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The amount of quercetin that was encapsulated in O/W emulsions was evaluated using absorbance 
measurements. 1 mL of sample from the middle of bottle was dissolved in DMSO (ratio 1:10), then 
centrifuged at 3000 rpm for 15 min. Aliquots of supernatant were taken and then filtered using 0.45 micron 
syringe filter (Millipore Corp. USA). The quercetin concentration was then determined by measuring the 
absorbance at 372 nm using a UV/VIS/NIR spectrophotometry (V-570, Jasco, Hachioji, Japan). The 
encapsulation efficiency (EEQ) of quercetin encapsulated in O/W emulsions was calculated using the 
following equation: 
   𝐸𝐸Q =  
QCs 
QCi
 × 100             (9.3) 
Where QCs is the quercetin concentration remained in O/W emulsion at a specific time and QCi is 
the initial quercetin concentration. 
9.3 Results and discussion 
Effect of quercetin concentration on formulation of O/W emulsions 
To formulate an efficient delivery system, the most important criteria to determine the loading capacity of 
the functional compound in the system. The physical state of a functional compound is known to have a 
major impact on its bioavailability 28). The melting point of quercetin is relatively very high (> 310 oC) and 
has a relative low water solubility (< 1g L-1). The low water solubility and high melting point of quercetin 
limits its use as functional ingredients in food and pharmaceutical products 13). Quercetin was solubilized in 
different oil medium at 90 oC according to the procedure described by Pool et al. 29) with slight 
modifications. The maximum solubility of quercetin in different oil medium was in between 0.1 to 0.6 mg 
mL-1. The solutions of quercetin with these concentrations remain stable for more than 30 days without 
showing any visible crystallization. To elevate the effect of quercetin concentration on O/W emulsions, we 
prepared dispersed phase containing 0.1 to 0.6 mg mL-1 in MCT, while 1% (w/w) Tween 20 in Milli-Q 
water served as continuous phase during MCE. The dispersed phase was injected into MC module at Jd of 
20 L m-2 h-1. Successful emulsification was conducting with different concentrations of quercetin. Fig. 9.3a 
shows the d3,2 and  RSF width of O/W emulsions containing different concentrations of quercetin. The d3,2 
ranged between 28.59 to 29.18 m with RSF width < 0.25.  The narrow span width indicates extreme 
monodispersity in the O/W emulsions encapsulating different concentrations of quercetin. There was 
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smooth generation of emulsion droplets from the MCs with different quercetin concentrations (Fig. 9.3b) 
and these emulsions retain about 20-40 g mL-1 of quercetin.  
The quercetin solubility in dispersed phase was slightly higher than previously reported by Pool, et 
al. 29), there study indicates nucleation of quercetin in MCT beyond 0.1 mg mL-1. However, such nucleation 
of quercetin was observed at 0.7 mg mL-1 in our study. Karadag et al. 30) reported two times higher 
solubility of quercetin in limonene oil in comparison to MCT when combined with Tween 80 and heated to 
130oC for 30 min.  
(a) 
 
(b) 
    
 
Figure 9.3: (a) Effect of quercetin concentration on O/W emulsions. The concentration effect was 
evaluated in MCT.  ( ) denote d3,2 of O/W emulsions, while open key denote their span width. (b) 
Optical micrographs indicating droplet generation with different concentrations of quercetin (i) at 
0.1 mg mL-1 (ii) 0.6 mg mL-1. 
 
(i) (ii) 
200 m 200 m 
 215 
 
Effect of different dispersed phases on droplet generation characteristics  
The ability of different food grade oils to encapsulate quercetin in O/W emulsions was investigated by 
using MCT, soybean oil, mixture of soybean oil and MCT (50:50% (v/v)), safflower oil and sesame oil. 
These oils were used on the basis of their broad usage and functionality in different food products. 0.4 mg 
mL-1 quercetin was solubilized in different oils and served as dispersed phase, while 1% (w/w) Tween 20 in 
Milli-Q water was used as continuous phase in MCE. The experiments were conducted by keeping Jd at 20 
L m-2 h-1 and the flow rate of continuous phase was maintained between 250 to 500 mL h-1. The physical 
properties of different dispersed phases were presented in Table 9.1.  All of these oils have viscosities (d) 
lower than the threshold value of 100 mPa s needed in MCE for successful droplet generation 31).  
 
Table 9.1: Fluid properties of emulsion system containing quercetin together with different food 
grade oil used for O/W emulsions formation.  
Emulsion phase Density Viscosity Interfacial tension 
(kg m-3) (mPa s) (mN m-1)*** 
Dispersed phase*    
Medium chain triglyceride (MCT) 943.8 ± 0.55 22.50 ± 0.10 6.0 ± 0.3 
Soybean oil 916.9 ± 0.45 49.46 ± 0.20 6.8 ± 0.2 
Mixture of MCT and soybean oil 930.1 ± 0.40 33.60 ± 0.22 6.5 ± 0.3 
Safflower oil 920.0 ± 0.30 51.50 ± 0.20 6.4 ± 0.1 
Sesame oil 916.1 ± 0.45 54.80 ± 0.10 6.5 ± 0.1 
Continuous phase**    
 Tween 20 998.9 ± 0.10 0.86 ± 0.01  
Decaglycerol monolaurate 999.7 ± 0.15 1.18 ± 0.01  
Sunsoft A-12E 999.9 ± 0.10 1.19 ± 0.01  
Sodium cholate 999.2 ± 0.12 1.29 ± 0.01  
Bovine serum albumin 998.0 ± 0.10 0.83 ± 0.01   
 
*Dispersed phase contains 0.4 mg mL-1 quercetin in different food grade oils, ** Continuous phase 
contains 1% (w/w) of each emulsifiers in Milli-Q water, *** Interfacial tension was observed in the 
presence of 1% (w/w) Tween 20 in Milli-Q water and 0.4 mg mL-1 quercetin in different oils. 
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Fig. 9.4a shows the effect of different dispersed phases on d3,2 and RSF width of O/W emulsions. 
Successful emulsification was conducted with different dispersed phase, and the d3,2 of emulsions ranged 
between 27.75 to 33.20 m with RSF width < 0.23. Fig. 9.4b depicts droplet formation from asymmetric 
straight-through MCs for different dispersed phases, all of these oil phases transformed spontaneously into 
uniform droplets without any physical deformation. A slightly higher d3,2 was observed with safflower and 
sesame oil in comparison to other soybean oil and MCT. This slight variation in droplet sizes might 
corresponds to different fatty acid composition, distribution of various bioactives and physical properties of 
oils 32). Kobayashi, et al. 31) pointed that that average droplet diameter of emulsions in straight-through 
MCE was greatly influenced by d not the type of oil. However, in our study we observed variation in 
droplet sizes with different oil types. Soybean, sesame and safflower oil have slight higher viscosities in 
comparison MCT and mixture of soybean oil and MCT. The higher d leads toward higher d3,2. This slight 
increase in droplet sizes has no marked influenced on droplet generation or monodispersity. All of the 
generated O/W emulsions in MCE have extreme monodispersity with RSF width < 0.23.   
(a) 
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(b) 
 
Figure 9.4: (a) Effect of different dispersed phases on d3,2 and span width of O/W emulsions.  
denote d3,2 of O/W emulsions and denote span width. (b) Droplet generation in MCE with 
different dispersed phases encapsulating quercetin.  
 
Effect of dispersed phase flux and continuous phase flow velocity on droplet generation characteristics  
Cross-flow membrane emulsification and MCE has great potential to produce monodisperse emulsions and 
emulsions with sensitive bioactive compounds. However, low flux of dispersed phase may be a limiting 
factor for emulsion production on a commercial scale 33). 
The effect of various levels of Jd (10-300 L m-2 h-1) and continuous phase velocity (𝑉c), (ranging 
from 2.8 mm s-1 to 22.8 mm s-1) on the droplet generation behavior,  d3,2 and RSF were evaluated.  The 
flow velocity along the MC chip surface (𝑉c, mm s-1) was determined as follows: 
𝑉𝑐 = 
𝑄c
𝐴
                 (9.4) 
MCT Soybean oil 
Soybean oil & MCT Safflower oil 
200 m 
200 m 
200 m 
Sesame oil 
200 m 
200 m 
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Where Qc is the continous phase flow rate (mm3 s-1) and A is the flow area along the MC chip 
surface (mm2). As depicted in Fig. 9.5a, the gradual increase in Jd, resulted in increased d3,2 and RSF of 
emulsions encapsulating quercetin. The size stable zone was in between Jd of 20-70 L m-2 h-1. In this stable 
zone the d3,2 was in between 28.22 to 29.57 m with RSF width < 0.33. Moreover, the emulsification using 
a Jd of above 100 L m-2 h-1 and a 𝑉c of 22.8 mm s-1 resulted in polydispersed droplets with a d3,2 of > 31.77 
and a RSF of > 0.70 (Fig 9.5b). At higher Jd the d3,2 depends on the oil flux inside the MCs. The size stable 
of quercetin loaded emulsions were slightly higher in comparison to previous study of -oryzanol loaded 
emulsions 24), they reported size stable zone in Jd between 10-40 L m-2 h-1. Whereas, increased droplet size 
with increasing flux agreed well with previous literature 34). Fig. 9.5c depicts the effect of 𝑉c on d3,2 and 
RSF of O/W emulsions encapsulating quercetin. The monodisperse emulsions formulated at low and high  
𝑉c shows no prominent difference in d3,2 and RSF. The size of emulsion droplets was independent of 𝑉c in 
straight-through MCE and agreed well with previous findings. 35) 
 
(a) 
 
 
(b) 
 
200 m 
30 L m-2 h-1 300 L m-2 h-1 
200 m 
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(c) 
 
 
 
Figure 9.5: (a) Effect of disperse phase flux on d3,2 and RSF width of O/W emulsions. ( ) denote 
d3,2 and ( ) denote RSF of O/W emulsions encapsulating quercetin. (b) Micrographs at disperse 
phase flux at 30 and 300  L m-2 h-1 captured at 1000 fps. continuous phase velocity was in between 14 
and 23 mm s-1. (c) Effect of continuous phase flow velocity on d3,2 and RSF width of O/W emulsions. (
) denote d3,2 and ( ) denote RSF of O/W emulsions. 
 
 
 
Effect of different emulsifiers on stability of O/W emulsions  
Emulsifier molecules have a critical role in the stability of oil droplets in MCE. The charge on the MC chip 
surface and electrostatic interactions of emulsifiers must kept in mind during MCE. Uniform oil droplets 
can be generated in MCE when MC chip surface has a non-attractive interaction with emulsifier molecules. 
Moreover, the stability of droplets correlate with the continuous phase, if it preferentially wet the surface of 
MC chip during emulsification 36).  
0.4 mg mL-1 quercetin was solubilized in MCT, while 1% (w/w) of different emulsifiers in Milli-Q 
water were used as continuous phase in MCE. The experiments were conducted by keeping Jd at 20 L m-2 h-
1 and the flow rate of continuous phase was maintained between 250 to 500 mL h-1. Stable droplet 
generation with uniform size was observed in all working channels with different food grade emulsifiers. 
There was neither the formation of irregularly size droplets, nor a continuous growth of the dispersed 
phase, which could result in a broad size distribution and polydispersity (Fig. 9.6a). The formed particles 
were detached rapidly from the channel tip with different emulsifiers. Fig. 9.6b depicts the d3,2 and RSF of 
O/W emulsions stabilized by different emulsifiers.  The d3,2 of emulsions stabilized by non-ionic 
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emulsifiers (Tween 20, Sunsoft A-12E and ML-750) were in between 28.50 to 28.85 m with RSF width < 
0.21. More stable droplet generation was observed (Fig. 9.6c) with non-ionic emulsifiers in droplet stable 
zone (Jd = 20-50 L m-2 h-1) in comparion to ionic (Na-cholate) and protein based emulsifiers (BSA). Slighly 
higher d3,2 (29.40 m, RSF <0.21) was observed in emulsions stabilized by Na-cholate, while BSA 
stabilized emulsions have much higher droplet diameter, the d3,2 increases to 34.48 m with RSF width < 
0.24. The results with non-ionic emulsifiers agreed well with previous studies of emulsification reporting 
that hydrophile-lipophile balance exceeding 10 produced unifrom droplets in MCE 37, 38). The effect of 
proteins as an emulsifiers on MCE was previously reported by Saito et al. 39). They reported increased in 
droplet diameter from 41.0 to 44.1 m in BSA stabilized emulsions with increasing Jd. Moreover, the 
generated emulsions droplets with BSA maintained monodispersity at high Jd. Our experiments with BSA 
was conducted at pH 7.1, indicating negative charge on BSA. The negative charge allows droplets to 
detached more smoothly from MCs 39). 
 
(a) 
 
 
 
 
 
 
Tween 20 ML-750 
200 m 200 m 
Sunsoft A-12E Na-cholate 
200 m 
200 m 
BSA 
200 m 
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(b) 
 
 
 
 
 
 
(c) 
                            
 
Figure 9.6: (a) Droplet generation behavior in straight-throught MCE encapsulating quercetin in 
O/W emulsions stabilized by different emulsifiers. (b) Effect of different emulsifers on d3,2 and RSF of 
O/W emulsions.  denote d3,2 of O/W emulsions and denote RSF width. (c) Effect of Jd on d3,2 
and RSF of emulsions in size stable zone. ( ) deonte Tween 20, ( ) Sunsoft A-12E, ( ) ML-
750, ( ) Na-cholate, ( ) donote BSA. The opens key donote RSF of O/W emulsions stabilized 
with Tween 20.  
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Long term stability of O/W emulsions encapsulating quercetin  
 The monodisperse O/W emulsions encapsulating 0.4 mg mL-1 quercetin and stabilized with 1% (w/w) 
different emulsifiers  were stored at 4 and 25 ± 1 oC for a period of 30 days. The emulsions were formulated 
by keeping Jd at 20 L m-2 h-1 and the continuous phase flow rate between 250 to 500 mL h-1. Fig. 9.7a shows 
the  d3,2 and RSF width of the O/W emulsions encapsulating quercetin at 4 ± 1 oC. There was a gradual 
decrease in d3,2 of emulsions stabilized with Sunsoft A-12E after 30 days of storage period in comparison to 
other emulsifiers. The decrease in droplet size can be attributed to Sunsoft A-12E absorption in the 
interfacial film 40). The d3,2 of emulsions stabilized by Na-cholate increased to 36.0 m after 7 days of 
storage. The increased in d3,2 of emulsions stabilized by Na-cholate at low temperature can be attributed to 
low aggregation number of Na-cholate. The aggregation number of pure Na-cholate (3 to 16) is highly 
influenced by the environmental parameters 41, 42). There was hardly any change in the d3,2 and RSF width 
of emulsions stabilized by Tween 20, ML-750 and BSA. The droplet size of emulsions stabilized by Tween 
20 and ML-750 remain in range from 28.31 to 28.88 m, while those stabilized by BSA was in range of  
34.09 to 34.59 m after 30 days of storage at 4 ± 1 oC.  
Fig. 9.7b depicts the stability profile of quercetin loaded emulsions stabilized by different 
emulsifiers at 25 ± 1 oC. There was slight decrease in d3,2 of emulsions stabilized with Tween 20, ML-750, 
Sunsoft A-12E and Na-cholate. The emulsions  stabilized with different emulsifiers maintained 
monodispersity with RSF < 0.35 after 30 days of storage at 25 ± 1 oC. There was sharp decrease in droplet 
diameter of emulsions stabilized with BSA and d3,2 decreased from 33.35 to 27.79 m with RSF width of > 
0.45 after 30 days of storage at 25oC. The decreased droplet size might be attributed to denaturation of BSA 
at 25oC. Moreover, partial denaturation of the adsorbed BSA on the surface of emulsions might decreased 
the droplet diameter 43). Saito et al. 44) reported good thermal stability of BSA stabilized emulsions in MCE 
ranged between 30-80oC. However, their study do not evaulate long term storage stability of BSA 
stabilized emulsions.  
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(a) 
 
 
(b) 
             
Figure 9.7: Storage stability of O/W emulsions encapsulating querectin. The data was presented in 
terms of d3,2 and RSF. (a) storage stability at 4 ± 1oC (b) storage stability at 25 ± 1oC. ( ) denote 
Tween 20, ( ) Sunsoft A-12E, ( ) ML-750, ( ) Na-cholate and ( ) denote BSA. The same 
open keys denote RSF of O/W emulsions encapsulating quercetin. 
 
Encaspulation efficiency of O/W emulsions encapsulating quercetin 
O/W emulsions stabilized with 1% (w/w) Tween 20 have better storage stability at 4 and 25oC in 
comparison to other emulsifiers, based upon better storage stability, encapsulation efficiency (EE) was 
investigated in emulsions stabilized with 1% (w/w) Tween 20. O/W emulsions were formulated by keeping 
Jd at 20 L m-2 h-1 and the continuous phase flow rate at 500 mL h-1. The optical micrographs of emulsion 
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droplets at 4 and 25oC after 30 days of storage were presented in Fig. 9.8a. The monodispersity was 
complete observed in these micrographs. At both storage temperatures the d3,2 varied between 28. 37 to 
28.90 m with RSF width < 0.27.  The EEs of emulsions stabilized with 1% (w/w) Tween 20 were depicted 
in Fig. 8b. The freshly formulated O/W emulsions retains about 31.50 g mL-1 of quercetin. There was 
gradual decrease in EE of quercetin with storage time at both 4 and 25oC. The EEs was about 79.68%  and 
70.15% at 4 and 25oC after 30 days of storage. The slightly higher EE in emulsions formulated by MCE 
can be attributed to narrow size droplet distribution (Fig. 9.8b). Moreover, in MCE the droplet generation 
was based upon difference in interfacial tension rather than high energy shear forces. The energy efficiency 
(Ee) in MCE using the WMS 1-2 was estimated by the following equation: 
∆𝐸𝑒xp =
∆𝑃d
ρd
                 (9.5) 
Where Eexp is the actual energy input for droplet generation in the straight-through MCE, Pd is 
the applied dispersed phase pressure (4.62 kPa) during MCE for 1 hour and d is the dispersed phase 
density containing 0.4 mg mL-1 quercetin in MCT. The calculated Eexpduring emulsification was 4.9 J kg-
1. The Eexp was comparable with oblong type straight-through MCE (5.0-14.2 J kg-1), previously reported 
by Kobayashi et al. 45). According to the Eexp must exceed the theoretical minimum energy (EThr). The 
EThr was calcuated from following equation: 
∆𝐸Thr = ∆𝐴γow =  
6γow
𝜌d𝑑3,2
             (9.6) 
Where A is the increase in interfacial area, ow is the interfacial tension between two phases, d is the 
dispersed phase density and d3,2 is the Sauter mean diameter of O/W emulsions. The EThr  at ambient 
temperature corresponds to 1.35 J kg-1. The Ee can be calculated from above equation: 
                 𝐸𝑒 =
∆𝐸Thr
∆𝐸exp
 × 100                     (9.7) 
The calculated Ee was 27.5% and was comparatively less than Ee of oblong type straight-through 
MCE 45). The Ee of oblong type MCE setups were 47-60% and grooved type MCE was 65% 21, 45). 
Quercetin was previously encapsulated in poly D, L-lactide (PLA) nanoparticles and have EE of 96.7% 46). 
Gilles et al. 47) studied the encapsulation of linoleic acid (LA) in the presence or absence of quercetin into a 
dual polymer system of whey protein and Kappa-carrageenan. The stability of quercetin stabilized LA was 
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examined to be 83%. Watanabe et al. 48) investigated lecithin-chitosan nanoparticles as a topical delivery 
system for quercetin. The quercetin-loaded nanoparticles showed higher permeation ability with 
entrapment efficiency of 48.5%.  Pool, et al. 29) encapsulated 0.1 mg mL-1 quercetin in O/W emulsions and 
observed 95% retention at different storage temperatures, however they noticed appreciable decrease in the 
level of quercetin in O/W emulsions initially containing 0.5 mg mL-1 quercetin after one month of storage. 
(a) 
                                                               
 
(b) 
 
Figure 9.8: (a) Optical micrographs of O/W emulsions encapsulating quercetin after 30 days of 
storage at 4 and 25oC. (b) Encapsulating efficiency (EEQ) and retention profile (RQ) of O/W 
emulsions encapsulating quercetin at 4 and 25oC. ( ) denote RQ at 4oC and ( ) denote RQ at 
25oC. ( ) presents EEQ at 4oC and ( ) presents EEQ at 25oC. 
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Chapter 10  
Encapsulation of -oryzanol plus -sitosterol in oil-in-water emulsions: 
Insights of formulation characteristics with microchannel 
emulsification* 
 
 
 
 
 
 
 
 
 
________________________________________________________________________ 
*This chapter is to be submitted as Khalid N, Kobayashi I, Neves M, Uemura K, Nakajima M, Nabetani H. 
Encapsulation of -oryzanol plus -sitosterol in oil-in-water emulsions: Insights of formulation 
characteristics with microchannel emulsification 
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10.1 Introduction 
An emulsion is a mixture of two immiscible liquids containing one liquid dispersed in the form of small 
droplets in another liquid that forms a continuous phase 1). These different phases constitute oil-in-water 
(O/W) or water-in-oil (W/O) emulsions like milk or butter 2). The emulsions play extremely important role 
in different applications like food processing 3), oil recovery 4), toxic material handling 5) and different drug 
deliveries 6). The emulsions are stabilized by using different emulsifiers and these emulsifiers migrates to 
the liquid-liquid interface and inhibit droplet coalescence and flocculation 2).  
Conventional methods for making emulsions involve drop breakup using high energy shear forces. 
These forces are not uniform entirely in emulsion system and contribute polydispersity in system 7). 
Moreover, these high shear forces have low energetic efficiencies and well as encapsulation efficiencies 7). 
Modern emulsification methods like microthread generation 8), viscoelastic shear 9), membrane extrusion 10) 
and microchannel emulsification 11) have been developed and optimized for better control over droplet size 
and system properties. These methods are more energy efficient and have better encapsulation efficiencies 
over time. The other attractive feature of microfluidic devices are fabrication of double, triple or even 
higher order emulsions with extreme monodispersity and unprecedented accuracy 12, 13).   
In this study we uses the striking features of microchannel emulsification (MCE) to encapsulate -
oryzanol together with -sitosterol in O/W emulsions. The term MCE was coined by Kawakatsu, et al. 11) 
and the system has capacity to form monodisperse emulsion droplets by using microchannel (MC) arrays 
precisely fabricated on single-crystal silicon microchip 11) or stainless steel microchips 14). These MC arrays 
can be fabricated as microgrooves horizontally to the microchip surface 11) or vertically as straight-through 
microholes 15). The grooved microchips exhibits low droplet productivity due to limited number of MCs but 
extremely productive in elucidating droplet generation behavior in MCs. The straight-thorough microchips 
consist of several hundreds of thousands of MCs and have monodisperse droplet productivity even at 
dripping regime of 50 mL h-1 15). The droplet generation process in MCE was comprehensively reviewed by 
Vladisavljevic et al. 16) and Vladisavljevic' et al. 17). Monodisperse emulsion droplets with diameters of 1 
m to 500 m and coefficient of variation below 5% have been successfully formulated through MCE 17). 
The MCE has been used to produce many encapsulated dispersions with improved properties such as  β-
carotene 18), oleuropein 19), γ-oryzanol 20), L-ascorbic acid 21) and ascorbic acid derivatives 22).  
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γ-oryzanol (Fig. 10.1a) is a naturally occurring component in rice bran and rice germ which 
consist of a mixture of ferulic acid esters of sterols and triterpene alcohols 23). There are increasing number 
of reports indicating the benefits, efficacy and safety of γ-oryzanol. The antioxidant effect of -oryzanol 
was well documented and excellent in inhibiting lipid peroxidation.  Kanno et al. 24) reported that -
oryzanol (0.5% ~1%) inhibited thermal oxidative polymerization of soybean oil. Wilson et al. 25) reported 
that -oryzanol reduced plasma cholesterol in hypercholesterolemic hamsters. There are number of clinical 
studies reported that -oryzanol is beneficial in the treatment of relieving menopausal (climacteric) 
symptom 26). -sitosterol (Fig. 10.1b) is a predominant phytosterol found in higher plants and as well as in 
human foods 27). -sitosterol is the most extensive studied phytosterol due to its role in 
hypercholesterolemia 28), cardiovascular diseases 29) and benign prostatic hyperplasia 30). β-sitosterol is used 
in a variety of enriched commercial foods such as fruits juice, milk, yoghurt and spreads. Safety concerns 
regarding the use of β-sitosterol have been well addressed in different in vivo and clinical studies 31, 32). 
There is a considerable interest in structuring, fortifying and supplementing food, oils and 
beverages with plant based phytochemicals. The difficulties behind phytosterols encapsulation includes 
hydrophobicity in food matrixes 33), degradability at high temperatures 34), low water solubility 35) and 
moisture contents 36). The present study was conducted to formulate O/W emulsions containing both -
oryzanol and -sitosterol. We investigated the effect of different concentrations of -oryzanol and -
sitosterol on droplet formation characteristics. Moreover, the physical and chemical stability of O/W 
emulsions stabilized by two different emulsifiers were also investigated during MCE. 
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Figure 10.1: Structural representation of bioactives (a) -oryzanol (b) -sitosterol. 
 
 
10.2 Material and methods 
Chemicals 
-oryzanol, ethyl acetate, chloroform, acetic anhydride, sulfuric acid and polyoxyethylene (20) sorbitan 
monolaurate (Tween 20) were purchased from Wako Pure Chemical Ind. (Osaka, Japan). Medium chain 
fatty acid triglyceride oil (MCT, sunsoft MCT-7) with a fatty acid residue composition of 75% caprylic 
acid and 25% capric acid was procured from Taiyo Kagaku Co. Ltd. (Mie, Japan). -sitosterol was 
purchased from MP biomedicals (lllkirch, France). Decaglycerol monolaurate (ML-750, HLB 14.8) was 
procured from Sakamoto Yakuhin Kogyo Co., Ltd (Osaka, Japan). Milli-Q water with a resistivity of 
18MΩ cm (pH 7.1) served as the continuous phase. All other chemicals used in this study were of 
analytical grade and used as received.  
 
A-symmetric microchannel array plate 
The emulsification experiments were conducted using 24 × 24 mm silicon MC plate (Model WMS 1-4, 
manufactured by EP. Tech Co., Ltd., Hitachi, Japan) containing 23, 348 MCs and four 2.0 mm diameter 
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holes at the corners of the plate, these holes were used to feed both phases and collect the produced 
emulsions. These MCs were fabricated by repeated process of photolithography and deep-reactive-ion 
etching (DRIE) and located within 10 × 10 mm square region in center of plate. The MC plate was 500 m 
thick (Fig. 10.2a), but was etched down to thickness of 100 m in the central region where MCs were 
located. Each MC consist of cylinderal microhole of 10m with 70 m depth on the outer side and a 
microslot (10 × 50 m cross section and 30 m depth) located on the inner side (Fig. 10.2c,d). The distance 
between the centers of adjacent MCs in the vertical rows was 70 m and the distance between the centers 
of MCs in the adjacent rows was 60 m (Fig. 10.2d). The MC plate was plasma oxidized to grow 
hydrophilic silicondioxide layer using oxygen plasma reactor (PR41, Yamato Science Co. Ltd., Tokyo, 
Japan).  
 
Dispersed and continuous phase preparation 
0.5-4.0% (w/w) -sitosterol was dissolved in heated MCT oil at 60± 2oC under water bath (HWA-50D, As 
One Co., Osaka, Japan) and stirred for 10 min at ambient temperature. Afterwards, 0.5-4.0% (w/w) -
oryzanol was added to pre-loaded -sitosterol solution and stirred for 20 min for proper dissolution. The -
sitosterol and -oryzanol loaded MCT oil was used as dispersed phase during MCE. The continuous phase 
comprises 1% (w/w) Tween 20 or 1% (w/w) ML-750 as emulsifiers in Milli-Q water and used as such 
during emulsification. The pH of continuous phase during emulsification was 7.2. 
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Figure 10.2: (a) Schematic representation of MC chip used in MCE. (b) Microscopic image of WMS 
1-4 silicon chip surface. Cylindered holes can be seen as black dots in the center of each slot. (c) 
Arrangement of MCs in WMS 1-4 chip. Each vertical row contains alternately 142 and 141 MCs. 
There are 83 vertical rows with 142 MCs and 82 rows with 141 MCs making the total number of 
MCs equal to 23,348 = 83 × 142 + 82 × 141. (d) Schematic view of the WMS 1-4 chip depth. 
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Emulsification procedure  
 
The MC plate was degassed in the continuous phase using ultrasonic water bath (VS-100 III, As One Co., 
Osaka, Japan) at a 100 kHz for 20 min, and then mounted in the six piece module assembly previously 
filled with continuous phase. Afterwards, the dispersed phase was injected through the MC plate at the flow 
rate ranging from 1 to 14 mL h-1 using syringe pump (Model 11, Harvard Apparatus Inc., Holliston, USA). 
The droplets were removed from the module by the continuous phase delivered from an elevated reservoir 
through the gap between the MC plate and cover slip. The droplets generation process during MCE in 
illustrated in Fig. 10.3a. The emulsification process was carried out for approximately 1 h and monitored 
through FASTCAM-1024 PCI high speed video system at 250 to 1000 fps (Photron, Tokyo, Japan) 
attached to an inverted metallographic microscope (MD-300EF; Nikon Co., Tokyo, Japan), as shown in 
Fig. 10.3b. 
 
Measurement and analysis 
A laser light scattering particle size analyzer (Beckman Coulter LS 13 320, Miami, FL) was used to 
measure the Sauter mean diameter (d3,2) of O/W emulsion droplets encapsulating -oryzanol and -
sitosterol. The particle size analyzer have ability to measure the size ranging from 0.04 to 2000 m with a 
resolution of 116 particle size channels. The width of droplet size distribution was expressed as relative 
span factor (RSF) and is defined as: 
RSF =  
𝐷𝑣,90−𝐷𝑣,10
𝐷𝑣,50
                   (10.1) 
Where Dv,90 and Dv,10 and  Dv,50 are the equivalent volume diameters at 90, 10 and 50% cumulative 
diameter, respectively. The droplet generation rate was estimated from the recorded videos obtained from 
FASTCAM-1024 PCI high speed video system at 1000 fps. 
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Figure 10.3: (a) Droplet generation representation through straight through MC arrays. (b) 
Schematic representation of an asymmetric straight through MCE setup. 
 
Measurement of fluid properties  
The densities of dispersed and continuous phases were measured using a density meter (DA-130 N, Kyoto 
Electronics Manufacturing Co., Ltd., Kyoto, Japan) at 25 ± 2oC. The viscosities of dispersed and 
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continuous phases were measured with a sine wave vibro viscometer (SV-10, A&D Co., Ltd., Tokyo, 
Japan) at 25 ± 2oC, later on absolute viscosity (η) was calculated by 
      𝜂 =  
𝜂mea
𝜌
                             (10.2) 
where ηmea is the measured fluid viscosity and ρ is the fluid density. The static interfacial tension between 
the oil and the aqueous phases was measured with a fully automatic interfacial tensiometer (PD-W, Kyowa 
Interface Sciences Co., Ltd., Saitama, Japan) using a pendant drop method. The key physical properties of 
dispersed and continuous phase were presented in Table 10.1. 
Table 10.1: Fluid properties of -sitosterol and -oryzanol used for preparing O/W emulsions. 
 
 
Concentration 
of bioactives* 
Dispersed phase Continuous phase 
  d  
(mPa s)
d  
(kg m-3)
d  
(mN m-
1)
Emulsifiers in c  
(mPa s)
c  
(kg m-3) Milli-Q water 
0.5% (w/w) 20.96 ± 0.06 945.96 ± 0.38 6.2 ± 0.2 1.0% (w/w)  
Tween 20 
0.86 ± 0.01 998.86 ± 0.06 
1.0% (w/w) 22.03 ± 0.06 946.03 ± 0.21 5.9 ± 0.2 1.0% (w/w)  
ML-750 
0.80 ± 0.01 999.70 ± 0.15 
2.0% (w/w) 23.80 ± 0.10 947.93 ± 0.06 5.1 ± 0.2    
3.0% (w/w) 26.70 ± 0.06 949.50 ± 0.10 4.1 ± 0.2    
4.0% (w/w) 29.73 ± 0.10 951.00 ± 0.10 2.7 ± 0.1    
 
 
* Dispersed phase contains both -sitosterol and -oryzanol. The interfacial tension was observed in the 
presence of 1% (w/w) Tween 20 in Milli-Q water 
 
Physical and chemical stability of O/W emulsions  
The physical stability of emulsion droplets at 4 and 25 ± 1°C was observed from d3,2 and RSF values. 
Moreover, droplet coalescence or flocculation was observed from microscopic observations using an 
optical microscope (DM IRM, Leica Microsystems, Wetzlar, Germany). The chemical stability of emulsion 
droplets at 4 and 25 ± 1°C was determined spectrophotometrically. -oryzanol was quantified in ethyl 
acetate, while chloroform was used to quantity -sitosterol. The spectral measurements of ethyl acetate and 
chloroform extracts were carried out using a UV/VIS/NIR spectrophotometer (V-570, Jasco, Hachioji, 
Japan).  
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-oryzanol quantification  
2 mL of the emulsion was extracted with 8 mL of ethyl acetate, followed by ultrasonic water bath at a 45 
kHz for 10 min (VS-100 III, As One Co., Osaka, Japan).  The extract was then centrifuged (KN-70, 
Kubota, Japan) at 3500 rpm for 15 min. A 1 mL aliquot of the supernatant was diluted five times with ethyl 
acetate and filtered through 0.45 micron syringe filter (Millipore Corp. USA). The filtered extract was then 
injected into a quartz cell with a 10 mm pass length. The absorbance of -oryzanol in emulsion extract was 
measured at 320 nm using an appropriate blank. A representative standard curve of absorbance versus 
concentration gave linear least-squares regression with a coefficient of determination (r2) of 0.9966. All 
experiments were repeated in triplicate and mean values were calculated. The Beer’s law was obeyed in the 
concentration range of 1-10 g mL-1. The encapsulation efficiency of -oryzanol in samples was calculated 
with the equation: 
EEOG(%) =  
𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑓𝑟𝑒𝑒 𝛾−𝑜𝑟𝑦𝑧𝑎𝑛𝑜𝑙 
𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑓𝑜𝑟𝑚𝑢𝑙𝑎𝑡𝑒𝑑 𝛾−𝑜𝑟𝑦𝑧𝑎𝑛𝑜𝑙
 × 100             (10.3) 

-sitosterol quantification  
2 mL of the emulsion was extracted with 4 mL of chloroform, followed by ultrasonic water bath at a 45 
kHz for 10 min (VS-100 III, As One Co., Osaka, Japan).  The extract was then centrifuged (KN-70, 
Kubota, Japan) at 3500 rpm for 15 min. A 1mL aliquot of the subnatant was diluted five times with 
chloroform and filtered through 0.45 micron syringe filter (Millipore Corp. USA). 2 mL of the Libermann-
Burchard reagent (composed of 10 mL acetic anhydride and 0.5 mL sulfuric acid), was added to the filtered 
extract and stored in dark at ambient temperature for 15 min. The presence of -sitosterol produces a 
characteristic green color whose absorbance was measured in a spectrophotometer at 640 nm using an 
appropriate blank 37).  A representative standard curve of absorbance versus concentration gave linear least-
squares regression with a coefficient of determination (r2) of 0.9970. All experiments were repeated in 
triplicate and mean values were calculated. The Beer’s law was obeyed in the concentration range of 10-
400 g mL-1. The encapsulation efficiency of -sitosterol in samples was calculated with the equation: 
EEBS(%) =  
𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑓𝑟𝑒𝑒 𝛽−𝑠𝑖𝑡𝑜𝑠𝑡𝑒𝑟𝑜𝑙 
𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑓𝑜𝑟𝑚𝑢𝑙𝑎𝑡𝑒𝑑 𝛽−𝑠𝑖𝑡𝑜𝑠𝑡𝑒𝑟𝑜𝑙
 × 100            (10.4) 
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10.3 Results and discussion 
Effect of -sitosterol and -oryzanol concentration on production characteristics of O/W emulsions  
The crystalline bioactives were detrimental to the stability of emulsion system, as they could greatly 
increase the droplet size and eventually reduce the encapsulation efficiency of emulsion system 38). The 
solubility of -sitosterol and -oryzanol in oil medium plays a critical role in the stability of emulsion 
droplets. The maximum solubility of -sitosterol and -oryzanol in MCT was evaluated from series of 
dilution experiments. Firstly, different concentrations (0.5-4.0% (w/w)) of -sitosterol was dissolved in 
MCT under water bath at 60 ± 2oC for a period of 20 min, the heating efficiently dissolve different 
concentrations within 10 min. The resistivity against crystallization was observed at 4oC for a period of 24 
h, all dilutions having concentration above 2% (w/w) shows large amount -sitosterol crystals just after 1 h 
of storage. Afterwards, different concentrations of (0.5-4.0% (w/w)) -oryzanol was added to pre-loaded -
sitosterol MCT oil at ambient temperature with continuous stirring for 20 min. All of oil samples 
completely dissolve -oryzanol and later stored at 4oC for a period of 24 h. The oil samples show 
crystallization beyond 2% (w/w) concentrations after 24 h.  
The MCE were conducted immediately after dissolving (0.5-4.0% (w/w)) of -sitosterol and -
oryzanol in MCT in order to assess the droplet generation characteristics and effect of different 
concentrations on d3,2 and RSF width of O/W emulsions. The continuous phase includes 1% (w/w) Tween 
20 in Milli-Q water. The dispersed phase was injected into the MC module at flow rate (Qd) of 1-5 mL h-1, 
while the continuous flow rate (Qc) was maintained at 500 mL h-1. Uniformly sized O/W emulsion droplets 
were generated from the asymmetric through holes with different concentrations of -sitosterol and -
oryzanol. Fig. 10.4a shows the concentration effect of -sitosterol and -oryzanol on d3,2 and RSF width of 
O/W emulsions generated at Qd of 1 mL h-1. There was almost no influence of concentration of dispersed 
phase on d3,2 of O/W emulsions (Fig. 10.4a). The d3,2 of emulsions remain in range from 27.90 to 27.40 m 
with RSF with less than 0.2 with increasing concentration of -sitosterol and -oryzanol.  
Initially there was no sign of wetting with different concentrations, but at higher Qd and dispersed 
phase concentration exceeding 1% (w/w), an increased in d3,2 was observed with RSF width exceeding 0.5 
(Fig. 10.4b). The increase in d3,2 was more prominent at dispersed phase concentration of 4% (w/w). 
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Moreover, the crystallization of -sitosterol and -oryzanol (Fig. 10.5a) was observed in disperse phase 
having concentration >2% (w/w) after 30 min of emulsification. The formulated O/W emulsions with 0.5-
1.0% (w/w) -sitosterol and -oryzanol shows no signs of crystallization even after 24 h of emulsification. 
The droplet generation with 1% (w/w) concentration is depicted in Fig. 10.5b. The droplets detached 
smoothly from the asymmetric through-holes without any significant wetting or unstable emulsion droplets. 
Our results of this study correlates well with previous study of Neves, et al. 18), they encapsulated 2.5% 
(w/w) -oryzanol in O/W emulsions using straight-though MCE with average droplet diameter of 28.8 m 
with coefficient of variation 3.8%.  
 
(a) 
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(b) 
                
Figure 10.4: (a) Effect of concentration of -sitosterol and -oryzanol on d3,2 and RSF width of O/W 
emulsions. ( ) denote d3,2 and ( ) denote RSF width of O/W emulsions. (b) Effect of 
concentration of -sitosterol and -oryzanol on d3,2 and RSF width of O/W emulsions under different 
dispersed phase flow rates. ( ) denote 0.5%, (  ) 1%, ( ) 2%, ( ) 3% and ( ) denote 
4% (w/w) -sitosterol and -oryzanol, while same shape open keys denote RSFs of O/W emulsions. 
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(b) 
         
Figure 10.5: (a) Microscopic images of O/W emulsions with increasing concentration of -sitosterol 
and -oryzanol (b) Droplet generation in MCE containing 1% (w/w) -sitosterol and -oryzanol. 
 
 
Effect of dispersed phase flow rate on preparation characteristics O/W emulsion droplets  
A considerable challenge in microfluidic devices is in obtaining emulsions at high dispersed phase fluxes, 
sufficient to make the process suitable for industrial applications. Moreover, appropriate control of Qd is 
needed to achieve monodisperse emulsions. The droplet production rate in MCE is proportional to Qd and 
later depends upon capillary number (the balance between the viscous and interfacial forces) 39).  
Fig. 10.6a depicts the effect of Qd on the d3,2 and RSF width of the generated droplets stabilized 
with 1% (w/w) Tween 20. The dispersed phase constitutes 1.0% (w/w) -sitosterol and -oryzanol in MCT. 
The MCE was conducted by maintaining Qd in between 0.5-14 mL h-1, while the continuous phase flow rate 
was varied between 500-1000 mL h-1. The d3,2 increased from 25.14 to 30.05 m with the increasing Qd. 
The increase in d3,2 have no impact on RSF width of O/W emulsions. The RSF width remain in range from 
0.22 to 0.27 with increasing Qd, only few channels produced polydispersed droplets (Fig. 10.6b) even at Qd 
of 14 mL h-1. There was no relative size stable zone as previously observed in many studies with MCE 40, 
41). The high stability of -sitosterol and -oryzanol loaded emulsions at Qd of 14 mL h-1 might attributed to 
surface activity of phytosterols that allow some of the -sitosterol and -oryzanol to migrate to the oil-water 
interface of emulsion droplets 42).  Fig. 10.7a shows the effect of Qc on d3,2 and RSF of O/W emulsions. The 
monodisperse emulsions formulated at different Qc shows no prominent difference in d3,2 and RSF. The size 
of emulsion droplets was independent of Qc in straight-through MCE and agreed well with previous 
findings 43). 
1.0% (w/w) 
5 mL h-1 100 m   50 m 
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We also investigated the influence of Qd on the droplet generation frequency per MC array chip (f) 
and is presented in Fig. 10.7b. f can be estimated by:  
𝑓 =  
𝑄d
Vav 
=  
6𝑄d
𝜋𝑑3,2
3                    (10.5) 
Where Qd is the dispersed phase flow rate in mL h-1 and Vav is the average droplet volume.  The 
monodisperse droplets produced at Qd of 10 mL h-1 have maximum productivity of 7.19×1014 s-1. During 
MCE, we observed more than 90% of MCs generated uniform sized droplets at Qd of 10 mL h-1. The 
droplet generation frequency from single MC (fMC) increased linearly with Qd and have fMC of 27.16 s-1 at 
Qd of 10 mL h-1 (Fig. 10.7b). The f in MCE greatly depends upon dispersed phase viscosity and can be 
increased to higher value using dispersed phases like alkanes or tetradecane 41). 
 
(a) 
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Figure 10.6: (a) Effect of disperse phase flow rate on d3,2 and RSF width of O/W emulsions 
encapsulating -sitosterol and -oryzanol. ( ) denote d3,2 and ( ) denote RSF width. (b) Droplet 
generation together with microscopic images at different dispersed phase flow rates. The arrow 
present polydisperse emulsion droplets.  
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(b) 
                             
Figure 10.7: (a) Effect of continuous phase flow rate on d3,2 and RSF width of O/W emulsions 
encapsulating -sitosterol and -oryzanol. ( ) denote d3,2 and ( ) denote RSF width. (b) The 
mean frequency of droplet generation, f as a function of the dispersed phase flow rate. ( ) denote 
frequency per MC array chip (range 1014 s-1) and ( ) shows mean frequency from a single 
microchannel. Best-fit line for whole MC array chip (R2 = 0.99): f =7 × 1013Qd +7 ×1013; Best-fit line 
for each single microchannel (R2 = 0.93): fMC =1.89Qd +7.22. 
 
Storage stability of O/W emulsion droplets encapsulating -sitosterol and -oryzanol 
Storage stability of O/W emulsion droplets encapsulating 1% (w/w) -sitosterol and -oryzanol was 
conducted at 4 and 25 ± 1oC for a period of 30 days. The storage stability was evaluated using either 1% 
(w/w) Tween 20 or 1% (w/w) ML-750 in Milli-Q water as continuous phase. The emulsion droplets were 
formulated by keeping Qd at 2 mL h-1. Immediately after the formulation all emulsions have light turbid 
appearance with good flow-ability. The physical appearance of O/W emulsions did not change during 
storage period. Fig. 10.8a shows the time changes in d3,2 and RSF width of the formulated O/W emulsions 
stabilized with 1% (w/w) Tween 20. There was hardly any change in d3,2 and RSF width of emulsions after 
30 days of storage. The d3,2 remain in ranged from 26.9 to 27.9 m  with RSF width <0.2 at 4 and 25 ± 1oC 
after 30 days of storage. Similarly, the emulsions stabilized with 1% (w/w) ML-750 (Fig. 10.8b) did not 
show any prominent change in droplet size distribution during stability evaluation, the d3,2 ranged from 
28.19 to 28.85 m  with RSF width <0.3 at 4 and 25 ± 1oC after 30 days of storage. Moreover, the 
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microscopic images (Fig. 10.8c) did not show any satellite droplets formation or coalescence during 
evaluated storage period.   
The higher stability of emulsion droplets with Tween 20 and ML-750 were due to strong 
hydrophobic moiety that stabilized the O/W interfaces for longer period of time 44). Moreover, the surface 
activity of -sitosterol and -oryzanol might attribute towards stability of emulsions droplets 42). 
Phytosterols have ability to inﬂuence the oxidative stability by themselves directly or indirectly through the 
alteration in the physical properties of the emulsion droplet due to their surface activity 45). Niraula et al. 46) 
showed that the presence of surface active agent reduces the interfacial free energy at the interface and 
thus, renders some degree of stability to the resulting emulsion system. Izadi et al. 47), reported that the 
stability of phytosterol dispersion could be correlated with the decrease in surface tension and particle size 
by using oil and emulsifier as components of oil phase. The stability results of our study correlates well 
with the study of Izadi, et al. 47). 
 
(a) 
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Figure 10.8: (a) Storage stability of O/W emulsions stabilized by 1% (w/w) Tween 20 encapsulating 
-sitosterol and -oryzanol at 4 and 25 ± 1oC. (b) Storage stability of O/W emulsions stabilized by 1% 
(w/w) ML-750 at 4 and 25 ± 1oC. ( ) denote d3,2 and ( ) denote RSF width at 4oC. ( ) shows 
d3,2  and ( ) shows RSF width at 25oC. (c) Microscopic images of O/W emulsions stabilized by 
either 1% (w/w) Tween 20 or ML-750 after 30 days of storage at 4 and 25 ± 1oC. 
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Encapsulation efficiencies of -sitosterol and -oryzanol in O/W emulsion droplets  
The freshly formulated O/W emulsions encapsulating -sitosterol and -oryzanol had initial retention of 
14.0 µg mL-1 -oryzanol and 53.5 µg mL-1 -sitosterol in emulsion system stabilized by 1% (w/w) Tween 
20. In comparison the emulsion system stabilized by 1% (w/w) ML-750 had almost similar initial retention 
of 13.8 µg mL-1 -oryzanol and 52.1 µg mL-1 -sitosterol. These initial retentions were regarded as 100% 
encapsulated efficiencies (EEs). In MCE there was difficulties in maintaining volume fraction (d) in 
comparison to conventional emulsification systems. The calculated d during MCE corresponds to 0.40%.  
Fig. 10.9 shows the EEs of -sitosterol and -oryzanol in emulsions stabilized by 1% (w/w) Tween 
20. There was slight decrease in EEs of -sitosterol with storage time (Fig. 10.9a). The O/W emulsions 
have -sitosterol EEs of more than 85% after 30 days of storage at 4 and 25 ± 1oC. Similarly, -oryzanol 
EEs of more than 80% was observed at 4oC and 86% at 25oC after 30 days of storage (Fig. 10.9b).  In 
comparison slightly less EEs were observed in emulsions stabilized by 1% (w/w) ML-750. -sitosterol EEs 
>80% was observed after 30 days of storage at 4 and 25 ± 1oC (Fig. 10.10a). More rapid decline in -
oryzanol EEs were noticed in emulsions stabilized with ML-750. After 30 days of storage, these emulsions 
have -oryzanol EEs around 50% at 4 and 25 ± 1oC (Fig. 10.10b). 
The decrease of -oryzanol EEs in emulsions stabilized by ML-750 can be attributed to the 
interaction of ML-750 with -oryzanol. The thinning of interfacial layer around emulsion droplets with 
storage time allows the partitioning of -oryzanol from oil phase to water phase. It is also possible that 
exchange phenomenan occur where -oryzanol is degraded in the water phase and re-partitions into the oil 
phase, especially at 25oC  48). Good EEs > 60% of -oryzanol in solid lipid nanoparticles (SLNs) were 
reported by Ruktanonchai et al. 49), their study shows that %EE of -oryzanol was strongly dependent on 
the type of solid lipid used. Hassani et al. 50) Prepared lecithin stabilized nanoliposomes encapsulating -
oryzanol and reported EE over 80% after 60 days of storage. The high EEs of -sitosterol with different 
emulsifiers can be correlated with stronger surface activity of -sitosterol 42).  This surface activity allow -
sitosterol to migrate at oil-water interface and restrict its partitioning between oil and water phase 42). The 
EEs in present study correlates well with the previous EEs of bioactives in MCE. The EE of L-ascorbic 
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acid in different emulsions prepared through MCE was more 80% after 10 d of storage period at 4oC 21). 
This high EE can be correlated with high degree of monodispersity in the emulsion system.  
(a) 
 
 
(b) 
                                        
Figure 10.9: Retention and encapsulating efficiencies (EEs) of -sitosterol and -oryzanol 
encapsulated O/W emulsions at 4 and 25 ± 1oC stabilized by 1% (w/w) Tween 20. (a)-sitosterol, 
(b)-oryzanol. ( ) denote -sitosterol and -oryzanol retention at 4oC ( ) denote -sitosterol and 
-oryzanol (EEs) at 4oC. ( ) -sitosterol and -oryzanol retention at and ( ) shows -sitosterol 
and -oryzanol (EEs) at 25oC. 
 
 
 
 
 
 
 
 
 
 
 250 
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(b) 
 
 
Figure 10.10: Retention and encapsulating efficiencies (EEs) of -sitosterol and -oryzanol 
encapsulated O/W emulsions at 4 and 25 ± 1oC stabilized by 1% (w/w) ML-750. (a)-sitosterol (b)-
oryzanol. ( ) denote -sitosterol and -oryzanol retention at 4oC ( ) denote -sitosterol and -
oryzanol (EEs) at 4oC. ( ) -sitosterol and -oryzanol retention at and ( ) shows -sitosterol 
and -oryzanol (EEs) at 25oC. 
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Chapter 2 deals with the formulation of monodisperse food-grade W/O/W emulsions loaded with a high 
concentration of L-AA in inner aqueous droplets through rotor-stator homogenization and subsequent 
MCE. The key point of this chapter is stable generation of uniformly sized W/O droplets that encapsulate a 
high concentration of L-AA via an asymmetric straight-through MC array, without visible leakage and 
breakage of inner aqueous droplets during MCE. Successful MCE is achieved under appropriate 
concentrations of the hydrophobic emulsifier added in the oil phase and the hydrophilic emulsifier added in 
the outer aqueous phase. Slight increases in W/O droplet size during storage may be attributed to slight and 
slow swelling of inner aqueous droplets. The formulated W/O/W emulsions had longer physical stability 
with L-AA retention during storage.  
Chapter 3 focuses on preparation of monodisperse aqueous microspheres loaded with L-AA using 
MCE. The methodology presented in this study enables producing encapsulated nutraceutical products 
containing high concentrations of L-AA. Appropriate control of Na-alginate and MgSO4 concentrations, 
compositions of the disperse and continuous phases, and operating conditions are needed to prepare stable 
monodisperse aqueous microspheres containing high concentrations of L-AA via MC arrays. The 
successful composition includes 1% (w/w) MgSO4, 2% (w/w) Na-alginate, and a maximum L-AA 
concentration of 30% (w/w). The results also indicated that partial linkage of Mg2+ ions with Na-alginate 
could develop a soft gel-like structure, resulting in smooth detachment and generation of microspheres 
from MC arrays. Uniformly sized aqueous microspheres generated under mild processing conditions with 
MCE could increase the encapsulation efficiency and storage stability of L-AA in different food and 
pharmaceutical products. The through-put studies with straight through MCE concludes optimized 
emulsification conditions at 20% (w/w) L-AA, 2% (w/w) Na-alginate and 1% (w/w) Mg2SO4 in the 
dispersed phase under Jd of 5 L m-2 h-1, while 5% (w/w) TGCR in water-saturated decane as the continuous 
phase. The resultant microspheres have good physical and chemical stability for more than 10 d at 40 oC. 
Moreover, they exhibit high EE of more than 70% during 10 d of evaluated period at 40 oC.  
Chapter 4 shows food-grade W/O emulsions containing L-AA up to 30% (w/v) in the dispersed 
aqueous phase using conventional approach. Adequate homogenization conditions enabled preparing W/O 
emulsions with an L-AA retention rate > 95%, regardless of L-AA concentration. The prepared W/O 
emulsions containing high concentration of L-AA were well stabilized at 4 and 25oC for more than 30 d 
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with good organoleptic profile. All prepared W/O emulsions showed relatively higher retention of ~50% at 
4oC and ~30% at 25oC after 30 d storage with first order kinetic fitting.  These findings were not affected 
by the type of oil used in this study. The above retention time could be further improved by using mixed 
emulsifier system or addition of some bulking agents like gelatin that increase the viscosity of dispersed 
phase.  
Chapter 5 deals with food-grade W/O/W emulsions containing a high concentration of L-AA using 
conventional emulsification system and selected compositions, including gelatin in the inner aqueous phase 
and glucose in both aqueous phases. In particular, the formulations containing gelatin contributed to better 
flowability and higher L-AA retention. The prepared W/O/W emulsions containing high concentrations of 
L-AA were physically stable with slight changes in droplet size and size distribution during 35 d of storage 
at 4 oC. The W/O/W emulsions also demonstrated relatively high retention of L-AA after 30 d of storage, 
and their retention kinetics followed a first-order kinetics equation. 
Chapter 6 shows monodisperse food-grade O/W emulsions loaded with ergocalciferol using 
grooved and straight through MCE. The key point of this research is stable generation of uniformly sized 
O/W droplets that encapsulate ergocalciferol via an asymmetric straight-through MC array, without any 
coalescence or wetting of dispersed phase during MCE. Successful grooved type MCE is achieved with 
different food grade vegetable oils and emulsifiers, when used at 1% (w/w) in Milli-Q water. The high 
through put studies with straight through MCE indicates successful operating conditions under low 
dispersed phase flux at 5 L m-2 h-1 and under 1% (w/w) Tween 20 as optimum emulsifier in Milli-Q water. 
There was hardly any increase in mean droplet diameter during 15 d of storage period. The formulated 
emulsions containing erogcalciferol have encapsulating efficiency of more than 85% after 10 d of storage 
time. The better physical and chemical stability correlates well with the monodispersity of system.  
Chapter 7 shows food grade monodisperse O/W emulsions containing both ergocalciferol and 
cholecalciferol using straight through MCE. In this study uniform sized emulsion droplets were stably 
generated via an asymmetric straight-through MC array, without any significant wetting or outflow of 
dispersed phase at optimum processing conditions. The optimum emulsification conditions evolves low 
dispersed phase flux at 10 L m-2 h-1 and under 1% (w/w) Tween 20 as potential hydrophilic emulsifier in 
Milli-Q water. The formulated emulsion droplets have good stability of more than 15 d at 4 and 25oC. 
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Moreover, they exhibit a good encapsulation efficiency of more than 65-75% at 4 and 25oC and during 
evaluated storage period.  
Chapter 8 utilizes both rotor-stator homogenizer (RSH) and high pressure homogenization (HPH) 
to fabricate both ergocalciferol and cholecalciferol emulsions. Moreover, the effect of different food grade 
oils on vitamin D emulsions was thoroughly studied. Nevertheless, there are studies that predicted the 
release profile of vitamin D in different nanoparticles, but there were no reports that describe the release 
profile of both ergocalciferol and cholecalciferol in emulsions prepared with RSH and HPH. This study 
showed that O/W emulsions formulated from RSH or HPH offers an inexpensive means to encapsulate 
vitamin D. Moreover, the formulation of these simple emulsion techniques is easily adoptable at industrial 
level. The study showed that droplet size of O/W emulsions encapsulating vitamin D depends upon 
homogenization speed and homogenization type. HPH significant reduces the droplet size to sub-micron 
level, yet polydispersity is the major problem in both types of homogenization techniques. The HPH 
stabilize the O/W emulsions to longer period of time without any significant deformation, on the other hand 
RSH at low speed destabilized the emulsions due to Oswald ripening and flocculation. Moreover, the study 
concluded that homogenization techniques have no marked effect on encapsulation efficiencies of vitamin 
D loaded emulsions. The prepared emulsions either with rotor-stator or high pressure homogenization 
retains about 50% of ergocalciferol and cholecalciferol after 7 d of storage at 4oC, afterwards followed 
rapid decline in encapsulation efficiencies.  
Chapter 9 deals with quercetin encapsulation. Quercetin has been claimed to have countless health 
benefits, but its poor solubility in aqeous solutions, low bioavailability, low permeability, cystallization and 
hydrophobic nature limits its applications in food products. The chapter demonstrated successful 
formulation of food grade O/W emulsions encapsulating quercetin through straight-through MCE. 
Quercetin at concentration of 0.4 mg mL-1 in different food grade oils does not influence the emulsion 
formation and monodispersity. The optimized production parameters includes dispersed phase flux of 20-
40 L m-2 h-1 and continuous flow velocity ranging between 5.0 mm s-1 to 20.0 mm s-1. The study also 
investigate the effect of different emulsifiers and conclude non-ionic emulsifiers as optimum emulsifiers 
that influence the storage stability. Protein based emulsifiers and ionic emulsifiers althrough produces 
monondisperse emulsion droplets but have impact on droplet size during storage at 4 and 25 oC. The 
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formulated O/W emulsions with 1% (w/w) Tween 20 have encapsulation efficiency of more than 80% and 
70% at 4 and 25oC after 30 d of storage. The better physical and chemical stability points the 
monodispersity of emulsions generated from MCE. Moreover, these emulsions were generated under 
extreme mild conditions with energy efficiency corresponds to 27.5%.  
Chapter 10 shows food grade monodisperse O/W emulsions encapsulating both -sitosterol and -
oryzanol using straight-through MCE. The optimized dispersed phase composition include 1% (w/w) -
sitosterol and -oryzanol in MCT, while 1% (w/w) Tween 20 in Milli-Q water as optimized continuous 
phase. The optimum MCE conditions evolves low dispersed phase flow rate of 2 mL h-1 with varying flow 
rate of continuous phase. These optimized conditions produces uniform sized emulsion droplets via an 
asymmetric straight-through MC array, without any outflow of dispersed phase. The formulated emulsion 
droplets have good stability of more than 30 d at 4 and 25 oC. Moreover, the formulated emulsions with -
sitosterol and -oryzanol have a good encapsulation efficiency of more than 80% at 4 and 25oC during 30 d 
of storage period.  
The research indicate that MCE is a promising technique for encapsulating bioactive compounds, 
with superior control of processing parameters and various other physical conditions. The forthcoming 
scaling up of MCE devices is expected to further improve the quality of different emulsions and make 
practical their production on industrial scales. 
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